#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Reward and executive control network resting-state functional connectivity is associated with impulsivity during reward-based decision making for cocaine users
#Text=Background:
#Text=Cocaine addiction is related to impulsive decision making that is mediated by brain circuitry involved in reward processing and executive functions, such as cognitive control and attentional salience.
1-1	0-6	Reward	_	
1-2	7-10	and	_	
1-3	11-20	executive	_	
1-4	21-28	control	_	
1-5	29-36	network	_	
1-6	37-50	resting-state	_	
1-7	51-61	functional	_	
1-8	62-74	connectivity	_	
1-9	75-77	is	_	
1-10	78-88	associated	_	
1-11	89-93	with	_	
1-12	94-105	impulsivity	_	
1-13	106-112	during	_	
1-14	113-125	reward-based	_	
1-15	126-134	decision	_	
1-16	135-141	making	_	
1-17	142-145	for	_	
1-18	146-153	cocaine	_	
1-19	154-159	users	_	
1-20	160-170	Background	_	
1-21	170-171	:	_	
1-22	172-179	Cocaine	_	
1-23	180-189	addiction	_	
1-24	190-192	is	_	
1-25	193-200	related	_	
1-26	201-203	to	_	
1-27	204-213	impulsive	_	
1-28	214-222	decision	_	
1-29	223-229	making	_	
1-30	230-234	that	_	
1-31	235-237	is	_	
1-32	238-246	mediated	_	
1-33	247-249	by	_	
1-34	250-255	brain	_	
1-35	256-265	circuitry	_	
1-36	266-274	involved	_	
1-37	275-277	in	_	
1-38	278-284	reward	_	
1-39	285-295	processing	_	
1-40	296-299	and	_	
1-41	300-309	executive	_	
1-42	310-319	functions	_	
1-43	319-320	,	_	
1-44	321-325	such	_	
1-45	326-328	as	_	
1-46	329-338	cognitive	_	
1-47	339-346	control	_	
1-48	347-350	and	_	
1-49	351-362	attentional	_	
1-50	363-371	salience	_	
1-51	371-372	.	_	

#Text=Resting-state functional connectivity between reward and executive control circuitry is altered among cocaine users, with concomitant deficits in impulsivity and learning.
2-1	373-386	Resting-state	_	
2-2	387-397	functional	_	
2-3	398-410	connectivity	_	
2-4	411-418	between	_	
2-5	419-425	reward	_	
2-6	426-429	and	_	
2-7	430-439	executive	_	
2-8	440-447	control	_	
2-9	448-457	circuitry	_	
2-10	458-460	is	_	
2-11	461-468	altered	_	
2-12	469-474	among	_	
2-13	475-482	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[1]	
2-14	483-488	users	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[1]	
2-15	488-489	,	_	
2-16	490-494	with	_	
2-17	495-506	concomitant	_	
2-18	507-515	deficits	_	
2-19	516-518	in	_	
2-20	519-530	impulsivity	_	
2-21	531-534	and	_	
2-22	535-543	learning	_	
2-23	543-544	.	_	

#Text=Prior research has examined how select brain regions interact to influence impulsive decision making for drug users; however, research examining interactions between large-scale brain networks and impulsive behavior is limited.
3-1	545-550	Prior	_	
3-2	551-559	research	_	
3-3	560-563	has	_	
3-4	564-572	examined	_	
3-5	573-576	how	_	
3-6	577-583	select	_	
3-7	584-589	brain	_	
3-8	590-597	regions	_	
3-9	598-606	interact	_	
3-10	607-609	to	_	
3-11	610-619	influence	_	
3-12	620-629	impulsive	_	
3-13	630-638	decision	_	
3-14	639-645	making	_	
3-15	646-649	for	_	
3-16	650-654	drug	_	
3-17	655-660	users	_	
3-18	660-661	;	_	
3-19	662-669	however	_	
3-20	669-670	,	_	
3-21	671-679	research	_	
3-22	680-689	examining	_	
3-23	690-702	interactions	_	
3-24	703-710	between	_	
3-25	711-722	large-scale	_	
3-26	723-728	brain	_	
3-27	729-737	networks	_	
3-28	738-741	and	_	
3-29	742-751	impulsive	_	
3-30	752-760	behavior	_	
3-31	761-763	is	_	
3-32	764-771	limited	_	
3-33	771-772	.	_	

#Text=Methods:
#Text=The current study compared reward and executive control network resting-state functional connectivity and its relationship to impulsive decision making between cocaine users (n=37) and non-cocaine using control participants (n=35).
4-1	773-780	Methods	_	
4-2	780-781	:	_	
4-3	782-785	The	_	
4-4	786-793	current	_	
4-5	794-799	study	_	
4-6	800-808	compared	_	
4-7	809-815	reward	_	
4-8	816-819	and	_	
4-9	820-829	executive	_	
4-10	830-837	control	_	
4-11	838-845	network	_	
4-12	846-859	resting-state	_	
4-13	860-870	functional	_	
4-14	871-883	connectivity	_	
4-15	884-887	and	_	
4-16	888-891	its	_	
4-17	892-904	relationship	_	
4-18	905-907	to	_	
4-19	908-917	impulsive	_	
4-20	918-926	decision	_	
4-21	927-933	making	_	
4-22	934-941	between	_	
4-23	942-949	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[2]	
4-24	950-955	users	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[2]	
4-25	956-957	(	_	
4-26	957-958	n	_	
4-27	958-959	=	_	
4-28	959-961	37	_	
4-29	961-962	)	_	
4-30	963-966	and	_	
4-31	967-978	non-cocaine	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-32	979-984	using	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[3]	
4-33	985-992	control	_	
4-34	993-1005	participants	_	
4-35	1006-1007	(	_	
4-36	1007-1008	n	_	
4-37	1008-1009	=	_	
4-38	1009-1011	35	_	
4-39	1011-1012	)	_	
4-40	1012-1013	.	_	

#Text=Participants completed computerized decision-making tasks and a separate resting-state functional magnetic resonance imaging scan.
5-1	1014-1026	Participants	_	
5-2	1027-1036	completed	_	
5-3	1037-1049	computerized	_	
5-4	1050-1065	decision-making	_	
5-5	1066-1071	tasks	_	
5-6	1072-1075	and	_	
5-7	1076-1077	a	_	
5-8	1078-1086	separate	_	
5-9	1087-1100	resting-state	_	
5-10	1101-1111	functional	_	
5-11	1112-1120	magnetic	_	
5-12	1121-1130	resonance	_	
5-13	1131-1138	imaging	_	
5-14	1139-1143	scan	_	
5-15	1143-1144	.	_	

#Text=Data underwent independent component, dual regression, and linear regression moderation analyses.
6-1	1145-1149	Data	_	
6-2	1150-1159	underwent	_	
6-3	1160-1171	independent	_	
6-4	1172-1181	component	_	
6-5	1181-1182	,	_	
6-6	1183-1187	dual	_	
6-7	1188-1198	regression	_	
6-8	1198-1199	,	_	
6-9	1200-1203	and	_	
6-10	1204-1210	linear	_	
6-11	1211-1221	regression	_	
6-12	1222-1232	moderation	_	
6-13	1233-1241	analyses	_	
6-14	1241-1242	.	_	

#Text=Results:
#Text=Higher impulsivity on the Balloon Analogue Risk Task (BART) was associated with inverse resting-state connectivity between the left cognitive control and subgenual anterior cingulate extended reward networks for cocaine users, while the opposite was found for controls.
7-1	1243-1250	Results	_	
7-2	1250-1251	:	_	
7-3	1252-1258	Higher	_	
7-4	1259-1270	impulsivity	_	
7-5	1271-1273	on	_	
7-6	1274-1277	the	_	
7-7	1278-1285	Balloon	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask[4]	
7-8	1286-1294	Analogue	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask[4]	
7-9	1295-1299	Risk	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask[4]	
7-10	1300-1304	Task	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask[4]	
7-11	1305-1306	(	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask[4]	
7-12	1306-1310	BART	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask[4]	
7-13	1310-1311	)	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask[4]	
7-14	1312-1315	was	_	
7-15	1316-1326	associated	_	
7-16	1327-1331	with	_	
7-17	1332-1339	inverse	_	
7-18	1340-1353	resting-state	_	
7-19	1354-1366	connectivity	_	
7-20	1367-1374	between	_	
7-21	1375-1378	the	_	
7-22	1379-1383	left	_	
7-23	1384-1393	cognitive	_	
7-24	1394-1401	control	_	
7-25	1402-1405	and	_	
7-26	1406-1415	subgenual	_	
7-27	1416-1424	anterior	_	
7-28	1425-1434	cingulate	_	
7-29	1435-1443	extended	_	
7-30	1444-1450	reward	_	
7-31	1451-1459	networks	_	
7-32	1460-1463	for	_	
7-33	1464-1471	cocaine	_	
7-34	1472-1477	users	_	
7-35	1477-1478	,	_	
7-36	1479-1484	while	_	
7-37	1485-1488	the	_	
7-38	1489-1497	opposite	_	
7-39	1498-1501	was	_	
7-40	1502-1507	found	_	
7-41	1508-1511	for	_	
7-42	1512-1520	controls	_	
7-43	1520-1521	.	_	

#Text=Less impulsivity on the monetary choice questionnaire was associated with stronger positive resting-state connectivity between the attentional salience and striatal core reward networks for controls, while cocaine users showed no association between impulsivity and resting-state connectivity of these networks.
8-1	1522-1526	Less	_	
8-2	1527-1538	impulsivity	_	
8-3	1539-1541	on	_	
8-4	1542-1545	the	_	
8-5	1546-1554	monetary	_	
8-6	1555-1561	choice	_	
8-7	1562-1575	questionnaire	_	
8-8	1576-1579	was	_	
8-9	1580-1590	associated	_	
8-10	1591-1595	with	_	
8-11	1596-1604	stronger	_	
8-12	1605-1613	positive	_	
8-13	1614-1627	resting-state	_	
8-14	1628-1640	connectivity	_	
8-15	1641-1648	between	_	
8-16	1649-1652	the	_	
8-17	1653-1664	attentional	_	
8-18	1665-1673	salience	_	
8-19	1674-1677	and	_	
8-20	1678-1686	striatal	_	
8-21	1687-1691	core	_	
8-22	1692-1698	reward	_	
8-23	1699-1707	networks	_	
8-24	1708-1711	for	_	
8-25	1712-1720	controls	_	
8-26	1720-1721	,	_	
8-27	1722-1727	while	_	
8-28	1728-1735	cocaine	_	
8-29	1736-1741	users	_	
8-30	1742-1748	showed	_	
8-31	1749-1751	no	_	
8-32	1752-1763	association	_	
8-33	1764-1771	between	_	
8-34	1772-1783	impulsivity	_	
8-35	1784-1787	and	_	
8-36	1788-1801	resting-state	_	
8-37	1802-1814	connectivity	_	
8-38	1815-1817	of	_	
8-39	1818-1823	these	_	
8-40	1824-1832	networks	_	
8-41	1832-1833	.	_	

#Text=Conclusions:
#Text=Cocaine users show aberrant associations between reward-executive control resting-state network coupling and impulsive decision making.
9-1	1834-1845	Conclusions	_	
9-2	1845-1846	:	_	
9-3	1847-1854	Cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[5]	
9-4	1855-1860	users	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[5]	
9-5	1861-1865	show	_	
9-6	1866-1874	aberrant	_	
9-7	1875-1887	associations	_	
9-8	1888-1895	between	_	
9-9	1896-1912	reward-executive	_	
9-10	1913-1920	control	_	
9-11	1921-1934	resting-state	_	
9-12	1935-1942	network	_	
9-13	1943-1951	coupling	_	
9-14	1952-1955	and	_	
9-15	1956-1965	impulsive	_	
9-16	1966-1974	decision	_	
9-17	1975-1981	making	_	
9-18	1981-1982	.	_	

#Text=The findings support the conclusion that an imbalance between reward and executive control circuitry contributes to impulsivity in drug use.
10-1	1983-1986	The	_	
10-2	1987-1995	findings	_	
10-3	1996-2003	support	_	
10-4	2004-2007	the	_	
10-5	2008-2018	conclusion	_	
10-6	2019-2023	that	_	
10-7	2024-2026	an	_	
10-8	2027-2036	imbalance	_	
10-9	2037-2044	between	_	
10-10	2045-2051	reward	_	
10-11	2052-2055	and	_	
10-12	2056-2065	executive	_	
10-13	2066-2073	control	_	
10-14	2074-2083	circuitry	_	
10-15	2084-2095	contributes	_	
10-16	2096-2098	to	_	
10-17	2099-2110	impulsivity	_	
10-18	2111-2113	in	_	
10-19	2114-2118	drug	_	
10-20	2119-2122	use	_	
10-21	2122-2123	.	_	

#Text=Introduction
#Text=Addiction is characterized by impulsive decision making that can lead to harmful longterm consequences.
11-1	2124-2136	Introduction	_	
11-2	2137-2146	Addiction	_	
11-3	2147-2149	is	_	
11-4	2150-2163	characterized	_	
11-5	2164-2166	by	_	
11-6	2167-2176	impulsive	_	
11-7	2177-2185	decision	_	
11-8	2186-2192	making	_	
11-9	2193-2197	that	_	
11-10	2198-2201	can	_	
11-11	2202-2206	lead	_	
11-12	2207-2209	to	_	
11-13	2210-2217	harmful	_	
11-14	2218-2226	longterm	_	
11-15	2227-2239	consequences	_	
11-16	2239-2240	.	_	

#Text=The progression from controlled, voluntary drug use to compulsive drug taking has been described as a shift from flexible prefrontal cortical control to automatic responding driven by corticostriatal circuitry.
12-1	2241-2244	The	_	
12-2	2245-2256	progression	_	
12-3	2257-2261	from	_	
12-4	2262-2272	controlled	_	
12-5	2272-2273	,	_	
12-6	2274-2283	voluntary	_	
12-7	2284-2288	drug	_	
12-8	2289-2292	use	_	
12-9	2293-2295	to	_	
12-10	2296-2306	compulsive	_	
12-11	2307-2311	drug	_	
12-12	2312-2318	taking	_	
12-13	2319-2322	has	_	
12-14	2323-2327	been	_	
12-15	2328-2337	described	_	
12-16	2338-2340	as	_	
12-17	2341-2342	a	_	
12-18	2343-2348	shift	_	
12-19	2349-2353	from	_	
12-20	2354-2362	flexible	_	
12-21	2363-2373	prefrontal	_	
12-22	2374-2382	cortical	_	
12-23	2383-2390	control	_	
12-24	2391-2393	to	_	
12-25	2394-2403	automatic	_	
12-26	2404-2414	responding	_	
12-27	2415-2421	driven	_	
12-28	2422-2424	by	_	
12-29	2425-2440	corticostriatal	_	
12-30	2441-2450	circuitry	_	
12-31	2450-2451	.	_	

#Text=The brain circuits that are implicated in addiction comprise several intrinsic functional neural networks that coordinate decision-making and learning.
13-1	2452-2455	The	_	
13-2	2456-2461	brain	_	
13-3	2462-2470	circuits	_	
13-4	2471-2475	that	_	
13-5	2476-2479	are	_	
13-6	2480-2490	implicated	_	
13-7	2491-2493	in	_	
13-8	2494-2503	addiction	_	
13-9	2504-2512	comprise	_	
13-10	2513-2520	several	_	
13-11	2521-2530	intrinsic	_	
13-12	2531-2541	functional	_	
13-13	2542-2548	neural	_	
13-14	2549-2557	networks	_	
13-15	2558-2562	that	_	
13-16	2563-2573	coordinate	_	
13-17	2574-2589	decision-making	_	
13-18	2590-2593	and	_	
13-19	2594-2602	learning	_	
13-20	2602-2603	.	_	

#Text=Measuring spontaneous, low-frequency fluctuations in neural activity throughout the brain during rest, commonly called resting-state functional connectivity (rsFC), provides a snapshot of the strength of functional connections between neural networks.
14-1	2604-2613	Measuring	_	
14-2	2614-2625	spontaneous	_	
14-3	2625-2626	,	_	
14-4	2627-2640	low-frequency	_	
14-5	2641-2653	fluctuations	_	
14-6	2654-2656	in	_	
14-7	2657-2663	neural	_	
14-8	2664-2672	activity	_	
14-9	2673-2683	throughout	_	
14-10	2684-2687	the	_	
14-11	2688-2693	brain	_	
14-12	2694-2700	during	_	
14-13	2701-2705	rest	_	
14-14	2705-2706	,	_	
14-15	2707-2715	commonly	_	
14-16	2716-2722	called	_	
14-17	2723-2736	resting-state	_	
14-18	2737-2747	functional	_	
14-19	2748-2760	connectivity	_	
14-20	2761-2762	(	_	
14-21	2762-2766	rsFC	_	
14-22	2766-2767	)	_	
14-23	2767-2768	,	_	
14-24	2769-2777	provides	_	
14-25	2778-2779	a	_	
14-26	2780-2788	snapshot	_	
14-27	2789-2791	of	_	
14-28	2792-2795	the	_	
14-29	2796-2804	strength	_	
14-30	2805-2807	of	_	
14-31	2808-2818	functional	_	
14-32	2819-2830	connections	_	
14-33	2831-2838	between	_	
14-34	2839-2845	neural	_	
14-35	2846-2854	networks	_	
14-36	2854-2855	.	_	

#Text=Addiction is associated with altered functional connectivity within corticostriatal networks that manage reward expectancies and learning, as well as executive control networks involved in attentional salience and cognitive control.
15-1	2856-2865	Addiction	_	
15-2	2866-2868	is	_	
15-3	2869-2879	associated	_	
15-4	2880-2884	with	_	
15-5	2885-2892	altered	_	
15-6	2893-2903	functional	_	
15-7	2904-2916	connectivity	_	
15-8	2917-2923	within	_	
15-9	2924-2939	corticostriatal	_	
15-10	2940-2948	networks	_	
15-11	2949-2953	that	_	
15-12	2954-2960	manage	_	
15-13	2961-2967	reward	_	
15-14	2968-2980	expectancies	_	
15-15	2981-2984	and	_	
15-16	2985-2993	learning	_	
15-17	2993-2994	,	_	
15-18	2995-2997	as	_	
15-19	2998-3002	well	_	
15-20	3003-3005	as	_	
15-21	3006-3015	executive	_	
15-22	3016-3023	control	_	
15-23	3024-3032	networks	_	
15-24	3033-3041	involved	_	
15-25	3042-3044	in	_	
15-26	3045-3056	attentional	_	
15-27	3057-3065	salience	_	
15-28	3066-3069	and	_	
15-29	3070-3079	cognitive	_	
15-30	3080-3087	control	_	
15-31	3087-3088	.	_	

#Text=Compared to non-drug-using controls, cocaine users have reduced connectivity within corticostriatal reward circuitry, which is predictive of compulsive drug use and relapse.
16-1	3089-3097	Compared	_	
16-2	3098-3100	to	_	
16-3	3101-3115	non-drug-using	_	
16-4	3116-3124	controls	_	
16-5	3124-3125	,	_	
16-6	3126-3133	cocaine	_	
16-7	3134-3139	users	_	
16-8	3140-3144	have	_	
16-9	3145-3152	reduced	_	
16-10	3153-3165	connectivity	_	
16-11	3166-3172	within	_	
16-12	3173-3188	corticostriatal	_	
16-13	3189-3195	reward	_	
16-14	3196-3205	circuitry	_	
16-15	3205-3206	,	_	
16-16	3207-3212	which	_	
16-17	3213-3215	is	_	
16-18	3216-3226	predictive	_	
16-19	3227-3229	of	_	
16-20	3230-3240	compulsive	_	
16-21	3241-3245	drug	_	
16-22	3246-3249	use	_	
16-23	3250-3253	and	_	
16-24	3254-3261	relapse	_	
16-25	3261-3262	.	_	

#Text=The core and extended reward networks are two distinct functional networks along the mesostriatal and mesolimbic dopamine pathways, respectively.
17-1	3263-3266	The	_	
17-2	3267-3271	core	_	
17-3	3272-3275	and	_	
17-4	3276-3284	extended	_	
17-5	3285-3291	reward	_	
17-6	3292-3300	networks	_	
17-7	3301-3304	are	_	
17-8	3305-3308	two	_	
17-9	3309-3317	distinct	_	
17-10	3318-3328	functional	_	
17-11	3329-3337	networks	_	
17-12	3338-3343	along	_	
17-13	3344-3347	the	_	
17-14	3348-3360	mesostriatal	_	
17-15	3361-3364	and	_	
17-16	3365-3375	mesolimbic	_	
17-17	3376-3384	dopamine	_	
17-18	3385-3393	pathways	_	
17-19	3393-3394	,	_	
17-20	3395-3407	respectively	_	
17-21	3407-3408	.	_	

#Text=The core reward network is comprised of the thalamus and basal ganglia, including the dorsal and ventral striatum, regions that are often implicated in reactivity to drug use and drug cues.
18-1	3409-3412	The	_	
18-2	3413-3417	core	_	
18-3	3418-3424	reward	_	
18-4	3425-3432	network	_	
18-5	3433-3435	is	_	
18-6	3436-3445	comprised	_	
18-7	3446-3448	of	_	
18-8	3449-3452	the	_	
18-9	3453-3461	thalamus	_	
18-10	3462-3465	and	_	
18-11	3466-3471	basal	_	
18-12	3472-3479	ganglia	_	
18-13	3479-3480	,	_	
18-14	3481-3490	including	_	
18-15	3491-3494	the	_	
18-16	3495-3501	dorsal	_	
18-17	3502-3505	and	_	
18-18	3506-3513	ventral	_	
18-19	3514-3522	striatum	_	
18-20	3522-3523	,	_	
18-21	3524-3531	regions	_	
18-22	3532-3536	that	_	
18-23	3537-3540	are	_	
18-24	3541-3546	often	_	
18-25	3547-3557	implicated	_	
18-26	3558-3560	in	_	
18-27	3561-3571	reactivity	_	
18-28	3572-3574	to	_	
18-29	3575-3579	drug	_	
18-30	3580-3583	use	_	
18-31	3584-3587	and	_	
18-32	3588-3592	drug	_	
18-33	3593-3597	cues	_	
18-34	3597-3598	.	_	

#Text=Acute drug administration alters neurotransmitter activity throughout this network and ultimately changes voluntary drug use into the compulsive drug taking behavior that is characteristic of addiction.
19-1	3599-3604	Acute	_	
19-2	3605-3609	drug	_	
19-3	3610-3624	administration	_	
19-4	3625-3631	alters	_	
19-5	3632-3648	neurotransmitter	_	
19-6	3649-3657	activity	_	
19-7	3658-3668	throughout	_	
19-8	3669-3673	this	_	
19-9	3674-3681	network	_	
19-10	3682-3685	and	_	
19-11	3686-3696	ultimately	_	
19-12	3697-3704	changes	_	
19-13	3705-3714	voluntary	_	
19-14	3715-3719	drug	_	
19-15	3720-3723	use	_	
19-16	3724-3728	into	_	
19-17	3729-3732	the	_	
19-18	3733-3743	compulsive	_	
19-19	3744-3748	drug	_	
19-20	3749-3755	taking	_	
19-21	3756-3764	behavior	_	
19-22	3765-3769	that	_	
19-23	3770-3772	is	_	
19-24	3773-3787	characteristic	_	
19-25	3788-3790	of	_	
19-26	3791-3800	addiction	_	
19-27	3800-3801	.	_	

#Text=The core reward network is functionally connected to an extended reward network consisting of the subgenual anterior cingulate cortex (ACC), medial orbitofrontal cortex (OFC), and medial prefrontal cortex (PFC).
20-1	3802-3805	The	_	
20-2	3806-3810	core	_	
20-3	3811-3817	reward	_	
20-4	3818-3825	network	_	
20-5	3826-3828	is	_	
20-6	3829-3841	functionally	_	
20-7	3842-3851	connected	_	
20-8	3852-3854	to	_	
20-9	3855-3857	an	_	
20-10	3858-3866	extended	_	
20-11	3867-3873	reward	_	
20-12	3874-3881	network	_	
20-13	3882-3892	consisting	_	
20-14	3893-3895	of	_	
20-15	3896-3899	the	_	
20-16	3900-3909	subgenual	_	
20-17	3910-3918	anterior	_	
20-18	3919-3928	cingulate	_	
20-19	3929-3935	cortex	_	
20-20	3936-3937	(	_	
20-21	3937-3940	ACC	_	
20-22	3940-3941	)	_	
20-23	3941-3942	,	_	
20-24	3943-3949	medial	_	
20-25	3950-3963	orbitofrontal	_	
20-26	3964-3970	cortex	_	
20-27	3971-3972	(	_	
20-28	3972-3975	OFC	_	
20-29	3975-3976	)	_	
20-30	3976-3977	,	_	
20-31	3978-3981	and	_	
20-32	3982-3988	medial	_	
20-33	3989-3999	prefrontal	_	
20-34	4000-4006	cortex	_	
20-35	4007-4008	(	_	
20-36	4008-4011	PFC	_	
20-37	4011-4012	)	_	
20-38	4012-4013	.	_	

#Text=The extended reward network is involved in the valuation and anticipation of drug rewards and drives drug urges and preoccupation with use, especially during withdrawal.
21-1	4014-4017	The	_	
21-2	4018-4026	extended	_	
21-3	4027-4033	reward	_	
21-4	4034-4041	network	_	
21-5	4042-4044	is	_	
21-6	4045-4053	involved	_	
21-7	4054-4056	in	_	
21-8	4057-4060	the	_	
21-9	4061-4070	valuation	_	
21-10	4071-4074	and	_	
21-11	4075-4087	anticipation	_	
21-12	4088-4090	of	_	
21-13	4091-4095	drug	_	
21-14	4096-4103	rewards	_	
21-15	4104-4107	and	_	
21-16	4108-4114	drives	_	
21-17	4115-4119	drug	_	
21-18	4120-4125	urges	_	
21-19	4126-4129	and	_	
21-20	4130-4143	preoccupation	_	
21-21	4144-4148	with	_	
21-22	4149-4152	use	_	
21-23	4152-4153	,	_	
21-24	4154-4164	especially	_	
21-25	4165-4171	during	_	
21-26	4172-4182	withdrawal	_	
21-27	4182-4183	.	_	

#Text=Cocaine users also show altered functional connectivity within select cortical brain regions associated with executive control, including the cognitive control and attentional salience networks.
22-1	4184-4191	Cocaine	_	
22-2	4192-4197	users	_	
22-3	4198-4202	also	_	
22-4	4203-4207	show	_	
22-5	4208-4215	altered	_	
22-6	4216-4226	functional	_	
22-7	4227-4239	connectivity	_	
22-8	4240-4246	within	_	
22-9	4247-4253	select	_	
22-10	4254-4262	cortical	_	
22-11	4263-4268	brain	_	
22-12	4269-4276	regions	_	
22-13	4277-4287	associated	_	
22-14	4288-4292	with	_	
22-15	4293-4302	executive	_	
22-16	4303-4310	control	_	
22-17	4310-4311	,	_	
22-18	4312-4321	including	_	
22-19	4322-4325	the	_	
22-20	4326-4335	cognitive	_	
22-21	4336-4343	control	_	
22-22	4344-4347	and	_	
22-23	4348-4359	attentional	_	
22-24	4360-4368	salience	_	
22-25	4369-4377	networks	_	
22-26	4377-4378	.	_	

#Text=The bilateral frontoparietal cortices encompassing the dorsolateral PFC (DLPFC) and posterior parietal cortex, mediate cognitive control functions such as inhibitory control, planning, and complex decision making.
23-1	4379-4382	The	_	
23-2	4383-4392	bilateral	_	
23-3	4393-4407	frontoparietal	_	
23-4	4408-4416	cortices	_	
23-5	4417-4429	encompassing	_	
23-6	4430-4433	the	_	
23-7	4434-4446	dorsolateral	_	
23-8	4447-4450	PFC	_	
23-9	4451-4452	(	_	
23-10	4452-4457	DLPFC	_	
23-11	4457-4458	)	_	
23-12	4459-4462	and	_	
23-13	4463-4472	posterior	_	
23-14	4473-4481	parietal	_	
23-15	4482-4488	cortex	_	
23-16	4488-4489	,	_	
23-17	4490-4497	mediate	_	
23-18	4498-4507	cognitive	_	
23-19	4508-4515	control	_	
23-20	4516-4525	functions	_	
23-21	4526-4530	such	_	
23-22	4531-4533	as	_	
23-23	4534-4544	inhibitory	_	
23-24	4545-4552	control	_	
23-25	4552-4553	,	_	
23-26	4554-4562	planning	_	
23-27	4562-4563	,	_	
23-28	4564-4567	and	_	
23-29	4568-4575	complex	_	
23-30	4576-4584	decision	_	
23-31	4585-4591	making	_	
23-32	4591-4592	.	_	

#Text=Functional activation of this network has been shown to be altered for cocaine users compared to controls during inhibitory control tasks such as the Stroop and Go/No-Go tasks.
24-1	4593-4603	Functional	_	
24-2	4604-4614	activation	_	
24-3	4615-4617	of	_	
24-4	4618-4622	this	_	
24-5	4623-4630	network	_	
24-6	4631-4634	has	_	
24-7	4635-4639	been	_	
24-8	4640-4645	shown	_	
24-9	4646-4648	to	_	
24-10	4649-4651	be	_	
24-11	4652-4659	altered	_	
24-12	4660-4663	for	_	
24-13	4664-4671	cocaine	_	
24-14	4672-4677	users	_	
24-15	4678-4686	compared	_	
24-16	4687-4689	to	_	
24-17	4690-4698	controls	_	
24-18	4699-4705	during	_	
24-19	4706-4716	inhibitory	_	
24-20	4717-4724	control	_	
24-21	4725-4730	tasks	_	
24-22	4731-4735	such	_	
24-23	4736-4738	as	_	
24-24	4739-4742	the	_	
24-25	4743-4749	Stroop	_	
24-26	4750-4753	and	_	
24-27	4754-4756	Go	_	
24-28	4756-4757	/	_	
24-29	4757-4762	No-Go	_	
24-30	4763-4768	tasks	_	
24-31	4768-4769	.	_	

#Text=The attentional salience network identifies salient external and interoceptive stimuli to inform decision making.
25-1	4770-4773	The	_	
25-2	4774-4785	attentional	_	
25-3	4786-4794	salience	_	
25-4	4795-4802	network	_	
25-5	4803-4813	identifies	_	
25-6	4814-4821	salient	_	
25-7	4822-4830	external	_	
25-8	4831-4834	and	_	
25-9	4835-4848	interoceptive	_	
25-10	4849-4856	stimuli	_	
25-11	4857-4859	to	_	
25-12	4860-4866	inform	_	
25-13	4867-4875	decision	_	
25-14	4876-4882	making	_	
25-15	4882-4883	.	_	

#Text=Cocaine users show aberrant rsFC of key regions in the salience network with other cortical regions involved in decision making compared to controls.
26-1	4884-4891	Cocaine	_	
26-2	4892-4897	users	_	
26-3	4898-4902	show	_	
26-4	4903-4911	aberrant	_	
26-5	4912-4916	rsFC	_	
26-6	4917-4919	of	_	
26-7	4920-4923	key	_	
26-8	4924-4931	regions	_	
26-9	4932-4934	in	_	
26-10	4935-4938	the	_	
26-11	4939-4947	salience	_	
26-12	4948-4955	network	_	
26-13	4956-4960	with	_	
26-14	4961-4966	other	_	
26-15	4967-4975	cortical	_	
26-16	4976-4983	regions	_	
26-17	4984-4992	involved	_	
26-18	4993-4995	in	_	
26-19	4996-5004	decision	_	
26-20	5005-5011	making	_	
26-21	5012-5020	compared	_	
26-22	5021-5023	to	_	
26-23	5024-5032	controls	_	
26-24	5032-5033	.	_	

#Text=Connectivity between reward and cortical executive control networks differentiate cocaine users from control participants.
27-1	5034-5046	Connectivity	_	
27-2	5047-5054	between	_	
27-3	5055-5061	reward	_	
27-4	5062-5065	and	_	
27-5	5066-5074	cortical	_	
27-6	5075-5084	executive	_	
27-7	5085-5092	control	_	
27-8	5093-5101	networks	_	
27-9	5102-5115	differentiate	_	
27-10	5116-5123	cocaine	_	
27-11	5124-5129	users	_	
27-12	5130-5134	from	_	
27-13	5135-5142	control	_	
27-14	5143-5155	participants	_	
27-15	5155-5156	.	_	

#Text=Studies examining functional network interactions in the context of addictive behaviors, however, are still limited.
28-1	5157-5164	Studies	_	
28-2	5165-5174	examining	_	
28-3	5175-5185	functional	_	
28-4	5186-5193	network	_	
28-5	5194-5206	interactions	_	
28-6	5207-5209	in	_	
28-7	5210-5213	the	_	
28-8	5214-5221	context	_	
28-9	5222-5224	of	_	
28-10	5225-5234	addictive	_	
28-11	5235-5244	behaviors	_	
28-12	5244-5245	,	_	
28-13	5246-5253	however	_	
28-14	5253-5254	,	_	
28-15	5255-5258	are	_	
28-16	5259-5264	still	_	
28-17	5265-5272	limited	_	
28-18	5272-5273	.	_	

#Text=The current study aimed to determine if altered rsFC between large-scale reward and executive control functional networks is predictive of impulsivity for cocaine users on three distinct decision-making tasks.
29-1	5274-5277	The	_	
29-2	5278-5285	current	_	
29-3	5286-5291	study	_	
29-4	5292-5297	aimed	_	
29-5	5298-5300	to	_	
29-6	5301-5310	determine	_	
29-7	5311-5313	if	_	
29-8	5314-5321	altered	_	
29-9	5322-5326	rsFC	_	
29-10	5327-5334	between	_	
29-11	5335-5346	large-scale	_	
29-12	5347-5353	reward	_	
29-13	5354-5357	and	_	
29-14	5358-5367	executive	_	
29-15	5368-5375	control	_	
29-16	5376-5386	functional	_	
29-17	5387-5395	networks	_	
29-18	5396-5398	is	_	
29-19	5399-5409	predictive	_	
29-20	5410-5412	of	_	
29-21	5413-5424	impulsivity	_	
29-22	5425-5428	for	_	
29-23	5429-5436	cocaine	_	
29-24	5437-5442	users	_	
29-25	5443-5445	on	_	
29-26	5446-5451	three	_	
29-27	5452-5460	distinct	_	
29-28	5461-5476	decision-making	_	
29-29	5477-5482	tasks	_	
29-30	5482-5483	.	_	

#Text=The tasks included the Monetary Choice Questionnaire (MCQ), measuring delay discounting, the Iowa Gambling Task (IGT), measuring reward-based learning, and the Balloon Analogue Risk Task (BART), measuring risk-taking propensity.
30-1	5484-5487	The	_	
30-2	5488-5493	tasks	_	
30-3	5494-5502	included	_	
30-4	5503-5506	the	_	
30-5	5507-5515	Monetary	_	
30-6	5516-5522	Choice	_	
30-7	5523-5536	Questionnaire	_	
30-8	5537-5538	(	_	
30-9	5538-5541	MCQ	_	
30-10	5541-5542	)	_	
30-11	5542-5543	,	_	
30-12	5544-5553	measuring	_	
30-13	5554-5559	delay	_	
30-14	5560-5571	discounting	_	
30-15	5571-5572	,	_	
30-16	5573-5576	the	_	
30-17	5577-5581	Iowa	_	
30-18	5582-5590	Gambling	_	
30-19	5591-5595	Task	_	
30-20	5596-5597	(	_	
30-21	5597-5600	IGT	_	
30-22	5600-5601	)	_	
30-23	5601-5602	,	_	
30-24	5603-5612	measuring	_	
30-25	5613-5625	reward-based	_	
30-26	5626-5634	learning	_	
30-27	5634-5635	,	_	
30-28	5636-5639	and	_	
30-29	5640-5643	the	_	
30-30	5644-5651	Balloon	_	
30-31	5652-5660	Analogue	_	
30-32	5661-5665	Risk	_	
30-33	5666-5670	Task	_	
30-34	5671-5672	(	_	
30-35	5672-5676	BART	_	
30-36	5676-5677	)	_	
30-37	5677-5678	,	_	
30-38	5679-5688	measuring	_	
30-39	5689-5700	risk-taking	_	
30-40	5701-5711	propensity	_	
30-41	5711-5712	.	_	

#Text=These tasks all engage the core and extended reward networks and the cognitive control and attentional salience networks.
31-1	5713-5718	These	_	
31-2	5719-5724	tasks	_	
31-3	5725-5728	all	_	
31-4	5729-5735	engage	_	
31-5	5736-5739	the	_	
31-6	5740-5744	core	_	
31-7	5745-5748	and	_	
31-8	5749-5757	extended	_	
31-9	5758-5764	reward	_	
31-10	5765-5773	networks	_	
31-11	5774-5777	and	_	
31-12	5778-5781	the	_	
31-13	5782-5791	cognitive	_	
31-14	5792-5799	control	_	
31-15	5800-5803	and	_	
31-16	5804-5815	attentional	_	
31-17	5816-5824	salience	_	
31-18	5825-5833	networks	_	
31-19	5833-5834	.	_	

#Text=Yet, the function of these networks differs for each task and may help to elucidate specific cocaine-related alterations in functional network connectivity that are associated with impulsive behavior.
32-1	5835-5838	Yet	_	
32-2	5838-5839	,	_	
32-3	5840-5843	the	_	
32-4	5844-5852	function	_	
32-5	5853-5855	of	_	
32-6	5856-5861	these	_	
32-7	5862-5870	networks	_	
32-8	5871-5878	differs	_	
32-9	5879-5882	for	_	
32-10	5883-5887	each	_	
32-11	5888-5892	task	_	
32-12	5893-5896	and	_	
32-13	5897-5900	may	_	
32-14	5901-5905	help	_	
32-15	5906-5908	to	_	
32-16	5909-5918	elucidate	_	
32-17	5919-5927	specific	_	
32-18	5928-5943	cocaine-related	_	
32-19	5944-5955	alterations	_	
32-20	5956-5958	in	_	
32-21	5959-5969	functional	_	
32-22	5970-5977	network	_	
32-23	5978-5990	connectivity	_	
32-24	5991-5995	that	_	
32-25	5996-5999	are	_	
32-26	6000-6010	associated	_	
32-27	6011-6015	with	_	
32-28	6016-6025	impulsive	_	
32-29	6026-6034	behavior	_	
32-30	6034-6035	.	_	

#Text=The MCQ offers participants a series of choices between smaller, immediate monetary rewards and larger, delayed monetary rewards.
33-1	6036-6039	The	_	
33-2	6040-6043	MCQ	_	
33-3	6044-6050	offers	_	
33-4	6051-6063	participants	_	
33-5	6064-6065	a	_	
33-6	6066-6072	series	_	
33-7	6073-6075	of	_	
33-8	6076-6083	choices	_	
33-9	6084-6091	between	_	
33-10	6092-6099	smaller	_	
33-11	6099-6100	,	_	
33-12	6101-6110	immediate	_	
33-13	6111-6119	monetary	_	
33-14	6120-6127	rewards	_	
33-15	6128-6131	and	_	
33-16	6132-6138	larger	_	
33-17	6138-6139	,	_	
33-18	6140-6147	delayed	_	
33-19	6148-6156	monetary	_	
33-20	6157-6164	rewards	_	
33-21	6164-6165	.	_	

#Text=Prior research shows that both the core and extended reward networks are involved in the choice of immediate rewards, while the activation of the insular cortex in the attentional salience network has been linked specifically to the choice of delayed rewards.
34-1	6166-6171	Prior	_	
34-2	6172-6180	research	_	
34-3	6181-6186	shows	_	
34-4	6187-6191	that	_	
34-5	6192-6196	both	_	
34-6	6197-6200	the	_	
34-7	6201-6205	core	_	
34-8	6206-6209	and	_	
34-9	6210-6218	extended	_	
34-10	6219-6225	reward	_	
34-11	6226-6234	networks	_	
34-12	6235-6238	are	_	
34-13	6239-6247	involved	_	
34-14	6248-6250	in	_	
34-15	6251-6254	the	_	
34-16	6255-6261	choice	_	
34-17	6262-6264	of	_	
34-18	6265-6274	immediate	_	
34-19	6275-6282	rewards	_	
34-20	6282-6283	,	_	
34-21	6284-6289	while	_	
34-22	6290-6293	the	_	
34-23	6294-6304	activation	_	
34-24	6305-6307	of	_	
34-25	6308-6311	the	_	
34-26	6312-6319	insular	_	
34-27	6320-6326	cortex	_	
34-28	6327-6329	in	_	
34-29	6330-6333	the	_	
34-30	6334-6345	attentional	_	
34-31	6346-6354	salience	_	
34-32	6355-6362	network	_	
34-33	6363-6366	has	_	
34-34	6367-6371	been	_	
34-35	6372-6378	linked	_	
34-36	6379-6391	specifically	_	
34-37	6392-6394	to	_	
34-38	6395-6398	the	_	
34-39	6399-6405	choice	_	
34-40	6406-6408	of	_	
34-41	6409-6416	delayed	_	
34-42	6417-6424	rewards	_	
34-43	6424-6425	.	_	

#Text=The cognitive control network is engaged during all monetary decisions and activity within the network increases with decision difficulty.
35-1	6426-6429	The	_	
35-2	6430-6439	cognitive	_	
35-3	6440-6447	control	_	
35-4	6448-6455	network	_	
35-5	6456-6458	is	_	
35-6	6459-6466	engaged	_	
35-7	6467-6473	during	_	
35-8	6474-6477	all	_	
35-9	6478-6486	monetary	_	
35-10	6487-6496	decisions	_	
35-11	6497-6500	and	_	
35-12	6501-6509	activity	_	
35-13	6510-6516	within	_	
35-14	6517-6520	the	_	
35-15	6521-6528	network	_	
35-16	6529-6538	increases	_	
35-17	6539-6543	with	_	
35-18	6544-6552	decision	_	
35-19	6553-6563	difficulty	_	
35-20	6563-6564	.	_	

#Text=Increased PFC cognitive control network connectivity has been linked to more delay discounting for cocaine users and methamphetamine users showed increased cognitive control network activity during easy monetary choices compared to controls; however, this activation may have been compensatory, since it was not associated with MCQ task performance.
36-1	6565-6574	Increased	_	
36-2	6575-6578	PFC	_	
36-3	6579-6588	cognitive	_	
36-4	6589-6596	control	_	
36-5	6597-6604	network	_	
36-6	6605-6617	connectivity	_	
36-7	6618-6621	has	_	
36-8	6622-6626	been	_	
36-9	6627-6633	linked	_	
36-10	6634-6636	to	_	
36-11	6637-6641	more	_	
36-12	6642-6647	delay	_	
36-13	6648-6659	discounting	_	
36-14	6660-6663	for	_	
36-15	6664-6671	cocaine	_	
36-16	6672-6677	users	_	
36-17	6678-6681	and	_	
36-18	6682-6697	methamphetamine	_	
36-19	6698-6703	users	_	
36-20	6704-6710	showed	_	
36-21	6711-6720	increased	_	
36-22	6721-6730	cognitive	_	
36-23	6731-6738	control	_	
36-24	6739-6746	network	_	
36-25	6747-6755	activity	_	
36-26	6756-6762	during	_	
36-27	6763-6767	easy	_	
36-28	6768-6776	monetary	_	
36-29	6777-6784	choices	_	
36-30	6785-6793	compared	_	
36-31	6794-6796	to	_	
36-32	6797-6805	controls	_	
36-33	6805-6806	;	_	
36-34	6807-6814	however	_	
36-35	6814-6815	,	_	
36-36	6816-6820	this	_	
36-37	6821-6831	activation	_	
36-38	6832-6835	may	_	
36-39	6836-6840	have	_	
36-40	6841-6845	been	_	
36-41	6846-6858	compensatory	_	
36-42	6858-6859	,	_	
36-43	6860-6865	since	_	
36-44	6866-6868	it	_	
36-45	6869-6872	was	_	
36-46	6873-6876	not	_	
36-47	6877-6887	associated	_	
36-48	6888-6892	with	_	
36-49	6893-6896	MCQ	_	
36-50	6897-6901	task	_	
36-51	6902-6913	performance	_	
36-52	6913-6914	.	_	

#Text=Given that stimulant users consistently choose smaller immediate monetary rewards over larger later monetary rewards, we expected to see higher discounting rates to be associated with a negative correlation, or imbalance, between the reward networks involved in immediate reward choices and the attentional salience network involved in delayed reward choices for cocaine users.
37-1	6915-6920	Given	_	
37-2	6921-6925	that	_	
37-3	6926-6935	stimulant	_	
37-4	6936-6941	users	_	
37-5	6942-6954	consistently	_	
37-6	6955-6961	choose	_	
37-7	6962-6969	smaller	_	
37-8	6970-6979	immediate	_	
37-9	6980-6988	monetary	_	
37-10	6989-6996	rewards	_	
37-11	6997-7001	over	_	
37-12	7002-7008	larger	_	
37-13	7009-7014	later	_	
37-14	7015-7023	monetary	_	
37-15	7024-7031	rewards	_	
37-16	7031-7032	,	_	
37-17	7033-7035	we	_	
37-18	7036-7044	expected	_	
37-19	7045-7047	to	_	
37-20	7048-7051	see	_	
37-21	7052-7058	higher	_	
37-22	7059-7070	discounting	_	
37-23	7071-7076	rates	_	
37-24	7077-7079	to	_	
37-25	7080-7082	be	_	
37-26	7083-7093	associated	_	
37-27	7094-7098	with	_	
37-28	7099-7100	a	_	
37-29	7101-7109	negative	_	
37-30	7110-7121	correlation	_	
37-31	7121-7122	,	_	
37-32	7123-7125	or	_	
37-33	7126-7135	imbalance	_	
37-34	7135-7136	,	_	
37-35	7137-7144	between	_	
37-36	7145-7148	the	_	
37-37	7149-7155	reward	_	
37-38	7156-7164	networks	_	
37-39	7165-7173	involved	_	
37-40	7174-7176	in	_	
37-41	7177-7186	immediate	_	
37-42	7187-7193	reward	_	
37-43	7194-7201	choices	_	
37-44	7202-7205	and	_	
37-45	7206-7209	the	_	
37-46	7210-7221	attentional	_	
37-47	7222-7230	salience	_	
37-48	7231-7238	network	_	
37-49	7239-7247	involved	_	
37-50	7248-7250	in	_	
37-51	7251-7258	delayed	_	
37-52	7259-7265	reward	_	
37-53	7266-7273	choices	_	
37-54	7274-7277	for	_	
37-55	7278-7285	cocaine	_	
37-56	7286-7291	users	_	
37-57	7291-7292	.	_	

#Text=Such a finding would lend support for the overvaluation of immediate rewards and undervaluation of delayed rewards in addiction.
38-1	7293-7297	Such	_	
38-2	7298-7299	a	_	
38-3	7300-7307	finding	_	
38-4	7308-7313	would	_	
38-5	7314-7318	lend	_	
38-6	7319-7326	support	_	
38-7	7327-7330	for	_	
38-8	7331-7334	the	_	
38-9	7335-7348	overvaluation	_	
38-10	7349-7351	of	_	
38-11	7352-7361	immediate	_	
38-12	7362-7369	rewards	_	
38-13	7370-7373	and	_	
38-14	7374-7388	undervaluation	_	
38-15	7389-7391	of	_	
38-16	7392-7399	delayed	_	
38-17	7400-7407	rewards	_	
38-18	7408-7410	in	_	
38-19	7411-7420	addiction	_	
38-20	7420-7421	.	_	

#Text=During the BART, a measure of risk-taking propensity, players accrue 1 cent for each balloon pump, but risk losing their money for that round if the balloon explodes.
39-1	7422-7428	During	_	
39-2	7429-7432	the	_	
39-3	7433-7437	BART	_	
39-4	7437-7438	,	_	
39-5	7439-7440	a	_	
39-6	7441-7448	measure	_	
39-7	7449-7451	of	_	
39-8	7452-7463	risk-taking	_	
39-9	7464-7474	propensity	_	
39-10	7474-7475	,	_	
39-11	7476-7483	players	_	
39-12	7484-7490	accrue	_	
39-13	7491-7492	1	_	
39-14	7493-7497	cent	_	
39-15	7498-7501	for	_	
39-16	7502-7506	each	_	
39-17	7507-7514	balloon	_	
39-18	7515-7519	pump	_	
39-19	7519-7520	,	_	
39-20	7521-7524	but	_	
39-21	7525-7529	risk	_	
39-22	7530-7536	losing	_	
39-23	7537-7542	their	_	
39-24	7543-7548	money	_	
39-25	7549-7552	for	_	
39-26	7553-7557	that	_	
39-27	7558-7563	round	_	
39-28	7564-7566	if	_	
39-29	7567-7570	the	_	
39-30	7571-7578	balloon	_	
39-31	7579-7587	explodes	_	
39-32	7587-7588	.	_	

#Text=Risk taking in the form of balloon pumps consistently activates mesostriatal regions in the core reward network as well as the bilateral attentional salience and cognitive control networks.
40-1	7589-7593	Risk	_	
40-2	7594-7600	taking	_	
40-3	7601-7603	in	_	
40-4	7604-7607	the	_	
40-5	7608-7612	form	_	
40-6	7613-7615	of	_	
40-7	7616-7623	balloon	_	
40-8	7624-7629	pumps	_	
40-9	7630-7642	consistently	_	
40-10	7643-7652	activates	_	
40-11	7653-7665	mesostriatal	_	
40-12	7666-7673	regions	_	
40-13	7674-7676	in	_	
40-14	7677-7680	the	_	
40-15	7681-7685	core	_	
40-16	7686-7692	reward	_	
40-17	7693-7700	network	_	
40-18	7701-7703	as	_	
40-19	7704-7708	well	_	
40-20	7709-7711	as	_	
40-21	7712-7715	the	_	
40-22	7716-7725	bilateral	_	
40-23	7726-7737	attentional	_	
40-24	7738-7746	salience	_	
40-25	7747-7750	and	_	
40-26	7751-7760	cognitive	_	
40-27	7761-7768	control	_	
40-28	7769-7777	networks	_	
40-29	7777-7778	.	_	

#Text=While some studies show activation of vmPFC and ACC of the extended reward network during balloon pumps, deactivations during balloon pumps is more commonly found with fMRI.
41-1	7779-7784	While	_	
41-2	7785-7789	some	_	
41-3	7790-7797	studies	_	
41-4	7798-7802	show	_	
41-5	7803-7813	activation	_	
41-6	7814-7816	of	_	
41-7	7817-7822	vmPFC	_	
41-8	7823-7826	and	_	
41-9	7827-7830	ACC	_	
41-10	7831-7833	of	_	
41-11	7834-7837	the	_	
41-12	7838-7846	extended	_	
41-13	7847-7853	reward	_	
41-14	7854-7861	network	_	
41-15	7862-7868	during	_	
41-16	7869-7876	balloon	_	
41-17	7877-7882	pumps	_	
41-18	7882-7883	,	_	
41-19	7884-7897	deactivations	_	
41-20	7898-7904	during	_	
41-21	7905-7912	balloon	_	
41-22	7913-7918	pumps	_	
41-23	7919-7921	is	_	
41-24	7922-7926	more	_	
41-25	7927-7935	commonly	_	
41-26	7936-7941	found	_	
41-27	7942-7946	with	_	
41-28	7947-7951	fMRI	_	
41-29	7951-7952	.	_	

#Text=A prior study correlated rsFC to BOLD activation during the BART and found that less right DLPFC modulation of risk during the BART was linked with increased whole-brain connectivity of a core reward seed network for methamphetamine users, and decreased connectivity of a right cognitive control seed network for controls.
42-1	7953-7954	A	_	
42-2	7955-7960	prior	_	
42-3	7961-7966	study	_	
42-4	7967-7977	correlated	_	
42-5	7978-7982	rsFC	_	
42-6	7983-7985	to	_	
42-7	7986-7990	BOLD	_	
42-8	7991-8001	activation	_	
42-9	8002-8008	during	_	
42-10	8009-8012	the	_	
42-11	8013-8017	BART	_	
42-12	8018-8021	and	_	
42-13	8022-8027	found	_	
42-14	8028-8032	that	_	
42-15	8033-8037	less	_	
42-16	8038-8043	right	_	
42-17	8044-8049	DLPFC	_	
42-18	8050-8060	modulation	_	
42-19	8061-8063	of	_	
42-20	8064-8068	risk	_	
42-21	8069-8075	during	_	
42-22	8076-8079	the	_	
42-23	8080-8084	BART	_	
42-24	8085-8088	was	_	
42-25	8089-8095	linked	_	
42-26	8096-8100	with	_	
42-27	8101-8110	increased	_	
42-28	8111-8122	whole-brain	_	
42-29	8123-8135	connectivity	_	
42-30	8136-8138	of	_	
42-31	8139-8140	a	_	
42-32	8141-8145	core	_	
42-33	8146-8152	reward	_	
42-34	8153-8157	seed	_	
42-35	8158-8165	network	_	
42-36	8166-8169	for	_	
42-37	8170-8185	methamphetamine	_	
42-38	8186-8191	users	_	
42-39	8191-8192	,	_	
42-40	8193-8196	and	_	
42-41	8197-8206	decreased	_	
42-42	8207-8219	connectivity	_	
42-43	8220-8222	of	_	
42-44	8223-8224	a	_	
42-45	8225-8230	right	_	
42-46	8231-8240	cognitive	_	
42-47	8241-8248	control	_	
42-48	8249-8253	seed	_	
42-49	8254-8261	network	_	
42-50	8262-8265	for	_	
42-51	8266-8274	controls	_	
42-52	8274-8275	.	_	

#Text=In this case, stronger links between reward and cognitive control circuitry appear to promote more balloon pumps (i.e., risk) during the task for stimulant users.
43-1	8276-8278	In	_	
43-2	8279-8283	this	_	
43-3	8284-8288	case	_	
43-4	8288-8289	,	_	
43-5	8290-8298	stronger	_	
43-6	8299-8304	links	_	
43-7	8305-8312	between	_	
43-8	8313-8319	reward	_	
43-9	8320-8323	and	_	
43-10	8324-8333	cognitive	_	
43-11	8334-8341	control	_	
43-12	8342-8351	circuitry	_	
43-13	8352-8358	appear	_	
43-14	8359-8361	to	_	
43-15	8362-8369	promote	_	
43-16	8370-8374	more	_	
43-17	8375-8382	balloon	_	
43-18	8383-8388	pumps	_	
43-19	8389-8390	(	_	
43-20	8390-8393	i.e	_	
43-21	8393-8394	.	_	
43-22	8394-8395	,	_	
43-23	8396-8400	risk	_	
43-24	8400-8401	)	_	
43-25	8402-8408	during	_	
43-26	8409-8412	the	_	
43-27	8413-8417	task	_	
43-28	8418-8421	for	_	
43-29	8422-8431	stimulant	_	
43-30	8432-8437	users	_	
43-31	8437-8438	.	_	

#Text=Therefore, we expected higher risk-taking propensity to be associated with stronger connectivity between the reward and cognitive control networks for cocaine users.
44-1	8439-8448	Therefore	_	
44-2	8448-8449	,	_	
44-3	8450-8452	we	_	
44-4	8453-8461	expected	_	
44-5	8462-8468	higher	_	
44-6	8469-8480	risk-taking	_	
44-7	8481-8491	propensity	_	
44-8	8492-8494	to	_	
44-9	8495-8497	be	_	
44-10	8498-8508	associated	_	
44-11	8509-8513	with	_	
44-12	8514-8522	stronger	_	
44-13	8523-8535	connectivity	_	
44-14	8536-8543	between	_	
44-15	8544-8547	the	_	
44-16	8548-8554	reward	_	
44-17	8555-8558	and	_	
44-18	8559-8568	cognitive	_	
44-19	8569-8576	control	_	
44-20	8577-8585	networks	_	
44-21	8586-8589	for	_	
44-22	8590-8597	cocaine	_	
44-23	8598-8603	users	_	
44-24	8603-8604	.	_	

#Text=Specifically, we expected to see stronger positive connectivity with the core reward network and stronger inverse connectivity with the extended reward network given their direction of task activation.
45-1	8605-8617	Specifically	_	
45-2	8617-8618	,	_	
45-3	8619-8621	we	_	
45-4	8622-8630	expected	_	
45-5	8631-8633	to	_	
45-6	8634-8637	see	_	
45-7	8638-8646	stronger	_	
45-8	8647-8655	positive	_	
45-9	8656-8668	connectivity	_	
45-10	8669-8673	with	_	
45-11	8674-8677	the	_	
45-12	8678-8682	core	_	
45-13	8683-8689	reward	_	
45-14	8690-8697	network	_	
45-15	8698-8701	and	_	
45-16	8702-8710	stronger	_	
45-17	8711-8718	inverse	_	
45-18	8719-8731	connectivity	_	
45-19	8732-8736	with	_	
45-20	8737-8740	the	_	
45-21	8741-8749	extended	_	
45-22	8750-8756	reward	_	
45-23	8757-8764	network	_	
45-24	8765-8770	given	_	
45-25	8771-8776	their	_	
45-26	8777-8786	direction	_	
45-27	8787-8789	of	_	
45-28	8790-8794	task	_	
45-29	8795-8805	activation	_	
45-30	8805-8806	.	_	

#Text=During the IGT, players choose from four card decks that have varying probabilities of winning and losing money with the end goal of learning which decks are advantageous.
46-1	8807-8813	During	_	
46-2	8814-8817	the	_	
46-3	8818-8821	IGT	_	
46-4	8821-8822	,	_	
46-5	8823-8830	players	_	
46-6	8831-8837	choose	_	
46-7	8838-8842	from	_	
46-8	8843-8847	four	_	
46-9	8848-8852	card	_	
46-10	8853-8858	decks	_	
46-11	8859-8863	that	_	
46-12	8864-8868	have	_	
46-13	8869-8876	varying	_	
46-14	8877-8890	probabilities	_	
46-15	8891-8893	of	_	
46-16	8894-8901	winning	_	
46-17	8902-8905	and	_	
46-18	8906-8912	losing	_	
46-19	8913-8918	money	_	
46-20	8919-8923	with	_	
46-21	8924-8927	the	_	
46-22	8928-8931	end	_	
46-23	8932-8936	goal	_	
46-24	8937-8939	of	_	
46-25	8940-8948	learning	_	
46-26	8949-8954	which	_	
46-27	8955-8960	decks	_	
46-28	8961-8964	are	_	
46-29	8965-8977	advantageous	_	
46-30	8977-8978	.	_	

#Text=Expected gains for card choices has been linked with extended reward activity while expected risk and learning from unanticipated outcomes during the IGT has been linked with core reward network activity.
47-1	8979-8987	Expected	_	
47-2	8988-8993	gains	_	
47-3	8994-8997	for	_	
47-4	8998-9002	card	_	
47-5	9003-9010	choices	_	
47-6	9011-9014	has	_	
47-7	9015-9019	been	_	
47-8	9020-9026	linked	_	
47-9	9027-9031	with	_	
47-10	9032-9040	extended	_	
47-11	9041-9047	reward	_	
47-12	9048-9056	activity	_	
47-13	9057-9062	while	_	
47-14	9063-9071	expected	_	
47-15	9072-9076	risk	_	
47-16	9077-9080	and	_	
47-17	9081-9089	learning	_	
47-18	9090-9094	from	_	
47-19	9095-9108	unanticipated	_	
47-20	9109-9117	outcomes	_	
47-21	9118-9124	during	_	
47-22	9125-9128	the	_	
47-23	9129-9132	IGT	_	
47-24	9133-9136	has	_	
47-25	9137-9141	been	_	
47-26	9142-9148	linked	_	
47-27	9149-9153	with	_	
47-28	9154-9158	core	_	
47-29	9159-9165	reward	_	
47-30	9166-9173	network	_	
47-31	9174-9182	activity	_	
47-32	9182-9183	.	_	

#Text=Improvement in IGT performance is associated with activation in both the cognitive control and attentional salience networks.
48-1	9184-9195	Improvement	_	
48-2	9196-9198	in	_	
48-3	9199-9202	IGT	_	
48-4	9203-9214	performance	_	
48-5	9215-9217	is	_	
48-6	9218-9228	associated	_	
48-7	9229-9233	with	_	
48-8	9234-9244	activation	_	
48-9	9245-9247	in	_	
48-10	9248-9252	both	_	
48-11	9253-9256	the	_	
48-12	9257-9266	cognitive	_	
48-13	9267-9274	control	_	
48-14	9275-9278	and	_	
48-15	9279-9290	attentional	_	
48-16	9291-9299	salience	_	
48-17	9300-9308	networks	_	
48-18	9308-9309	.	_	

#Text=Stimulant users show deficits in contingency-based learning on the IGT, which has been associated with increased right-sided extended reward (i.e., medial OFC) and decreased right-sided cognitive control (i.e., DLPFC) network activity compared to controls in a study using positron emission tomography (PET).
49-1	9310-9319	Stimulant	_	
49-2	9320-9325	users	_	
49-3	9326-9330	show	_	
49-4	9331-9339	deficits	_	
49-5	9340-9342	in	_	
49-6	9343-9360	contingency-based	_	
49-7	9361-9369	learning	_	
49-8	9370-9372	on	_	
49-9	9373-9376	the	_	
49-10	9377-9380	IGT	_	
49-11	9380-9381	,	_	
49-12	9382-9387	which	_	
49-13	9388-9391	has	_	
49-14	9392-9396	been	_	
49-15	9397-9407	associated	_	
49-16	9408-9412	with	_	
49-17	9413-9422	increased	_	
49-18	9423-9434	right-sided	_	
49-19	9435-9443	extended	_	
49-20	9444-9450	reward	_	
49-21	9451-9452	(	_	
49-22	9452-9455	i.e	_	
49-23	9455-9456	.	_	
49-24	9456-9457	,	_	
49-25	9458-9464	medial	_	
49-26	9465-9468	OFC	_	
49-27	9468-9469	)	_	
49-28	9470-9473	and	_	
49-29	9474-9483	decreased	_	
49-30	9484-9495	right-sided	_	
49-31	9496-9505	cognitive	_	
49-32	9506-9513	control	_	
49-33	9514-9515	(	_	
49-34	9515-9518	i.e	_	
49-35	9518-9519	.	_	
49-36	9519-9520	,	_	
49-37	9521-9526	DLPFC	_	
49-38	9526-9527	)	_	
49-39	9528-9535	network	_	
49-40	9536-9544	activity	_	
49-41	9545-9553	compared	_	
49-42	9554-9556	to	_	
49-43	9557-9565	controls	_	
49-44	9566-9568	in	_	
49-45	9569-9570	a	_	
49-46	9571-9576	study	_	
49-47	9577-9582	using	_	
49-48	9583-9591	positron	_	
49-49	9592-9600	emission	_	
49-50	9601-9611	tomography	_	
49-51	9612-9613	(	_	
49-52	9613-9616	PET	_	
49-53	9616-9617	)	_	
49-54	9617-9618	.	_	

#Text=A separate study found that hyperperfusion in the left cognitive control network at rest was linked to worse IGT performance for cocaine users.
50-1	9619-9620	A	_	
50-2	9621-9629	separate	_	
50-3	9630-9635	study	_	
50-4	9636-9641	found	_	
50-5	9642-9646	that	_	
50-6	9647-9661	hyperperfusion	_	
50-7	9662-9664	in	_	
50-8	9665-9668	the	_	
50-9	9669-9673	left	_	
50-10	9674-9683	cognitive	_	
50-11	9684-9691	control	_	
50-12	9692-9699	network	_	
50-13	9700-9702	at	_	
50-14	9703-9707	rest	_	
50-15	9708-9711	was	_	
50-16	9712-9718	linked	_	
50-17	9719-9721	to	_	
50-18	9722-9727	worse	_	
50-19	9728-9731	IGT	_	
50-20	9732-9743	performance	_	
50-21	9744-9747	for	_	
50-22	9748-9755	cocaine	_	
50-23	9756-9761	users	_	
50-24	9761-9762	.	_	

#Text=Given these findings, we expected a negative correlation of the extended reward network and cognitive control network to be linked to worse learning on the IGT, which would support hypotheses that addiction is characterized by overvaluation of expected gains and reduced cognitive control.
51-1	9763-9768	Given	_	
51-2	9769-9774	these	_	
51-3	9775-9783	findings	_	
51-4	9783-9784	,	_	
51-5	9785-9787	we	_	
51-6	9788-9796	expected	_	
51-7	9797-9798	a	_	
51-8	9799-9807	negative	_	
51-9	9808-9819	correlation	_	
51-10	9820-9822	of	_	
51-11	9823-9826	the	_	
51-12	9827-9835	extended	_	
51-13	9836-9842	reward	_	
51-14	9843-9850	network	_	
51-15	9851-9854	and	_	
51-16	9855-9864	cognitive	_	
51-17	9865-9872	control	_	
51-18	9873-9880	network	_	
51-19	9881-9883	to	_	
51-20	9884-9886	be	_	
51-21	9887-9893	linked	_	
51-22	9894-9896	to	_	
51-23	9897-9902	worse	_	
51-24	9903-9911	learning	_	
51-25	9912-9914	on	_	
51-26	9915-9918	the	_	
51-27	9919-9922	IGT	_	
51-28	9922-9923	,	_	
51-29	9924-9929	which	_	
51-30	9930-9935	would	_	
51-31	9936-9943	support	_	
51-32	9944-9954	hypotheses	_	
51-33	9955-9959	that	_	
51-34	9960-9969	addiction	_	
51-35	9970-9972	is	_	
51-36	9973-9986	characterized	_	
51-37	9987-9989	by	_	
51-38	9990-10003	overvaluation	_	
51-39	10004-10006	of	_	
51-40	10007-10015	expected	_	
51-41	10016-10021	gains	_	
51-42	10022-10025	and	_	
51-43	10026-10033	reduced	_	
51-44	10034-10043	cognitive	_	
51-45	10044-10051	control	_	
51-46	10051-10052	.	_	

#Text=Materials and methods
#Text=Participants
#Text=The sample included 37 cocaine users and 35 non-cocaine users (controls) who participated in one of two fMRI studies assessing the effects of cocaine and HIV on brain function and decision making.
52-1	10053-10062	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[6]	
52-2	10063-10066	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[6]	
52-3	10067-10074	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[6]	
52-4	10075-10087	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-5	10088-10091	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-6	10092-10098	sample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-7	10099-10107	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-8	10108-10110	37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-9	10111-10118	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[8]	
52-10	10119-10124	users	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[8]	
52-11	10125-10128	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-12	10129-10131	35	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-13	10132-10143	non-cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
52-14	10144-10149	users	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
52-15	10150-10151	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
52-16	10151-10159	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
52-17	10159-10160	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
52-18	10161-10164	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-19	10165-10177	participated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-20	10178-10180	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-21	10181-10184	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-22	10185-10187	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-23	10188-10191	two	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-24	10192-10196	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[10]	
52-25	10197-10204	studies	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-26	10205-10214	assessing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-27	10215-10218	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-28	10219-10226	effects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-29	10227-10229	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-30	10230-10237	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-31	10238-10241	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-32	10242-10245	HIV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-33	10246-10248	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-34	10249-10254	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-35	10255-10263	function	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-36	10264-10267	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-37	10268-10276	decision	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-38	10277-10283	making	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
52-39	10283-10284	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=The current analysis included only HIV-negative participants, verified with an OraQuick rapid HIV test.
53-1	10285-10288	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-2	10289-10296	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-3	10297-10305	analysis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-4	10306-10314	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-5	10315-10319	only	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-6	10320-10332	HIV-negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-7	10333-10345	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-8	10345-10346	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-9	10347-10355	verified	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-10	10356-10360	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-11	10361-10363	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-12	10364-10372	OraQuick	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-13	10372-10373		http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-14	10374-10379	rapid	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-15	10380-10383	HIV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-16	10384-10388	test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
53-17	10388-10389	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=Cocaine users met the following criteria: 3 days of past-month cocaine use or a cocaine-positive urine drug screen, 1 year of regular cocaine use, and lifetime cocaine dependence.
54-1	10390-10397	Cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[13]	
54-2	10398-10403	users	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse[13]	
54-3	10404-10407	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-4	10408-10411	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-5	10412-10421	following	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-6	10422-10430	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-7	10430-10431	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-8	10432-10433		http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-9	10433-10434	3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-10	10435-10439	days	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-11	10440-10442	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-12	10443-10453	past-month	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-13	10454-10461	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-14	10462-10465	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-15	10466-10468	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-16	10469-10470	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-17	10471-10487	cocaine-positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-18	10488-10493	urine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-19	10494-10498	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-20	10499-10505	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-21	10505-10506	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-22	10507-10508		http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-23	10508-10509	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-24	10510-10514	year	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-25	10515-10517	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-26	10518-10525	regular	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-27	10526-10533	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-28	10534-10537	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-29	10537-10538	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-30	10539-10542	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-31	10543-10551	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-32	10552-10559	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-33	10560-10570	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
54-34	10570-10571	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	

#Text=Current alcohol and marijuana dependence were permitted if cocaine dependence was the principal diagnosis.
55-1	10572-10579	Current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-2	10580-10587	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-3	10588-10591	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-4	10592-10601	marijuana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-5	10602-10612	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-6	10613-10617	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-7	10618-10627	permitted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-8	10628-10630	if	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-9	10631-10638	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-10	10639-10649	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-11	10650-10653	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-12	10654-10657	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-13	10658-10667	principal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-14	10668-10677	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
55-15	10677-10678	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=The control group met the following criteria: no lifetime cocaine use disorder, no history of regular cocaine use, 0 days of cocaine use in the past year, and a cocaine-negative drug screen.
56-1	10679-10682	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-2	10683-10690	control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-3	10691-10696	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-4	10697-10700	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-5	10701-10704	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-6	10705-10714	following	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-7	10715-10723	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-8	10723-10724	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-9	10725-10727	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-10	10728-10736	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-11	10737-10744	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-12	10745-10748	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-13	10749-10757	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-14	10757-10758	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-15	10759-10761	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-16	10762-10769	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-17	10770-10772	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-18	10773-10780	regular	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-19	10781-10788	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-20	10789-10792	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-21	10792-10793	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-22	10794-10795	0	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-23	10796-10800	days	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-24	10801-10803	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-25	10804-10811	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-26	10812-10815	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-27	10816-10818	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-28	10819-10822	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-29	10823-10827	past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-30	10828-10832	year	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-31	10832-10833	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-32	10834-10837	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-33	10838-10839	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-34	10840-10856	cocaine-negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-35	10857-10861	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-36	10862-10868	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
56-37	10868-10869	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Past alcohol and marijuana dependence in full sustained remission were permitted.
57-1	10870-10874	Past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-2	10875-10882	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-3	10883-10886	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-4	10887-10896	marijuana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-5	10897-10907	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-6	10908-10910	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-7	10911-10915	full	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-8	10916-10925	sustained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-9	10926-10935	remission	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-10	10936-10940	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-11	10941-10950	permitted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
57-12	10950-10951	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	

#Text=In all groups, alcohol, marijuana, and nicotine use were permitted, and for all other drugs, individuals were excluded for lifetime dependence, history of >2 years of regular use, and/or a positive drug screen (except for prescribed medications).
58-1	10952-10954	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-2	10955-10958	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-3	10959-10965	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-4	10965-10966	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-5	10967-10974	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-6	10974-10975	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-7	10976-10985	marijuana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-8	10985-10986	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-9	10987-10990	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-10	10991-10999	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-11	11000-11003	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-12	11004-11008	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-13	11009-11018	permitted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-14	11018-11019	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-15	11020-11023	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-16	11024-11027	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-17	11028-11031	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-18	11032-11037	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-19	11038-11043	drugs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-20	11043-11044	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-21	11045-11056	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-22	11057-11061	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-23	11062-11070	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-24	11071-11074	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-25	11075-11083	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-26	11084-11094	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-27	11094-11095	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-28	11096-11103	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-29	11104-11106	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-30	11107-11108	>	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-31	11108-11109	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-32	11110-11115	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-33	11116-11118	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-34	11119-11126	regular	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-35	11127-11130	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-36	11130-11131	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-37	11132-11135	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-38	11135-11136	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-39	11136-11138	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-40	11139-11140	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-41	11141-11149	positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-42	11150-11154	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-43	11155-11161	screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-44	11162-11163	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-45	11163-11169	except	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-46	11170-11173	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-47	11174-11184	prescribed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-48	11185-11196	medications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-49	11196-11197	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	
58-50	11197-11198	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]	

#Text=Additional exclusion criteria were: English non-fluency or illiteracy; <8th grade education; severe learning disability with functional impairment; serious neurological disorders (e.g., multiple sclerosis); lifetime history of severe head trauma with loss of consciousness >30 minutes and persistent functional decline; indicators of severe mental illness or acute psychiatric distress (e.g., schizophrenia, major depressive disorder with suicidal ideation); pregnancy; physical disabilities impeding participation (e.g., blindness); and impaired mental status.
59-1	11199-11209	Additional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-2	11210-11219	exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-3	11220-11228	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-4	11229-11233	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-5	11233-11234	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-6	11235-11242	English	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-7	11243-11254	non-fluency	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-8	11255-11257	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-9	11258-11268	illiteracy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-10	11268-11269	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-11	11270-11271	<	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-12	11271-11274	8th	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-13	11275-11280	grade	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-14	11281-11290	education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-15	11290-11291	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-16	11292-11298	severe	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-17	11299-11307	learning	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-18	11308-11318	disability	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-19	11319-11323	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-20	11324-11334	functional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-21	11335-11345	impairment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-22	11345-11346	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-23	11347-11354	serious	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-24	11355-11367	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-25	11368-11377	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-26	11378-11379	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-27	11379-11382	e.g	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-28	11382-11383	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-29	11383-11384	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-30	11385-11393	multiple	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-31	11394-11403	sclerosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-32	11403-11404	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-33	11404-11405	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-34	11406-11414	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-35	11415-11422	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-36	11423-11425	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-37	11426-11432	severe	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-38	11433-11437	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-39	11438-11444	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-40	11445-11449	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-41	11450-11454	loss	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-42	11455-11457	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-43	11458-11471	consciousness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-44	11472-11473	>	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-45	11473-11475	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-46	11476-11483	minutes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-47	11484-11487	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-48	11488-11498	persistent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-49	11499-11509	functional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-50	11510-11517	decline	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-51	11517-11518	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-52	11519-11529	indicators	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-53	11530-11532	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-54	11533-11539	severe	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-55	11540-11546	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-56	11547-11554	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-57	11555-11557	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-58	11558-11563	acute	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-59	11564-11575	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-60	11576-11584	distress	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-61	11585-11586	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-62	11586-11589	e.g	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-63	11589-11590	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-64	11590-11591	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-65	11592-11605	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-66	11605-11606	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-67	11607-11612	major	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-68	11613-11623	depressive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-69	11624-11632	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-70	11633-11637	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-71	11638-11646	suicidal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-72	11647-11655	ideation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-73	11655-11656	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-74	11656-11657	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-75	11658-11667	pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-76	11667-11668	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-77	11669-11677	physical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-78	11678-11690	disabilities	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-79	11691-11699	impeding	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-80	11700-11713	participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-81	11714-11715	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-82	11715-11718	e.g	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-83	11718-11719	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-84	11719-11720	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-85	11721-11730	blindness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-86	11730-11731	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-87	11731-11732	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-88	11733-11736	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-89	11737-11745	impaired	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-90	11746-11752	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-91	11753-11759	status	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
59-92	11759-11760	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	

#Text=Procedures
#Text=Participants were recruited from the Raleigh-Durham area between October 2011 and May 2015 via advertisements in local newspapers and websites, flyers and brochures at community-based organizations, and participant referrals.
60-1	11761-11771	Procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-2	11772-11784	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-3	11785-11789	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-4	11790-11799	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-5	11800-11804	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-6	11805-11808	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-7	11809-11823	Raleigh-Durham	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-8	11824-11828	area	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-9	11829-11836	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-10	11837-11844	October	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-11	11845-11849	2011	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-12	11850-11853	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-13	11854-11857	May	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-14	11858-11862	2015	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-15	11863-11866	via	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-16	11867-11881	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-17	11882-11884	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-18	11885-11890	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-19	11891-11901	newspapers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-20	11902-11905	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-21	11906-11914	websites	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-22	11914-11915	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-23	11916-11922	flyers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-24	11923-11926	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-25	11927-11936	brochures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-26	11937-11939	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-27	11940-11955	community-based	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-28	11956-11969	organizations	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-29	11969-11970	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-30	11971-11974	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-31	11975-11986	participant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-32	11987-11996	referrals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
60-33	11996-11997	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	

#Text=After a brief telephone pre-screen, interested individuals completed a comprehensive in-person screening of psychiatric, substance abuse, and medical histories and urine drug and pregnancy testing, as described previously.
61-1	11998-12003	After	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-2	12004-12005	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-3	12006-12011	brief	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-4	12012-12021	telephone	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-5	12022-12032	pre-screen	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-6	12032-12033	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-7	12034-12044	interested	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-8	12045-12056	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-9	12057-12066	completed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-10	12067-12068	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-11	12069-12082	comprehensive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-12	12083-12092	in-person	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-13	12093-12102	screening	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-14	12103-12105	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-15	12106-12117	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-16	12117-12118	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-17	12119-12128	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-18	12129-12134	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-19	12134-12135	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-20	12136-12139	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-21	12140-12147	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-22	12148-12157	histories	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-23	12158-12161	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-24	12162-12167	urine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-25	12168-12172	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-26	12173-12176	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-27	12177-12186	pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-28	12187-12194	testing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-29	12194-12195	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-30	12196-12198	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-31	12199-12208	described	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-32	12209-12219	previously	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	
61-33	12219-12220	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]	

#Text=Participants also provided a release of information for research staff to request and review their medical records to corroborate self-reported medical history.
62-1	12221-12233	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-2	12234-12238	also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-3	12239-12247	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-4	12248-12249	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-5	12250-12257	release	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-6	12258-12260	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-7	12261-12272	information	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-8	12273-12276	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-9	12277-12285	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-10	12286-12291	staff	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-11	12292-12294	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-12	12295-12302	request	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-13	12303-12306	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-14	12307-12313	review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-15	12314-12319	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-16	12320-12327	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-17	12328-12335	records	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-18	12336-12338	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-19	12339-12350	corroborate	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-20	12351-12364	self-reported	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-21	12365-12372	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-22	12373-12380	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	
62-23	12380-12381	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]	

#Text=Eligible participants returned to complete a neurobehavioral assessment that included a neuropsychological battery and computerized decision-making tasks, and an MRI brain scan.
63-1	12382-12390	Eligible	_	
63-2	12391-12403	participants	_	
63-3	12404-12412	returned	_	
63-4	12413-12415	to	_	
63-5	12416-12424	complete	_	
63-6	12425-12426	a	_	
63-7	12427-12442	neurobehavioral	_	
63-8	12443-12453	assessment	_	
63-9	12454-12458	that	_	
63-10	12459-12467	included	_	
63-11	12468-12469	a	_	
63-12	12470-12488	neuropsychological	_	
63-13	12489-12496	battery	_	
63-14	12497-12500	and	_	
63-15	12501-12513	computerized	_	
63-16	12514-12529	decision-making	_	
63-17	12530-12535	tasks	_	
63-18	12535-12536	,	_	
63-19	12537-12540	and	_	
63-20	12541-12543	an	_	
63-21	12544-12547	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
63-22	12548-12553	brain	_	
63-23	12554-12558	scan	_	
63-24	12558-12559	.	_	

#Text=Participants were instructed to abstain from using cocaine or other drugs for at least four hours prior to the MRI scan depending on the study protocol.
64-1	12560-12572	Participants	_	
64-2	12573-12577	were	_	
64-3	12578-12588	instructed	_	
64-4	12589-12591	to	_	
64-5	12592-12599	abstain	_	
64-6	12600-12604	from	_	
64-7	12605-12610	using	_	
64-8	12611-12618	cocaine	_	
64-9	12619-12621	or	_	
64-10	12622-12627	other	_	
64-11	12628-12633	drugs	_	
64-12	12634-12637	for	_	
64-13	12638-12640	at	_	
64-14	12641-12646	least	_	
64-15	12647-12651	four	_	
64-16	12652-12657	hours	_	
64-17	12658-12663	prior	_	
64-18	12664-12666	to	_	
64-19	12667-12670	the	_	
64-20	12671-12674	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
64-21	12675-12679	scan	_	
64-22	12680-12689	depending	_	
64-23	12690-12692	on	_	
64-24	12693-12696	the	_	
64-25	12697-12702	study	_	
64-26	12703-12711	protocol	_	
64-27	12711-12712	.	_	

#Text=Smokers were allowed to smoke prior to the scan to avoid nicotine withdrawal effects.
65-1	12713-12720	Smokers	_	
65-2	12721-12725	were	_	
65-3	12726-12733	allowed	_	
65-4	12734-12736	to	_	
65-5	12737-12742	smoke	_	
65-6	12743-12748	prior	_	
65-7	12749-12751	to	_	
65-8	12752-12755	the	_	
65-9	12756-12760	scan	_	
65-10	12761-12763	to	_	
65-11	12764-12769	avoid	_	
65-12	12770-12778	nicotine	_	
65-13	12779-12789	withdrawal	_	
65-14	12790-12797	effects	_	
65-15	12797-12798	.	_	

#Text=All procedures were approved by the institutional review boards at Duke University Health System and University of North Carolina at Chapel Hill.
66-1	12799-12802	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-2	12803-12813	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-3	12814-12818	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-4	12819-12827	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-5	12828-12830	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-6	12831-12834	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-7	12835-12848	institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-8	12849-12855	review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-9	12856-12862	boards	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-10	12863-12865	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-11	12866-12870	Duke	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-12	12871-12881	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-13	12882-12888	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-14	12889-12895	System	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-15	12896-12899	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-16	12900-12910	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-17	12911-12913	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-18	12914-12919	North	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-19	12920-12928	Carolina	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-20	12929-12931	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-21	12932-12938	Chapel	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-22	12939-12943	Hill	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	
66-23	12943-12944	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[22]	

#Text=Computerized decision-making tasks
#Text=During the neurobehavioral assessment, participants completed the BART, MCQ, and IGT.
67-1	12945-12957	Computerized	_	
67-2	12958-12973	decision-making	_	
67-3	12974-12979	tasks	_	
67-4	12980-12986	During	_	
67-5	12987-12990	the	_	
67-6	12991-13006	neurobehavioral	_	
67-7	13007-13017	assessment	_	
67-8	13017-13018	,	_	
67-9	13019-13031	participants	_	
67-10	13032-13041	completed	_	
67-11	13042-13045	the	_	
67-12	13046-13050	BART	_	
67-13	13050-13051	,	_	
67-14	13052-13055	MCQ	_	
67-15	13055-13056	,	_	
67-16	13057-13060	and	_	
67-17	13061-13064	IGT	_	
67-18	13064-13065	.	_	

#Text=For the BART, participants use a virtual balloon pump to blow up a series of 30 balloons, accruing 1 cent in a temporary bank for each pump.
68-1	13066-13069	For	_	
68-2	13070-13073	the	_	
68-3	13074-13078	BART	http://maven.renci.org/NeuroBridge/neurobridge#BalloonAnalogueRiskTask	
68-4	13078-13079	,	_	
68-5	13080-13092	participants	_	
68-6	13093-13096	use	_	
68-7	13097-13098	a	_	
68-8	13099-13106	virtual	_	
68-9	13107-13114	balloon	_	
68-10	13115-13119	pump	_	
68-11	13120-13122	to	_	
68-12	13123-13127	blow	_	
68-13	13128-13130	up	_	
68-14	13131-13132	a	_	
68-15	13133-13139	series	_	
68-16	13140-13142	of	_	
68-17	13143-13145	30	_	
68-18	13146-13154	balloons	_	
68-19	13154-13155	,	_	
68-20	13156-13164	accruing	_	
68-21	13165-13166	1	_	
68-22	13167-13171	cent	_	
68-23	13172-13174	in	_	
68-24	13175-13176	a	_	
68-25	13177-13186	temporary	_	
68-26	13187-13191	bank	_	
68-27	13192-13195	for	_	
68-28	13196-13200	each	_	
68-29	13201-13205	pump	_	
68-30	13205-13206	.	_	

#Text=However, if the balloon explodes, all money for that balloon is lost.
69-1	13207-13214	However	_	
69-2	13214-13215	,	_	
69-3	13216-13218	if	_	
69-4	13219-13222	the	_	
69-5	13223-13230	balloon	_	
69-6	13231-13239	explodes	_	
69-7	13239-13240	,	_	
69-8	13241-13244	all	_	
69-9	13245-13250	money	_	
69-10	13251-13254	for	_	
69-11	13255-13259	that	_	
69-12	13260-13267	balloon	_	
69-13	13268-13270	is	_	
69-14	13271-13275	lost	_	
69-15	13275-13276	.	_	

#Text=Risk taking propensity was defined as the average number of pumps on un-popped balloons, with higher scores indicating higher risk-taking propensity.
70-1	13277-13281	Risk	_	
70-2	13282-13288	taking	_	
70-3	13289-13299	propensity	_	
70-4	13300-13303	was	_	
70-5	13304-13311	defined	_	
70-6	13312-13314	as	_	
70-7	13315-13318	the	_	
70-8	13319-13326	average	_	
70-9	13327-13333	number	_	
70-10	13334-13336	of	_	
70-11	13337-13342	pumps	_	
70-12	13343-13345	on	_	
70-13	13346-13355	un-popped	_	
70-14	13356-13364	balloons	_	
70-15	13364-13365	,	_	
70-16	13366-13370	with	_	
70-17	13371-13377	higher	_	
70-18	13378-13384	scores	_	
70-19	13385-13395	indicating	_	
70-20	13396-13402	higher	_	
70-21	13403-13414	risk-taking	_	
70-22	13415-13425	propensity	_	
70-23	13425-13426	.	_	

#Text=Participants completed an adapted version of the MCQ during which they made 36 choices between smaller immediate rewards (ranging from $5 to $80) and larger delayed rewards (ranging from $25 to $85 and from 1 to 186 days).
71-1	13427-13439	Participants	_	
71-2	13440-13449	completed	_	
71-3	13450-13452	an	_	
71-4	13453-13460	adapted	_	
71-5	13461-13468	version	_	
71-6	13469-13471	of	_	
71-7	13472-13475	the	_	
71-8	13476-13479	MCQ	_	
71-9	13480-13486	during	_	
71-10	13487-13492	which	_	
71-11	13493-13497	they	_	
71-12	13498-13502	made	_	
71-13	13503-13505	36	_	
71-14	13506-13513	choices	_	
71-15	13514-13521	between	_	
71-16	13522-13529	smaller	_	
71-17	13530-13539	immediate	_	
71-18	13540-13547	rewards	_	
71-19	13548-13549	(	_	
71-20	13549-13556	ranging	_	
71-21	13557-13561	from	_	
71-22	13562-13564	$5	_	
71-23	13565-13567	to	_	
71-24	13568-13571	$80	_	
71-25	13571-13572	)	_	
71-26	13573-13576	and	_	
71-27	13577-13583	larger	_	
71-28	13584-13591	delayed	_	
71-29	13592-13599	rewards	_	
71-30	13600-13601	(	_	
71-31	13601-13608	ranging	_	
71-32	13609-13613	from	_	
71-33	13614-13617	$25	_	
71-34	13618-13620	to	_	
71-35	13621-13624	$85	_	
71-36	13625-13628	and	_	
71-37	13629-13633	from	_	
71-38	13634-13635	1	_	
71-39	13636-13638	to	_	
71-40	13639-13642	186	_	
71-41	13643-13647	days	_	
71-42	13647-13648	)	_	
71-43	13648-13649	.	_	

#Text=An individuals point of indifference where the perceived value of a smaller immediate reward is equivalent to a larger delayed reward was computed using the following hyperbolic function: Vimmediate= Vdelayed/(1 + kD), in which V is value in dollars, D is delay in days, and k is a free parameter that determines the discount rate.
72-1	13650-13652	An	_	
72-2	13653-13663	individual	_	
72-3	13663-13664		_	
72-4	13664-13665	s	_	
72-5	13666-13671	point	_	
72-6	13672-13674	of	_	
72-7	13675-13687	indifference	_	
72-8	13688-13693	where	_	
72-9	13694-13697	the	_	
72-10	13698-13707	perceived	_	
72-11	13708-13713	value	_	
72-12	13714-13716	of	_	
72-13	13717-13718	a	_	
72-14	13719-13726	smaller	_	
72-15	13727-13736	immediate	_	
72-16	13737-13743	reward	_	
72-17	13744-13746	is	_	
72-18	13747-13757	equivalent	_	
72-19	13758-13760	to	_	
72-20	13761-13762	a	_	
72-21	13763-13769	larger	_	
72-22	13770-13777	delayed	_	
72-23	13778-13784	reward	_	
72-24	13785-13788	was	_	
72-25	13789-13797	computed	_	
72-26	13798-13803	using	_	
72-27	13804-13807	the	_	
72-28	13808-13817	following	_	
72-29	13818-13828	hyperbolic	_	
72-30	13829-13837	function	_	
72-31	13837-13838	:	_	
72-32	13839-13849	Vimmediate	_	
72-33	13849-13850	=	_	
72-34	13851-13859	Vdelayed	_	
72-35	13859-13860	/	_	
72-36	13860-13861	(	_	
72-37	13861-13862	1	_	
72-38	13863-13864	+	_	
72-39	13865-13867	kD	_	
72-40	13867-13868	)	_	
72-41	13868-13869	,	_	
72-42	13870-13872	in	_	
72-43	13873-13878	which	_	
72-44	13879-13880	V	_	
72-45	13881-13883	is	_	
72-46	13884-13889	value	_	
72-47	13890-13892	in	_	
72-48	13893-13900	dollars	_	
72-49	13900-13901	,	_	
72-50	13902-13903	D	_	
72-51	13904-13906	is	_	
72-52	13907-13912	delay	_	
72-53	13913-13915	in	_	
72-54	13916-13920	days	_	
72-55	13920-13921	,	_	
72-56	13922-13925	and	_	
72-57	13926-13927	k	_	
72-58	13928-13930	is	_	
72-59	13931-13932	a	_	
72-60	13933-13937	free	_	
72-61	13938-13947	parameter	_	
72-62	13948-13952	that	_	
72-63	13953-13963	determines	_	
72-64	13964-13967	the	_	
72-65	13968-13976	discount	_	
72-66	13977-13981	rate	_	
72-67	13981-13982	.	_	

#Text=K values ranged from 0.00016 to 4.00 and the natural log of the mean k value was used for analyses.
73-1	13983-13984	K	_	
73-2	13985-13991	values	_	
73-3	13992-13998	ranged	_	
73-4	13999-14003	from	_	
73-5	14004-14011	0.00016	_	
73-6	14012-14014	to	_	
73-7	14015-14019	4.00	_	
73-8	14020-14023	and	_	
73-9	14024-14027	the	_	
73-10	14028-14035	natural	_	
73-11	14036-14039	log	_	
73-12	14040-14042	of	_	
73-13	14043-14046	the	_	
73-14	14047-14051	mean	_	
73-15	14052-14053	k	_	
73-16	14054-14059	value	_	
73-17	14060-14063	was	_	
73-18	14064-14068	used	_	
73-19	14069-14072	for	_	
73-20	14073-14081	analyses	_	
73-21	14081-14082	.	_	

#Text=This task was adapted from the original scale to include nine extra items to accommodate a wider range in delay discounting (impulsive) behavior for cocaine users whose scores may be limited by a ceiling effect [see for details].
74-1	14083-14087	This	_	
74-2	14088-14092	task	_	
74-3	14093-14096	was	_	
74-4	14097-14104	adapted	_	
74-5	14105-14109	from	_	
74-6	14110-14113	the	_	
74-7	14114-14122	original	_	
74-8	14123-14128	scale	_	
74-9	14129-14131	to	_	
74-10	14132-14139	include	_	
74-11	14140-14144	nine	_	
74-12	14145-14150	extra	_	
74-13	14151-14156	items	_	
74-14	14157-14159	to	_	
74-15	14160-14171	accommodate	_	
74-16	14172-14173	a	_	
74-17	14174-14179	wider	_	
74-18	14180-14185	range	_	
74-19	14186-14188	in	_	
74-20	14189-14194	delay	_	
74-21	14195-14206	discounting	_	
74-22	14207-14208	(	_	
74-23	14208-14217	impulsive	_	
74-24	14217-14218	)	_	
74-25	14219-14227	behavior	_	
74-26	14228-14231	for	_	
74-27	14232-14239	cocaine	_	
74-28	14240-14245	users	_	
74-29	14246-14251	whose	_	
74-30	14252-14258	scores	_	
74-31	14259-14262	may	_	
74-32	14263-14265	be	_	
74-33	14266-14273	limited	_	
74-34	14274-14276	by	_	
74-35	14277-14278	a	_	
74-36	14279-14286	ceiling	_	
74-37	14287-14293	effect	_	
74-38	14294-14295	[	_	
74-39	14295-14298	see	_	
74-40	14299-14302	for	_	
74-41	14303-14310	details	_	
74-42	14310-14311	]	_	
74-43	14311-14312	.	_	

#Text=For the IGT, participants selected cards from four decks to accumulate as much money as possible.
75-1	14313-14316	For	_	
75-2	14317-14320	the	_	
75-3	14321-14324	IGT	_	
75-4	14324-14325	,	_	
75-5	14326-14338	participants	_	
75-6	14339-14347	selected	_	
75-7	14348-14353	cards	_	
75-8	14354-14358	from	_	
75-9	14359-14363	four	_	
75-10	14364-14369	decks	_	
75-11	14370-14372	to	_	
75-12	14373-14383	accumulate	_	
75-13	14384-14386	as	_	
75-14	14387-14391	much	_	
75-15	14392-14397	money	_	
75-16	14398-14400	as	_	
75-17	14401-14409	possible	_	
75-18	14409-14410	.	_	

#Text=All cards were followed by feedback that the participant won a specified monetary amount, but some cards were also followed by feedback that the participant lost a specified monetary amount in addition to their win amount.
76-1	14411-14414	All	_	
76-2	14415-14420	cards	_	
76-3	14421-14425	were	_	
76-4	14426-14434	followed	_	
76-5	14435-14437	by	_	
76-6	14438-14446	feedback	_	
76-7	14447-14451	that	_	
76-8	14452-14455	the	_	
76-9	14456-14467	participant	_	
76-10	14468-14471	won	_	
76-11	14472-14473	a	_	
76-12	14474-14483	specified	_	
76-13	14484-14492	monetary	_	
76-14	14493-14499	amount	_	
76-15	14499-14500	,	_	
76-16	14501-14504	but	_	
76-17	14505-14509	some	_	
76-18	14510-14515	cards	_	
76-19	14516-14520	were	_	
76-20	14521-14525	also	_	
76-21	14526-14534	followed	_	
76-22	14535-14537	by	_	
76-23	14538-14546	feedback	_	
76-24	14547-14551	that	_	
76-25	14552-14555	the	_	
76-26	14556-14567	participant	_	
76-27	14568-14572	lost	_	
76-28	14573-14574	a	_	
76-29	14575-14584	specified	_	
76-30	14585-14593	monetary	_	
76-31	14594-14600	amount	_	
76-32	14601-14603	in	_	
76-33	14604-14612	addition	_	
76-34	14613-14615	to	_	
76-35	14616-14621	their	_	
76-36	14622-14625	win	_	
76-37	14626-14632	amount	_	
76-38	14632-14633	.	_	

#Text=A green bar increased in size on the screen for each win amount and a red bar increased in size for each loss amount.
77-1	14634-14635	A	_	
77-2	14636-14641	green	_	
77-3	14642-14645	bar	_	
77-4	14646-14655	increased	_	
77-5	14656-14658	in	_	
77-6	14659-14663	size	_	
77-7	14664-14666	on	_	
77-8	14667-14670	the	_	
77-9	14671-14677	screen	_	
77-10	14678-14681	for	_	
77-11	14682-14686	each	_	
77-12	14687-14690	win	_	
77-13	14691-14697	amount	_	
77-14	14698-14701	and	_	
77-15	14702-14703	a	_	
77-16	14704-14707	red	_	
77-17	14708-14711	bar	_	
77-18	14712-14721	increased	_	
77-19	14722-14724	in	_	
77-20	14725-14729	size	_	
77-21	14730-14733	for	_	
77-22	14734-14738	each	_	
77-23	14739-14743	loss	_	
77-24	14744-14750	amount	_	
77-25	14750-14751	.	_	

#Text=A score of contingency-based learning was determined by the number of cards picked from the negative-expected-value decks subtracted from the number of cards picked from the positive-expected-value decks.
78-1	14752-14753	A	_	
78-2	14754-14759	score	_	
78-3	14760-14762	of	_	
78-4	14763-14780	contingency-based	_	
78-5	14781-14789	learning	_	
78-6	14790-14793	was	_	
78-7	14794-14804	determined	_	
78-8	14805-14807	by	_	
78-9	14808-14811	the	_	
78-10	14812-14818	number	_	
78-11	14819-14821	of	_	
78-12	14822-14827	cards	_	
78-13	14828-14834	picked	_	
78-14	14835-14839	from	_	
78-15	14840-14843	the	_	
78-16	14844-14867	negative-expected-value	_	
78-17	14868-14873	decks	_	
78-18	14874-14884	subtracted	_	
78-19	14885-14889	from	_	
78-20	14890-14893	the	_	
78-21	14894-14900	number	_	
78-22	14901-14903	of	_	
78-23	14904-14909	cards	_	
78-24	14910-14916	picked	_	
78-25	14917-14921	from	_	
78-26	14922-14925	the	_	
78-27	14926-14949	positive-expected-value	_	
78-28	14950-14955	decks	_	
78-29	14955-14956	.	_	

#Text=Higher scores indicate better contingency-based learning.
79-1	14957-14963	Higher	_	
79-2	14964-14970	scores	_	
79-3	14971-14979	indicate	_	
79-4	14980-14986	better	_	
79-5	14987-15004	contingency-based	_	
79-6	15005-15013	learning	_	
79-7	15013-15014	.	_	

#Text=MRI data acquisition
#Text=All scans were performed at Duke University Hospital using a 3T GE MR750 (Milwaukee, WI, USA) scanner with an eight-channel head coil.
80-1	15015-15018	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
80-2	15019-15023	data	_	
80-3	15024-15035	acquisition	_	
80-4	15036-15039	All	_	
80-5	15040-15045	scans	_	
80-6	15046-15050	were	_	
80-7	15051-15060	performed	_	
80-8	15061-15063	at	_	
80-9	15064-15068	Duke	_	
80-10	15069-15079	University	_	
80-11	15080-15088	Hospital	_	
80-12	15089-15094	using	_	
80-13	15095-15096	a	_	
80-14	15097-15099	3T	_	
80-15	15100-15102	GE	_	
80-16	15103-15108	MR750	_	
80-17	15109-15110	(	_	
80-18	15110-15119	Milwaukee	_	
80-19	15119-15120	,	_	
80-20	15121-15123	WI	_	
80-21	15123-15124	,	_	
80-22	15125-15128	USA	_	
80-23	15128-15129	)	_	
80-24	15130-15137	scanner	_	
80-25	15138-15142	with	_	
80-26	15143-15145	an	_	
80-27	15146-15159	eight-channel	_	
80-28	15160-15164	head	_	
80-29	15165-15169	coil	_	
80-30	15169-15170	.	_	

#Text=Whole-brain BOLD images were collected using T2*-weighted echo-planar imaging with the following parameters: TR=2s; TE=27ms (study 1) or 25 ms (study 2); FOV=24cm; in-plane matrix size= 64  64; and slice thickness= 3.8mm, resulting in 39 axial slices (study 1) or 35 slices (study 2), each with a voxel size of 3.75mm  3.75mm  3.8mm, for a total of 150 (study 1) or 156 volumes (study 2).
81-1	15171-15182	Whole-brain	_	
81-2	15183-15187	BOLD	_	
81-3	15188-15194	images	_	
81-4	15195-15199	were	_	
81-5	15200-15209	collected	_	
81-6	15210-15215	using	_	
81-7	15216-15218	T2	_	
81-8	15218-15219	*	_	
81-9	15219-15220	-	_	
81-10	15220-15228	weighted	_	
81-11	15229-15240	echo-planar	_	
81-12	15241-15248	imaging	_	
81-13	15249-15253	with	_	
81-14	15254-15257	the	_	
81-15	15258-15267	following	_	
81-16	15268-15278	parameters	_	
81-17	15278-15279	:	_	
81-18	15280-15282	TR	_	
81-19	15282-15283	=	_	
81-20	15283-15285	2s	_	
81-21	15285-15286	;	_	
81-22	15287-15289	TE	_	
81-23	15289-15290	=	_	
81-24	15290-15294	27ms	_	
81-25	15295-15296	(	_	
81-26	15296-15301	study	_	
81-27	15302-15303	1	_	
81-28	15303-15304	)	_	
81-29	15305-15307	or	_	
81-30	15308-15310	25	_	
81-31	15311-15313	ms	_	
81-32	15314-15315	(	_	
81-33	15315-15320	study	_	
81-34	15321-15322	2	_	
81-35	15322-15323	)	_	
81-36	15323-15324	;	_	
81-37	15325-15328	FOV	_	
81-38	15328-15329	=	_	
81-39	15329-15333	24cm	_	
81-40	15333-15334	;	_	
81-41	15335-15343	in-plane	_	
81-42	15344-15350	matrix	_	
81-43	15351-15355	size	_	
81-44	15355-15356	=	_	
81-45	15357-15359	64	_	
81-46	15360-15361		_	
81-47	15362-15364	64	_	
81-48	15364-15365	;	_	
81-49	15366-15369	and	_	
81-50	15370-15375	slice	_	
81-51	15376-15385	thickness	_	
81-52	15385-15386	=	_	
81-53	15387-15392	3.8mm	_	
81-54	15392-15393	,	_	
81-55	15394-15403	resulting	_	
81-56	15404-15406	in	_	
81-57	15407-15409	39	_	
81-58	15410-15415	axial	_	
81-59	15416-15422	slices	_	
81-60	15423-15424	(	_	
81-61	15424-15429	study	_	
81-62	15430-15431	1	_	
81-63	15431-15432	)	_	
81-64	15433-15435	or	_	
81-65	15436-15438	35	_	
81-66	15439-15445	slices	_	
81-67	15446-15447	(	_	
81-68	15447-15452	study	_	
81-69	15453-15454	2	_	
81-70	15454-15455	)	_	
81-71	15455-15456	,	_	
81-72	15457-15461	each	_	
81-73	15462-15466	with	_	
81-74	15467-15468	a	_	
81-75	15469-15474	voxel	_	
81-76	15475-15479	size	_	
81-77	15480-15482	of	_	
81-78	15483-15489	3.75mm	_	
81-79	15490-15491		_	
81-80	15492-15498	3.75mm	_	
81-81	15499-15500		_	
81-82	15501-15506	3.8mm	_	
81-83	15506-15507	,	_	
81-84	15508-15511	for	_	
81-85	15512-15513	a	_	
81-86	15514-15519	total	_	
81-87	15520-15522	of	_	
81-88	15523-15526	150	_	
81-89	15527-15528	(	_	
81-90	15528-15533	study	_	
81-91	15534-15535	1	_	
81-92	15535-15536	)	_	
81-93	15537-15539	or	_	
81-94	15540-15543	156	_	
81-95	15544-15551	volumes	_	
81-96	15552-15553	(	_	
81-97	15553-15558	study	_	
81-98	15559-15560	2	_	
81-99	15560-15561	)	_	
81-100	15561-15562	.	_	

#Text=Participants were instructed to view a cross-hair displayed via projector onto a screen within the scanner bore.
82-1	15563-15575	Participants	_	
82-2	15576-15580	were	_	
82-3	15581-15591	instructed	_	
82-4	15592-15594	to	_	
82-5	15595-15599	view	_	
82-6	15600-15601	a	_	
82-7	15602-15612	cross-hair	_	
82-8	15613-15622	displayed	_	
82-9	15623-15626	via	_	
82-10	15627-15636	projector	_	
82-11	15637-15641	onto	_	
82-12	15642-15643	a	_	
82-13	15644-15650	screen	_	
82-14	15651-15657	within	_	
82-15	15658-15661	the	_	
82-16	15662-15669	scanner	_	
82-17	15670-15674	bore	_	
82-18	15674-15675	.	_	

#Text=Tl-weighted structural images used for registration were acquired with the following parameters: TR=8.096ms (study 1) and 8.156ms (study 2); TE=3.18ms; FOV=25.6cm; flip angle=12; in-plane matrix size=256256; slice thickness=lmm; and number of slices = 166.
83-1	15676-15687	Tl-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging	
83-2	15688-15698	structural	_	
83-3	15699-15705	images	_	
83-4	15706-15710	used	_	
83-5	15711-15714	for	_	
83-6	15715-15727	registration	_	
83-7	15728-15732	were	_	
83-8	15733-15741	acquired	_	
83-9	15742-15746	with	_	
83-10	15747-15750	the	_	
83-11	15751-15760	following	_	
83-12	15761-15771	parameters	_	
83-13	15771-15772	:	_	
83-14	15773-15775	TR	_	
83-15	15775-15776	=	_	
83-16	15776-15783	8.096ms	_	
83-17	15784-15785	(	_	
83-18	15785-15790	study	_	
83-19	15791-15792	1	_	
83-20	15792-15793	)	_	
83-21	15794-15797	and	_	
83-22	15798-15805	8.156ms	_	
83-23	15806-15807	(	_	
83-24	15807-15812	study	_	
83-25	15813-15814	2	_	
83-26	15814-15815	)	_	
83-27	15815-15816	;	_	
83-28	15817-15819	TE	_	
83-29	15819-15820	=	_	
83-30	15820-15826	3.18ms	_	
83-31	15826-15827	;	_	
83-32	15828-15831	FOV	_	
83-33	15831-15832	=	_	
83-34	15832-15838	25.6cm	_	
83-35	15838-15839	;	_	
83-36	15840-15844	flip	_	
83-37	15845-15850	angle	_	
83-38	15850-15851	=	_	
83-39	15851-15853	12	_	
83-40	15853-15854		_	
83-41	15854-15855	;	_	
83-42	15856-15864	in-plane	_	
83-43	15865-15871	matrix	_	
83-44	15872-15876	size	_	
83-45	15876-15877	=	_	
83-46	15877-15880	256	_	
83-47	15880-15881		_	
83-48	15881-15884	256	_	
83-49	15884-15885	;	_	
83-50	15886-15891	slice	_	
83-51	15892-15901	thickness	_	
83-52	15901-15902	=	_	
83-53	15902-15905	lmm	_	
83-54	15905-15906	;	_	
83-55	15907-15910	and	_	
83-56	15911-15917	number	_	
83-57	15918-15920	of	_	
83-58	15921-15927	slices	_	
83-59	15928-15929	=	_	
83-60	15930-15933	166	_	
83-61	15933-15934	.	_	

#Text=There was a similar proportion of participants from each study in the cocaine use and control groups (2(1, 72)=0.83, p=.36).
#Text=2.5 Data analysis
#Text=Standard flvfRI preprocessing.
84-1	15935-15940	There	_	
84-2	15941-15944	was	_	
84-3	15945-15946	a	_	
84-4	15947-15954	similar	_	
84-5	15955-15965	proportion	_	
84-6	15966-15968	of	_	
84-7	15969-15981	participants	_	
84-8	15982-15986	from	_	
84-9	15987-15991	each	_	
84-10	15992-15997	study	_	
84-11	15998-16000	in	_	
84-12	16001-16004	the	_	
84-13	16005-16012	cocaine	_	
84-14	16013-16016	use	_	
84-15	16017-16020	and	_	
84-16	16021-16028	control	_	
84-17	16029-16035	groups	_	
84-18	16036-16037	(	_	
84-19	16037-16039	2	_	
84-20	16039-16040	(	_	
84-21	16040-16041	1	_	
84-22	16041-16042	,	_	
84-23	16043-16045	72	_	
84-24	16045-16046	)	_	
84-25	16046-16047	=	_	
84-26	16047-16051	0.83	_	
84-27	16051-16052	,	_	
84-28	16053-16054	p	_	
84-29	16054-16055	=	_	
84-30	16055-16058	.36	_	
84-31	16058-16059	)	_	
84-32	16059-16060	.	_	
84-33	16061-16064	2.5	_	
84-34	16065-16069	Data	_	
84-35	16070-16078	analysis	_	
84-36	16079-16087	Standard	_	
84-37	16088-16094	flvfRI	_	
84-38	16095-16108	preprocessing	_	
84-39	16108-16109	.	_	

#Text=Image preprocessing and analyses were performed with FSL 5.0.1.
85-1	16110-16115	Image	_	
85-2	16116-16129	preprocessing	_	
85-3	16130-16133	and	_	
85-4	16134-16142	analyses	_	
85-5	16143-16147	were	_	
85-6	16148-16157	performed	_	
85-7	16158-16162	with	_	
85-8	16163-16166	FSL	_	
85-9	16167-16172	5.0.1	_	
85-10	16172-16173	.	_	

#Text=Images were skull-stripped, corrected for slice timing, registered to high resolution anatomical images (full search, 12 degrees of freedom [DOF]) and to standard MNI-152 space (nonlinear registration, normal search, 12 DOF), spatially smoothed (full-width-half-maximum= 6mm), and intensity normalized (mean= 1000).
86-1	16174-16180	Images	_	
86-2	16181-16185	were	_	
86-3	16186-16200	skull-stripped	_	
86-4	16200-16201	,	_	
86-5	16202-16211	corrected	_	
86-6	16212-16215	for	_	
86-7	16216-16221	slice	_	
86-8	16222-16228	timing	_	
86-9	16228-16229	,	_	
86-10	16230-16240	registered	_	
86-11	16241-16243	to	_	
86-12	16244-16248	high	_	
86-13	16249-16259	resolution	_	
86-14	16260-16270	anatomical	_	
86-15	16271-16277	images	_	
86-16	16278-16279	(	_	
86-17	16279-16283	full	_	
86-18	16284-16290	search	_	
86-19	16290-16291	,	_	
86-20	16292-16294	12	_	
86-21	16295-16302	degrees	_	
86-22	16303-16305	of	_	
86-23	16306-16313	freedom	_	
86-24	16314-16315	[	_	
86-25	16315-16318	DOF	_	
86-26	16318-16319	]	_	
86-27	16319-16320	)	_	
86-28	16321-16324	and	_	
86-29	16325-16327	to	_	
86-30	16328-16336	standard	_	
86-31	16337-16340	MNI	_	
86-32	16340-16341	-	_	
86-33	16341-16344	152	_	
86-34	16345-16350	space	_	
86-35	16351-16352	(	_	
86-36	16352-16361	nonlinear	_	
86-37	16362-16374	registration	_	
86-38	16374-16375	,	_	
86-39	16376-16382	normal	_	
86-40	16383-16389	search	_	
86-41	16389-16390	,	_	
86-42	16391-16393	12	_	
86-43	16394-16397	DOF	_	
86-44	16397-16398	)	_	
86-45	16398-16399	,	_	
86-46	16400-16409	spatially	_	
86-47	16410-16418	smoothed	_	
86-48	16419-16420	(	_	
86-49	16420-16443	full-width-half-maximum	_	
86-50	16443-16444	=	_	
86-51	16445-16448	6mm	_	
86-52	16448-16449	)	_	
86-53	16449-16450	,	_	
86-54	16451-16454	and	_	
86-55	16455-16464	intensity	_	
86-56	16465-16475	normalized	_	
86-57	16476-16477	(	_	
86-58	16477-16481	mean	_	
86-59	16481-16482	=	_	
86-60	16483-16487	1000	_	
86-61	16487-16488	)	_	
86-62	16488-16489	.	_	

#Text=All scans were shortened to 145 volumes during preprocessing.
87-1	16490-16493	All	_	
87-2	16494-16499	scans	_	
87-3	16500-16504	were	_	
87-4	16505-16514	shortened	_	
87-5	16515-16517	to	_	
87-6	16518-16521	145	_	
87-7	16522-16529	volumes	_	
87-8	16530-16536	during	_	
87-9	16537-16550	preprocessing	_	
87-10	16550-16551	.	_	

#Text=Given the sensitivity of resting state analyses to motion artifacts and other forms of signal noise, the data underwent extensive preprocessing.
88-1	16552-16557	Given	_	
88-2	16558-16561	the	_	
88-3	16562-16573	sensitivity	_	
88-4	16574-16576	of	_	
88-5	16577-16584	resting	_	
88-6	16585-16590	state	_	
88-7	16591-16599	analyses	_	
88-8	16600-16602	to	_	
88-9	16603-16609	motion	_	
88-10	16610-16619	artifacts	_	
88-11	16620-16623	and	_	
88-12	16624-16629	other	_	
88-13	16630-16635	forms	_	
88-14	16636-16638	of	_	
88-15	16639-16645	signal	_	
88-16	16646-16651	noise	_	
88-17	16651-16652	,	_	
88-18	16653-16656	the	_	
88-19	16657-16661	data	_	
88-20	16662-16671	underwent	_	
88-21	16672-16681	extensive	_	
88-22	16682-16695	preprocessing	_	
88-23	16695-16696	.	_	

#Text=FSLs MCFLIRT intra-modal motion correction tool was used to correct for motion parameters.
89-1	16697-16700	FSL	_	
89-2	16700-16701		_	
89-3	16701-16702	s	_	
89-4	16703-16710	MCFLIRT	_	
89-5	16711-16722	intra-modal	_	
89-6	16723-16729	motion	_	
89-7	16730-16740	correction	_	
89-8	16741-16745	tool	_	
89-9	16746-16749	was	_	
89-10	16750-16754	used	_	
89-11	16755-16757	to	_	
89-12	16758-16765	correct	_	
89-13	16766-16769	for	_	
89-14	16770-16776	motion	_	
89-15	16777-16787	parameters	_	
89-16	16787-16788	.	_	

#Text=No participants were excluded for relative mean displacement >0.3 mm (M= 0.09 mm, SD= 0.05).
90-1	16789-16791	No	_	
90-2	16792-16804	participants	_	
90-3	16805-16809	were	_	
90-4	16810-16818	excluded	_	
90-5	16819-16822	for	_	
90-6	16823-16831	relative	_	
90-7	16832-16836	mean	_	
90-8	16837-16849	displacement	_	
90-9	16850-16851	>	_	
90-10	16851-16854	0.3	_	
90-11	16855-16857	mm	_	
90-12	16858-16859	(	_	
90-13	16859-16860	M	_	
90-14	16860-16861	=	_	
90-15	16862-16866	0.09	_	
90-16	16867-16869	mm	_	
90-17	16869-16870	,	_	
90-18	16871-16873	SD	_	
90-19	16873-16874	=	_	
90-20	16875-16879	0.05	_	
90-21	16879-16880	)	_	
90-22	16880-16881	.	_	

#Text=The preprocessed functional data were further motion-corrected with independent component analysis-based automatic removal of motion artifacts (ICA-AROMA), which employs an algorithm to identify and regress out signal associated with artifacts, while preserving signal of interest.
91-1	16882-16885	The	_	
91-2	16886-16898	preprocessed	_	
91-3	16899-16909	functional	_	
91-4	16910-16914	data	_	
91-5	16915-16919	were	_	
91-6	16920-16927	further	_	
91-7	16928-16944	motion-corrected	_	
91-8	16945-16949	with	_	
91-9	16950-16961	independent	_	
91-10	16962-16971	component	_	
91-11	16972-16986	analysis-based	_	
91-12	16987-16996	automatic	_	
91-13	16997-17004	removal	_	
91-14	17005-17007	of	_	
91-15	17008-17014	motion	_	
91-16	17015-17024	artifacts	_	
91-17	17025-17026	(	_	
91-18	17026-17035	ICA-AROMA	_	
91-19	17035-17036	)	_	
91-20	17036-17037	,	_	
91-21	17038-17043	which	_	
91-22	17044-17051	employs	_	
91-23	17052-17054	an	_	
91-24	17055-17064	algorithm	_	
91-25	17065-17067	to	_	
91-26	17068-17076	identify	_	
91-27	17077-17080	and	_	
91-28	17081-17088	regress	_	
91-29	17089-17092	out	_	
91-30	17093-17099	signal	_	
91-31	17100-17110	associated	_	
91-32	17111-17115	with	_	
91-33	17116-17125	artifacts	_	
91-34	17125-17126	,	_	
91-35	17127-17132	while	_	
91-36	17133-17143	preserving	_	
91-37	17144-17150	signal	_	
91-38	17151-17153	of	_	
91-39	17154-17162	interest	_	
91-40	17162-17163	.	_	

#Text=As the final preprocessing step, a high-pass temporal filter of 100 seconds was applied and the filtered, denoised data were registered to MNI standard space.
92-1	17164-17166	As	_	
92-2	17167-17170	the	_	
92-3	17171-17176	final	_	
92-4	17177-17190	preprocessing	_	
92-5	17191-17195	step	_	
92-6	17195-17196	,	_	
92-7	17197-17198	a	_	
92-8	17199-17208	high-pass	_	
92-9	17209-17217	temporal	_	
92-10	17218-17224	filter	_	
92-11	17225-17227	of	_	
92-12	17228-17231	100	_	
92-13	17232-17239	seconds	_	
92-14	17240-17243	was	_	
92-15	17244-17251	applied	_	
92-16	17252-17255	and	_	
92-17	17256-17259	the	_	
92-18	17260-17268	filtered	_	
92-19	17268-17269	,	_	
92-20	17270-17278	denoised	_	
92-21	17279-17283	data	_	
92-22	17284-17288	were	_	
92-23	17289-17299	registered	_	
92-24	17300-17302	to	_	
92-25	17303-17306	MNI	_	
92-26	17307-17315	standard	_	
92-27	17316-17321	space	_	
92-28	17321-17322	.	_	

#Text=Using FSLs motion outliers tool, cocaine users had higher average root mean square intensity differences (refrms) for each run after correction with ICA-AROMA (t(70)=2.77, p=.007).
93-1	17323-17328	Using	_	
93-2	17329-17332	FSL	_	
93-3	17332-17333		_	
93-4	17333-17334	s	_	
93-5	17335-17341	motion	_	
93-6	17342-17350	outliers	_	
93-7	17351-17355	tool	_	
93-8	17355-17356	,	_	
93-9	17357-17364	cocaine	_	
93-10	17365-17370	users	_	
93-11	17371-17374	had	_	
93-12	17375-17381	higher	_	
93-13	17382-17389	average	_	
93-14	17390-17394	root	_	
93-15	17395-17399	mean	_	
93-16	17400-17406	square	_	
93-17	17407-17416	intensity	_	
93-18	17417-17428	differences	_	
93-19	17429-17430	(	_	
93-20	17430-17436	refrms	_	
93-21	17436-17437	)	_	
93-22	17438-17441	for	_	
93-23	17442-17446	each	_	
93-24	17447-17450	run	_	
93-25	17451-17456	after	_	
93-26	17457-17467	correction	_	
93-27	17468-17472	with	_	
93-28	17473-17482	ICA-AROMA	_	
93-29	17483-17484	(	_	
93-30	17484-17485	t	_	
93-31	17485-17486	(	_	
93-32	17486-17488	70	_	
93-33	17488-17489	)	_	
93-34	17489-17490	=	_	
93-35	17490-17494	2.77	_	
93-36	17494-17495	,	_	
93-37	17496-17497	p	_	
93-38	17497-17498	=	_	
93-39	17498-17502	.007	_	
93-40	17502-17503	)	_	
93-41	17503-17504	.	_	

#Text=To control for group differences, refrms was included as a covariate in all group-level analyses.
94-1	17505-17507	To	_	
94-2	17508-17515	control	_	
94-3	17516-17519	for	_	
94-4	17520-17525	group	_	
94-5	17526-17537	differences	_	
94-6	17537-17538	,	_	
94-7	17539-17545	refrms	_	
94-8	17546-17549	was	_	
94-9	17550-17558	included	_	
94-10	17559-17561	as	_	
94-11	17562-17563	a	_	
94-12	17564-17573	covariate	_	
94-13	17574-17576	in	_	
94-14	17577-17580	all	_	
94-15	17581-17592	group-level	_	
94-16	17593-17601	analyses	_	
94-17	17601-17602	.	_	

#Text=Finally, as described in the next section, probabilistic independent component analysis (PICA) was used to isolate artifactual motion-related networks from our networks of interest.
95-1	17603-17610	Finally	_	
95-2	17610-17611	,	_	
95-3	17612-17614	as	_	
95-4	17615-17624	described	_	
95-5	17625-17627	in	_	
95-6	17628-17631	the	_	
95-7	17632-17636	next	_	
95-8	17637-17644	section	_	
95-9	17644-17645	,	_	
95-10	17646-17659	probabilistic	_	
95-11	17660-17671	independent	_	
95-12	17672-17681	component	_	
95-13	17682-17690	analysis	_	
95-14	17691-17692	(	_	
95-15	17692-17696	PICA	_	
95-16	17696-17697	)	_	
95-17	17698-17701	was	_	
95-18	17702-17706	used	_	
95-19	17707-17709	to	_	
95-20	17710-17717	isolate	_	
95-21	17718-17729	artifactual	_	
95-22	17730-17744	motion-related	_	
95-23	17745-17753	networks	_	
95-24	17754-17758	from	_	
95-25	17759-17762	our	_	
95-26	17763-17771	networks	_	
95-27	17772-17774	of	_	
95-28	17775-17783	interest	_	
95-29	17783-17784	.	_	

#Text=Network identification.
96-1	17785-17792	Network	_	
96-2	17793-17807	identification	_	
96-3	17807-17808	.	_	

#Text=To identify reward and executive control networks, functional runs from all participants were subjected to PICA using MELODIC with multi-session temporal concatenation and automatic component estimation.
97-1	17809-17811	To	_	
97-2	17812-17820	identify	_	
97-3	17821-17827	reward	_	
97-4	17828-17831	and	_	
97-5	17832-17841	executive	_	
97-6	17842-17849	control	_	
97-7	17850-17858	networks	_	
97-8	17858-17859	,	_	
97-9	17860-17870	functional	_	
97-10	17871-17875	runs	_	
97-11	17876-17880	from	_	
97-12	17881-17884	all	_	
97-13	17885-17897	participants	_	
97-14	17898-17902	were	_	
97-15	17903-17912	subjected	_	
97-16	17913-17915	to	_	
97-17	17916-17920	PICA	_	
97-18	17921-17926	using	_	
97-19	17927-17934	MELODIC	_	
97-20	17935-17939	with	_	
97-21	17940-17953	multi-session	_	
97-22	17954-17962	temporal	_	
97-23	17963-17976	concatenation	_	
97-24	17977-17980	and	_	
97-25	17981-17990	automatic	_	
97-26	17991-18000	component	_	
97-27	18001-18011	estimation	_	
97-28	18011-18012	.	_	

#Text=Pre-processing in MELODIC included masking of non-brain voxels, voxel-wise de-meaning of the data, and normalization of the voxel-wise variance.
98-1	18013-18027	Pre-processing	_	
98-2	18028-18030	in	_	
98-3	18031-18038	MELODIC	_	
98-4	18039-18047	included	_	
98-5	18048-18055	masking	_	
98-6	18056-18058	of	_	
98-7	18059-18068	non-brain	_	
98-8	18069-18075	voxels	_	
98-9	18075-18076	,	_	
98-10	18077-18087	voxel-wise	_	
98-11	18088-18098	de-meaning	_	
98-12	18099-18101	of	_	
98-13	18102-18105	the	_	
98-14	18106-18110	data	_	
98-15	18110-18111	,	_	
98-16	18112-18115	and	_	
98-17	18116-18129	normalization	_	
98-18	18130-18132	of	_	
98-19	18133-18136	the	_	
98-20	18137-18147	voxel-wise	_	
98-21	18148-18156	variance	_	
98-22	18156-18157	.	_	

#Text=Component maps were thresholded using an alternative hypothesis test based on fitting a Gaussian/gamma mixture model to the distribution of voxel intensities within spatial maps and controlling the local false-discovery rate at p < 0.05.
99-1	18158-18167	Component	_	
99-2	18168-18172	maps	_	
99-3	18173-18177	were	_	
99-4	18178-18189	thresholded	_	
99-5	18190-18195	using	_	
99-6	18196-18198	an	_	
99-7	18199-18210	alternative	_	
99-8	18211-18221	hypothesis	_	
99-9	18222-18226	test	_	
99-10	18227-18232	based	_	
99-11	18233-18235	on	_	
99-12	18236-18243	fitting	_	
99-13	18244-18245	a	_	
99-14	18246-18254	Gaussian	_	
99-15	18254-18255	/	_	
99-16	18255-18260	gamma	_	
99-17	18261-18268	mixture	_	
99-18	18269-18274	model	_	
99-19	18275-18277	to	_	
99-20	18278-18281	the	_	
99-21	18282-18294	distribution	_	
99-22	18295-18297	of	_	
99-23	18298-18303	voxel	_	
99-24	18304-18315	intensities	_	
99-25	18316-18322	within	_	
99-26	18323-18330	spatial	_	
99-27	18331-18335	maps	_	
99-28	18336-18339	and	_	
99-29	18340-18351	controlling	_	
99-30	18352-18355	the	_	
99-31	18356-18361	local	_	
99-32	18362-18377	false-discovery	_	
99-33	18378-18382	rate	_	
99-34	18383-18385	at	_	
99-35	18386-18387	p	_	
99-36	18388-18389	<	_	
99-37	18390-18394	0.05	_	
99-38	18394-18395	.	_	

#Text=The analysis resulted in 29 independent components (automatic estimation).
100-1	18396-18399	The	_	
100-2	18400-18408	analysis	_	
100-3	18409-18417	resulted	_	
100-4	18418-18420	in	_	
100-5	18421-18423	29	_	
100-6	18424-18435	independent	_	
100-7	18436-18446	components	_	
100-8	18447-18448	(	_	
100-9	18448-18457	automatic	_	
100-10	18458-18468	estimation	_	
100-11	18468-18469	)	_	
100-12	18469-18470	.	_	

#Text=Network identification.
101-1	18471-18478	Network	_	
101-2	18479-18493	identification	_	
101-3	18493-18494	.	_	

#Text=Networks of interest were chosen a priori from independent component network (ICN) templates identified by.
102-1	18495-18503	Networks	_	
102-2	18504-18506	of	_	
102-3	18507-18515	interest	_	
102-4	18516-18520	were	_	
102-5	18521-18527	chosen	_	
102-6	18528-18529	a	_	
102-7	18530-18536	priori	_	
102-8	18537-18541	from	_	
102-9	18542-18553	independent	_	
102-10	18554-18563	component	_	
102-11	18564-18571	network	_	
102-12	18572-18573	(	_	
102-13	18573-18576	ICN	_	
102-14	18576-18577	)	_	
102-15	18578-18587	templates	_	
102-16	18588-18598	identified	_	
102-17	18599-18601	by	_	
102-18	18601-18602	.	_	

#Text=The networks of interest for the current study included the: 1) core reward network located in the bilateral basal ganglia (BG) and thalamus (Laird ICN 3); 2) extended reward network in the subgenual ACC and OFC (Laird ICN 2); 3) attentional salience network in the bilateral anterior insula, frontal opercula, and ACC (Laird ICN 4); and right and left-lateralized fronto-parietal cognitive control networks (Laird ICNs 15 and 18, respectively).
103-1	18603-18606	The	_	
103-2	18607-18615	networks	_	
103-3	18616-18618	of	_	
103-4	18619-18627	interest	_	
103-5	18628-18631	for	_	
103-6	18632-18635	the	_	
103-7	18636-18643	current	_	
103-8	18644-18649	study	_	
103-9	18650-18658	included	_	
103-10	18659-18662	the	_	
103-11	18662-18663	:	_	
103-12	18664-18665	1	_	
103-13	18665-18666	)	_	
103-14	18667-18671	core	_	
103-15	18672-18678	reward	_	
103-16	18679-18686	network	_	
103-17	18687-18694	located	_	
103-18	18695-18697	in	_	
103-19	18698-18701	the	_	
103-20	18702-18711	bilateral	_	
103-21	18712-18717	basal	_	
103-22	18718-18725	ganglia	_	
103-23	18726-18727	(	_	
103-24	18727-18729	BG	_	
103-25	18729-18730	)	_	
103-26	18731-18734	and	_	
103-27	18735-18743	thalamus	_	
103-28	18744-18745	(	_	
103-29	18745-18750	Laird	_	
103-30	18751-18754	ICN	_	
103-31	18755-18756	3	_	
103-32	18756-18757	)	_	
103-33	18757-18758	;	_	
103-34	18759-18760	2	_	
103-35	18760-18761	)	_	
103-36	18762-18770	extended	_	
103-37	18771-18777	reward	_	
103-38	18778-18785	network	_	
103-39	18786-18788	in	_	
103-40	18789-18792	the	_	
103-41	18793-18802	subgenual	_	
103-42	18803-18806	ACC	_	
103-43	18807-18810	and	_	
103-44	18811-18814	OFC	_	
103-45	18815-18816	(	_	
103-46	18816-18821	Laird	_	
103-47	18822-18825	ICN	_	
103-48	18826-18827	2	_	
103-49	18827-18828	)	_	
103-50	18828-18829	;	_	
103-51	18830-18831	3	_	
103-52	18831-18832	)	_	
103-53	18833-18844	attentional	_	
103-54	18845-18853	salience	_	
103-55	18854-18861	network	_	
103-56	18862-18864	in	_	
103-57	18865-18868	the	_	
103-58	18869-18878	bilateral	_	
103-59	18879-18887	anterior	_	
103-60	18888-18894	insula	_	
103-61	18894-18895	,	_	
103-62	18896-18903	frontal	_	
103-63	18904-18912	opercula	_	
103-64	18912-18913	,	_	
103-65	18914-18917	and	_	
103-66	18918-18921	ACC	_	
103-67	18922-18923	(	_	
103-68	18923-18928	Laird	_	
103-69	18929-18932	ICN	_	
103-70	18933-18934	4	_	
103-71	18934-18935	)	_	
103-72	18935-18936	;	_	
103-73	18937-18940	and	_	
103-74	18941-18946	right	_	
103-75	18947-18950	and	_	
103-76	18951-18967	left-lateralized	_	
103-77	18968-18983	fronto-parietal	_	
103-78	18984-18993	cognitive	_	
103-79	18994-19001	control	_	
103-80	19002-19010	networks	_	
103-81	19011-19012	(	_	
103-82	19012-19017	Laird	_	
103-83	19018-19022	ICNs	_	
103-84	19023-19025	15	_	
103-85	19026-19029	and	_	
103-86	19030-19032	18	_	
103-87	19032-19033	,	_	
103-88	19034-19046	respectively	_	
103-89	19046-19047	)	_	
103-90	19047-19048	.	_	

#Text=To identify the components derived from our own study sample that best represented the Laird ICN templates of interest, spatial partial correlations were run with FSLUTILS on the 29 components derived from the current sample with the five ICN templates provided by Laird and colleagues.
104-1	19049-19051	To	_	
104-2	19052-19060	identify	_	
104-3	19061-19064	the	_	
104-4	19065-19075	components	_	
104-5	19076-19083	derived	_	
104-6	19084-19088	from	_	
104-7	19089-19092	our	_	
104-8	19093-19096	own	_	
104-9	19097-19102	study	_	
104-10	19103-19109	sample	_	
104-11	19110-19114	that	_	
104-12	19115-19119	best	_	
104-13	19120-19131	represented	_	
104-14	19132-19135	the	_	
104-15	19136-19141	Laird	_	
104-16	19142-19145	ICN	_	
104-17	19146-19155	templates	_	
104-18	19156-19158	of	_	
104-19	19159-19167	interest	_	
104-20	19167-19168	,	_	
104-21	19169-19176	spatial	_	
104-22	19177-19184	partial	_	
104-23	19185-19197	correlations	_	
104-24	19198-19202	were	_	
104-25	19203-19206	run	_	
104-26	19207-19211	with	_	
104-27	19212-19220	FSLUTILS	_	
104-28	19221-19223	on	_	
104-29	19224-19227	the	_	
104-30	19228-19230	29	_	
104-31	19231-19241	components	_	
104-32	19242-19249	derived	_	
104-33	19250-19254	from	_	
104-34	19255-19258	the	_	
104-35	19259-19266	current	_	
104-36	19267-19273	sample	_	
104-37	19274-19278	with	_	
104-38	19279-19282	the	_	
104-39	19283-19287	five	_	
104-40	19288-19291	ICN	_	
104-41	19292-19301	templates	_	
104-42	19302-19310	provided	_	
104-43	19311-19313	by	_	
104-44	19314-19319	Laird	_	
104-45	19320-19323	and	_	
104-46	19324-19334	colleagues	_	
104-47	19334-19335	.	_	

#Text=The sample components with the strongest correlations to each ICN templates of interest were used in all subsequent analyses.
105-1	19336-19339	The	_	
105-2	19340-19346	sample	_	
105-3	19347-19357	components	_	
105-4	19358-19362	with	_	
105-5	19363-19366	the	_	
105-6	19367-19376	strongest	_	
105-7	19377-19389	correlations	_	
105-8	19390-19392	to	_	
105-9	19393-19397	each	_	
105-10	19398-19401	ICN	_	
105-11	19402-19411	templates	_	
105-12	19412-19414	of	_	
105-13	19415-19423	interest	_	
105-14	19424-19428	were	_	
105-15	19429-19433	used	_	
105-16	19434-19436	in	_	
105-17	19437-19440	all	_	
105-18	19441-19451	subsequent	_	
105-19	19452-19460	analyses	_	
105-20	19460-19461	.	_	

#Text=Only correlations greater than 0.2 were considered and the strongest correlations ranged from 0.40 to 0.60.
106-1	19462-19466	Only	_	
106-2	19467-19479	correlations	_	
106-3	19480-19487	greater	_	
106-4	19488-19492	than	_	
106-5	19493-19496	0.2	_	
106-6	19497-19501	were	_	
106-7	19502-19512	considered	_	
106-8	19513-19516	and	_	
106-9	19517-19520	the	_	
106-10	19521-19530	strongest	_	
106-11	19531-19543	correlations	_	
106-12	19544-19550	ranged	_	
106-13	19551-19555	from	_	
106-14	19556-19560	0.40	_	
106-15	19561-19563	to	_	
106-16	19564-19568	0.60	_	
106-17	19568-19569	.	_	

#Text=See Figure 1 for the final set of ICA components and correlation coefficients with the Laird ICNs of interest.
107-1	19570-19573	See	_	
107-2	19574-19580	Figure	_	
107-3	19581-19582	1	_	
107-4	19583-19586	for	_	
107-5	19587-19590	the	_	
107-6	19591-19596	final	_	
107-7	19597-19600	set	_	
107-8	19601-19603	of	_	
107-9	19604-19607	ICA	_	
107-10	19608-19618	components	_	
107-11	19619-19622	and	_	
107-12	19623-19634	correlation	_	
107-13	19635-19647	coefficients	_	
107-14	19648-19652	with	_	
107-15	19653-19656	the	_	
107-16	19657-19662	Laird	_	
107-17	19663-19667	ICNs	_	
107-18	19668-19670	of	_	
107-19	19671-19679	interest	_	
107-20	19679-19680	.	_	

#Text=Dual regression.
108-1	19681-19685	Dual	_	
108-2	19686-19696	regression	_	
108-3	19696-19697	.	_	

#Text=Dual regression was conducted to estimate a version of each group-level spatial map and time-course for each participants 4D data.
109-1	19698-19702	Dual	_	
109-2	19703-19713	regression	_	
109-3	19714-19717	was	_	
109-4	19718-19727	conducted	_	
109-5	19728-19730	to	_	
109-6	19731-19739	estimate	_	
109-7	19740-19741	a	_	
109-8	19742-19749	version	_	
109-9	19750-19752	of	_	
109-10	19753-19757	each	_	
109-11	19758-19769	group-level	_	
109-12	19770-19777	spatial	_	
109-13	19778-19781	map	_	
109-14	19782-19785	and	_	
109-15	19786-19797	time-course	_	
109-16	19798-19801	for	_	
109-17	19802-19806	each	_	
109-18	19807-19818	participant	_	
109-19	19818-19819		_	
109-20	19819-19820	s	_	
109-21	19821-19823	4D	_	
109-22	19824-19828	data	_	
109-23	19828-19829	.	_	

#Text=In stage one, the group spatial maps were regressed onto each participants 4D dataset to give a set of time-courses.
110-1	19830-19832	In	_	
110-2	19833-19838	stage	_	
110-3	19839-19842	one	_	
110-4	19842-19843	,	_	
110-5	19844-19847	the	_	
110-6	19848-19853	group	_	
110-7	19854-19861	spatial	_	
110-8	19862-19866	maps	_	
110-9	19867-19871	were	_	
110-10	19872-19881	regressed	_	
110-11	19882-19886	onto	_	
110-12	19887-19891	each	_	
110-13	19892-19903	participant	_	
110-14	19903-19904		_	
110-15	19904-19905	s	_	
110-16	19906-19908	4D	_	
110-17	19909-19916	dataset	_	
110-18	19917-19919	to	_	
110-19	19920-19924	give	_	
110-20	19925-19926	a	_	
110-21	19927-19930	set	_	
110-22	19931-19933	of	_	
110-23	19934-19946	time-courses	_	
110-24	19946-19947	.	_	

#Text=In stage two, those time-courses were then regressed onto the same 4D dataset to get a subject-specific set of spatial maps.
111-1	19948-19950	In	_	
111-2	19951-19956	stage	_	
111-3	19957-19960	two	_	
111-4	19960-19961	,	_	
111-5	19962-19967	those	_	
111-6	19968-19980	time-courses	_	
111-7	19981-19985	were	_	
111-8	19986-19990	then	_	
111-9	19991-20000	regressed	_	
111-10	20001-20005	onto	_	
111-11	20006-20009	the	_	
111-12	20010-20014	same	_	
111-13	20015-20017	4D	_	
111-14	20018-20025	dataset	_	
111-15	20026-20028	to	_	
111-16	20029-20032	get	_	
111-17	20033-20034	a	_	
111-18	20035-20051	subject-specific	_	
111-19	20052-20055	set	_	
111-20	20056-20058	of	_	
111-21	20059-20066	spatial	_	
111-22	20067-20071	maps	_	
111-23	20071-20072	.	_	

#Text=This analysis resulted in a component time-course and spatial map for each subject and each component.
112-1	20073-20077	This	_	
112-2	20078-20086	analysis	_	
112-3	20087-20095	resulted	_	
112-4	20096-20098	in	_	
112-5	20099-20100	a	_	
112-6	20101-20110	component	_	
112-7	20111-20122	time-course	_	
112-8	20123-20126	and	_	
112-9	20127-20134	spatial	_	
112-10	20135-20138	map	_	
112-11	20139-20142	for	_	
112-12	20143-20147	each	_	
112-13	20148-20155	subject	_	
112-14	20156-20159	and	_	
112-15	20160-20164	each	_	
112-16	20165-20174	component	_	
112-17	20174-20175	.	_	

#Text=We performed a small-volume correction by restricting the analysis to only include voxels within a component mask derived from the group-ICA analysis that was chosen a priori.
113-1	20176-20178	We	_	
113-2	20179-20188	performed	_	
113-3	20189-20190	a	_	
113-4	20191-20203	small-volume	_	
113-5	20204-20214	correction	_	
113-6	20215-20217	by	_	
113-7	20218-20229	restricting	_	
113-8	20230-20233	the	_	
113-9	20234-20242	analysis	_	
113-10	20243-20245	to	_	
113-11	20246-20250	only	_	
113-12	20251-20258	include	_	
113-13	20259-20265	voxels	_	
113-14	20266-20272	within	_	
113-15	20273-20274	a	_	
113-16	20275-20284	component	_	
113-17	20285-20289	mask	_	
113-18	20290-20297	derived	_	
113-19	20298-20302	from	_	
113-20	20303-20306	the	_	
113-21	20307-20316	group-ICA	_	
113-22	20317-20325	analysis	_	
113-23	20326-20330	that	_	
113-24	20331-20334	was	_	
113-25	20335-20341	chosen	_	
113-26	20342-20343	a	_	
113-27	20344-20350	priori	_	
113-28	20350-20351	.	_	

#Text=To do this, the group-ICA components were thresholded at p.05, binarized, and included in the dual-regression script as masks for stages one and two, and only stage one time-courses and stage two spatial maps for the masked components were included in subsequent analyses.
114-1	20352-20354	To	_	
114-2	20355-20357	do	_	
114-3	20358-20362	this	_	
114-4	20362-20363	,	_	
114-5	20364-20367	the	_	
114-6	20368-20377	group-ICA	_	
114-7	20378-20388	components	_	
114-8	20389-20393	were	_	
114-9	20394-20405	thresholded	_	
114-10	20406-20408	at	_	
114-11	20409-20410	p	_	
114-12	20410-20411		_	
114-13	20411-20414	.05	_	
114-14	20414-20415	,	_	
114-15	20416-20425	binarized	_	
114-16	20425-20426	,	_	
114-17	20427-20430	and	_	
114-18	20431-20439	included	_	
114-19	20440-20442	in	_	
114-20	20443-20446	the	_	
114-21	20447-20462	dual-regression	_	
114-22	20463-20469	script	_	
114-23	20470-20472	as	_	
114-24	20473-20478	masks	_	
114-25	20479-20482	for	_	
114-26	20483-20489	stages	_	
114-27	20490-20493	one	_	
114-28	20494-20497	and	_	
114-29	20498-20501	two	_	
114-30	20501-20502	,	_	
114-31	20503-20506	and	_	
114-32	20507-20511	only	_	
114-33	20512-20517	stage	_	
114-34	20518-20521	one	_	
114-35	20522-20534	time-courses	_	
114-36	20535-20538	and	_	
114-37	20539-20544	stage	_	
114-38	20545-20548	two	_	
114-39	20549-20556	spatial	_	
114-40	20557-20561	maps	_	
114-41	20562-20565	for	_	
114-42	20566-20569	the	_	
114-43	20570-20576	masked	_	
114-44	20577-20587	components	_	
114-45	20588-20592	were	_	
114-46	20593-20601	included	_	
114-47	20602-20604	in	_	
114-48	20605-20615	subsequent	_	
114-49	20616-20624	analyses	_	
114-50	20624-20625	.	_	

#Text=Between-network connectivity.
115-1	20626-20641	Between-network	_	
115-2	20642-20654	connectivity	_	
115-3	20654-20655	.	_	

#Text=We used the time-courses from the first stage of the dual-regression analyses to conduct partial correlations on the components for each subject.
116-1	20656-20658	We	_	
116-2	20659-20663	used	_	
116-3	20664-20667	the	_	
116-4	20668-20680	time-courses	_	
116-5	20681-20685	from	_	
116-6	20686-20689	the	_	
116-7	20690-20695	first	_	
116-8	20696-20701	stage	_	
116-9	20702-20704	of	_	
116-10	20705-20708	the	_	
116-11	20709-20724	dual-regression	_	
116-12	20725-20733	analyses	_	
116-13	20734-20736	to	_	
116-14	20737-20744	conduct	_	
116-15	20745-20752	partial	_	
116-16	20753-20765	correlations	_	
116-17	20766-20768	on	_	
116-18	20769-20772	the	_	
116-19	20773-20783	components	_	
116-20	20784-20787	for	_	
116-21	20788-20792	each	_	
116-22	20793-20800	subject	_	
116-23	20800-20801	.	_	

#Text=The time-courses consisted of component connectivity estimates (volume-wise slope in the regression) for each of the 145 volumes for each component.
117-1	20802-20805	The	_	
117-2	20806-20818	time-courses	_	
117-3	20819-20828	consisted	_	
117-4	20829-20831	of	_	
117-5	20832-20841	component	_	
117-6	20842-20854	connectivity	_	
117-7	20855-20864	estimates	_	
117-8	20865-20866	(	_	
117-9	20866-20877	volume-wise	_	
117-10	20878-20883	slope	_	
117-11	20884-20886	in	_	
117-12	20887-20890	the	_	
117-13	20891-20901	regression	_	
117-14	20901-20902	)	_	
117-15	20903-20906	for	_	
117-16	20907-20911	each	_	
117-17	20912-20914	of	_	
117-18	20915-20918	the	_	
117-19	20919-20922	145	_	
117-20	20923-20930	volumes	_	
117-21	20931-20934	for	_	
117-22	20935-20939	each	_	
117-23	20940-20949	component	_	
117-24	20949-20950	.	_	

#Text=This resulted in a correlation matrix in which each element was the pairwise association between two networks.
118-1	20951-20955	This	_	
118-2	20956-20964	resulted	_	
118-3	20965-20967	in	_	
118-4	20968-20969	a	_	
118-5	20970-20981	correlation	_	
118-6	20982-20988	matrix	_	
118-7	20989-20991	in	_	
118-8	20992-20997	which	_	
118-9	20998-21002	each	_	
118-10	21003-21010	element	_	
118-11	21011-21014	was	_	
118-12	21015-21018	the	_	
118-13	21019-21027	pairwise	_	
118-14	21028-21039	association	_	
118-15	21040-21047	between	_	
118-16	21048-21051	two	_	
118-17	21052-21060	networks	_	
118-18	21060-21061	.	_	

#Text=The resulting correlation coefficients of rsFC between the resting state networks of interest were then transformed to Fishers Z statistics to normalize the distributions.
119-1	21062-21065	The	_	
119-2	21066-21075	resulting	_	
119-3	21076-21087	correlation	_	
119-4	21088-21100	coefficients	_	
119-5	21101-21103	of	_	
119-6	21104-21108	rsFC	_	
119-7	21109-21116	between	_	
119-8	21117-21120	the	_	
119-9	21121-21128	resting	_	
119-10	21129-21134	state	_	
119-11	21135-21143	networks	_	
119-12	21144-21146	of	_	
119-13	21147-21155	interest	_	
119-14	21156-21160	were	_	
119-15	21161-21165	then	_	
119-16	21166-21177	transformed	_	
119-17	21178-21180	to	_	
119-18	21181-21187	Fisher	_	
119-19	21187-21188		_	
119-20	21188-21189	s	_	
119-21	21190-21191	Z	_	
119-22	21192-21202	statistics	_	
119-23	21203-21205	to	_	
119-24	21206-21215	normalize	_	
119-25	21216-21219	the	_	
119-26	21220-21233	distributions	_	
119-27	21233-21234	.	_	

#Text=Between-network connectivity strength was compared across groups with a series of one-way analyses of covariance with age, gender, years of education, and motion (refrms) as covariates using SPSS Version 22.
120-1	21235-21250	Between-network	_	
120-2	21251-21263	connectivity	_	
120-3	21264-21272	strength	_	
120-4	21273-21276	was	_	
120-5	21277-21285	compared	_	
120-6	21286-21292	across	_	
120-7	21293-21299	groups	_	
120-8	21300-21304	with	_	
120-9	21305-21306	a	_	
120-10	21307-21313	series	_	
120-11	21314-21316	of	_	
120-12	21317-21324	one-way	_	
120-13	21325-21333	analyses	_	
120-14	21334-21336	of	_	
120-15	21337-21347	covariance	_	
120-16	21348-21352	with	_	
120-17	21353-21356	age	_	
120-18	21356-21357	,	_	
120-19	21358-21364	gender	_	
120-20	21364-21365	,	_	
120-21	21366-21371	years	_	
120-22	21372-21374	of	_	
120-23	21375-21384	education	_	
120-24	21384-21385	,	_	
120-25	21386-21389	and	_	
120-26	21390-21396	motion	_	
120-27	21397-21398	(	_	
120-28	21398-21404	refrms	_	
120-29	21404-21405	)	_	
120-30	21406-21408	as	_	
120-31	21409-21419	covariates	_	
120-32	21420-21425	using	_	
120-33	21426-21430	SPSS	_	
120-34	21431-21438	Version	_	
120-35	21439-21441	22	_	
120-36	21441-21442	.	_	

#Text=Moderation analyses.
121-1	21443-21453	Moderation	_	
121-2	21454-21462	analyses	_	
121-3	21462-21463	.	_	

#Text=To determine if cocaine use moderated the association between rsFC and impulsivity, group by rsFC interactions on task scores were examined using Process software in SPSS.
122-1	21464-21466	To	_	
122-2	21467-21476	determine	_	
122-3	21477-21479	if	_	
122-4	21480-21487	cocaine	_	
122-5	21488-21491	use	_	
122-6	21492-21501	moderated	_	
122-7	21502-21505	the	_	
122-8	21506-21517	association	_	
122-9	21518-21525	between	_	
122-10	21526-21530	rsFC	_	
122-11	21531-21534	and	_	
122-12	21535-21546	impulsivity	_	
122-13	21546-21547	,	_	
122-14	21548-21553	group	_	
122-15	21554-21556	by	_	
122-16	21557-21561	rsFC	_	
122-17	21562-21574	interactions	_	
122-18	21575-21577	on	_	
122-19	21578-21582	task	_	
122-20	21583-21589	scores	_	
122-21	21590-21594	were	_	
122-22	21595-21603	examined	_	
122-23	21604-21609	using	_	
122-24	21610-21617	Process	_	
122-25	21618-21626	software	_	
122-26	21627-21629	in	_	
122-27	21630-21634	SPSS	_	
122-28	21634-21635	.	_	

#Text=We tested for group by rsFC interaction effects on task performance with age, gender, years of education, and motion (refrms) included as covariates.
123-1	21636-21638	We	_	
123-2	21639-21645	tested	_	
123-3	21646-21649	for	_	
123-4	21650-21655	group	_	
123-5	21656-21658	by	_	
123-6	21659-21663	rsFC	_	
123-7	21664-21675	interaction	_	
123-8	21676-21683	effects	_	
123-9	21684-21686	on	_	
123-10	21687-21691	task	_	
123-11	21692-21703	performance	_	
123-12	21704-21708	with	_	
123-13	21709-21712	age	_	
123-14	21712-21713	,	_	
123-15	21714-21720	gender	_	
123-16	21720-21721	,	_	
123-17	21722-21727	years	_	
123-18	21728-21730	of	_	
123-19	21731-21740	education	_	
123-20	21740-21741	,	_	
123-21	21742-21745	and	_	
123-22	21746-21752	motion	_	
123-23	21753-21754	(	_	
123-24	21754-21760	refrms	_	
123-25	21760-21761	)	_	
123-26	21762-21770	included	_	
123-27	21771-21773	as	_	
123-28	21774-21784	covariates	_	
123-29	21784-21785	.	_	

#Text=Results
#Text=Participant characteristics
#Text=Participant characteristics by group are displayed in Table 1.
124-1	21786-21793	Results	_	
124-2	21794-21805	Participant	_	
124-3	21806-21821	characteristics	_	
124-4	21822-21833	Participant	_	
124-5	21834-21849	characteristics	_	
124-6	21850-21852	by	_	
124-7	21853-21858	group	_	
124-8	21859-21862	are	_	
124-9	21863-21872	displayed	_	
124-10	21873-21875	in	_	
124-11	21876-21881	Table	_	
124-12	21882-21883	1	_	
124-13	21883-21884	.	_	

#Text=Of the cocaine users, 95% met criteria for current dependence and 92% reported smoking cocaine as their primary route of administration.
125-1	21885-21887	Of	_	
125-2	21888-21891	the	_	
125-3	21892-21899	cocaine	_	
125-4	21900-21905	users	_	
125-5	21905-21906	,	_	
125-6	21907-21910	95%	_	
125-7	21911-21914	met	_	
125-8	21915-21923	criteria	_	
125-9	21924-21927	for	_	
125-10	21928-21935	current	_	
125-11	21936-21946	dependence	_	
125-12	21947-21950	and	_	
125-13	21951-21954	92%	_	
125-14	21955-21963	reported	_	
125-15	21964-21971	smoking	_	
125-16	21972-21979	cocaine	_	
125-17	21980-21982	as	_	
125-18	21983-21988	their	_	
125-19	21989-21996	primary	_	
125-20	21997-22002	route	_	
125-21	22003-22005	of	_	
125-22	22006-22020	administration	_	
125-23	22020-22021	.	_	

#Text=They had used cocaine regularly for an average of 17.30 (SD=7.68) years and had used 10.46 (SD=7.57) days out of the past 30.
126-1	22022-22026	They	_	
126-2	22027-22030	had	_	
126-3	22031-22035	used	_	
126-4	22036-22043	cocaine	_	
126-5	22044-22053	regularly	_	
126-6	22054-22057	for	_	
126-7	22058-22060	an	_	
126-8	22061-22068	average	_	
126-9	22069-22071	of	_	
126-10	22072-22077	17.30	_	
126-11	22078-22079	(	_	
126-12	22079-22081	SD	_	
126-13	22081-22082	=	_	
126-14	22082-22086	7.68	_	
126-15	22086-22087	)	_	
126-16	22088-22093	years	_	
126-17	22094-22097	and	_	
126-18	22098-22101	had	_	
126-19	22102-22106	used	_	
126-20	22107-22112	10.46	_	
126-21	22113-22114	(	_	
126-22	22114-22116	SD	_	
126-23	22116-22117	=	_	
126-24	22117-22121	7.57	_	
126-25	22121-22122	)	_	
126-26	22123-22127	days	_	
126-27	22128-22131	out	_	
126-28	22132-22134	of	_	
126-29	22135-22138	the	_	
126-30	22139-22143	past	_	
126-31	22144-22146	30	_	
126-32	22146-22147	.	_	

#Text=On the day of the fMRI scan, participants reported last using cocaine an average of 3.14 days prior (SD= 3.42) and 26 participants (72%) tested positive for cocaine on the urine screen.
127-1	22148-22150	On	_	
127-2	22151-22154	the	_	
127-3	22155-22158	day	_	
127-4	22159-22161	of	_	
127-5	22162-22165	the	_	
127-6	22166-22170	fMRI	_	
127-7	22171-22175	scan	_	
127-8	22175-22176	,	_	
127-9	22177-22189	participants	_	
127-10	22190-22198	reported	_	
127-11	22199-22203	last	_	
127-12	22204-22209	using	_	
127-13	22210-22217	cocaine	_	
127-14	22218-22220	an	_	
127-15	22221-22228	average	_	
127-16	22229-22231	of	_	
127-17	22232-22236	3.14	_	
127-18	22237-22241	days	_	
127-19	22242-22247	prior	_	
127-20	22248-22249	(	_	
127-21	22249-22251	SD	_	
127-22	22251-22252	=	_	
127-23	22253-22257	3.42	_	
127-24	22257-22258	)	_	
127-25	22259-22262	and	_	
127-26	22263-22265	26	_	
127-27	22266-22278	participants	_	
127-28	22279-22280	(	_	
127-29	22280-22283	72%	_	
127-30	22283-22284	)	_	
127-31	22285-22291	tested	_	
127-32	22292-22300	positive	_	
127-33	22301-22304	for	_	
127-34	22305-22312	cocaine	_	
127-35	22313-22315	on	_	
127-36	22316-22319	the	_	
127-37	22320-22325	urine	_	
127-38	22326-22332	screen	_	
127-39	22332-22333	.	_	

#Text=Cocaine users were slightly older and less educated.
128-1	22334-22341	Cocaine	_	
128-2	22342-22347	users	_	
128-3	22348-22352	were	_	
128-4	22353-22361	slightly	_	
128-5	22362-22367	older	_	
128-6	22368-22371	and	_	
128-7	22372-22376	less	_	
128-8	22377-22385	educated	_	
128-9	22385-22386	.	_	

#Text=Cocaine users reported significantly more use of other substances, including cigarettes, alcohol to intoxication, and marijuana.
129-1	22387-22394	Cocaine	_	
129-2	22395-22400	users	_	
129-3	22401-22409	reported	_	
129-4	22410-22423	significantly	_	
129-5	22424-22428	more	_	
129-6	22429-22432	use	_	
129-7	22433-22435	of	_	
129-8	22436-22441	other	_	
129-9	22442-22452	substances	_	
129-10	22452-22453	,	_	
129-11	22454-22463	including	_	
129-12	22464-22474	cigarettes	_	
129-13	22474-22475	,	_	
129-14	22476-22483	alcohol	_	
129-15	22484-22486	to	_	
129-16	22487-22499	intoxication	_	
129-17	22499-22500	,	_	
129-18	22501-22504	and	_	
129-19	22505-22514	marijuana	_	
129-20	22514-22515	.	_	

#Text=For this reason, the cocaine use group is more aptly described as having a cocaine use disorder with polysubstance use.
130-1	22516-22519	For	_	
130-2	22520-22524	this	_	
130-3	22525-22531	reason	_	
130-4	22531-22532	,	_	
130-5	22533-22536	the	_	
130-6	22537-22544	cocaine	_	
130-7	22545-22548	use	_	
130-8	22549-22554	group	_	
130-9	22555-22557	is	_	
130-10	22558-22562	more	_	
130-11	22563-22568	aptly	_	
130-12	22569-22578	described	_	
130-13	22579-22581	as	_	
130-14	22582-22588	having	_	
130-15	22589-22590	a	_	
130-16	22591-22598	cocaine	_	
130-17	22599-22602	use	_	
130-18	22603-22611	disorder	_	
130-19	22612-22616	with	_	
130-20	22617-22630	polysubstance	_	
130-21	22631-22634	use	_	
130-22	22634-22635	.	_	

#Text=Polysubstance use was not an exclusion criterion to ensure that the results generalize to the general population where polysubstance use is pervasive among cocaine users.
131-1	22636-22649	Polysubstance	_	
131-2	22650-22653	use	_	
131-3	22654-22657	was	_	
131-4	22658-22661	not	_	
131-5	22662-22664	an	_	
131-6	22665-22674	exclusion	_	
131-7	22675-22684	criterion	_	
131-8	22685-22687	to	_	
131-9	22688-22694	ensure	_	
131-10	22695-22699	that	_	
131-11	22700-22703	the	_	
131-12	22704-22711	results	_	
131-13	22712-22722	generalize	_	
131-14	22723-22725	to	_	
131-15	22726-22729	the	_	
131-16	22730-22737	general	_	
131-17	22738-22748	population	_	
131-18	22749-22754	where	_	
131-19	22755-22768	polysubstance	_	
131-20	22769-22772	use	_	
131-21	22773-22775	is	_	
131-22	22776-22785	pervasive	_	
131-23	22786-22791	among	_	
131-24	22792-22799	cocaine	_	
131-25	22800-22805	users	_	
131-26	22805-22806	.	_	

#Text=Cocaine users had significantly higher discounting rates on the MCQ (Table 1).
132-1	22807-22814	Cocaine	_	
132-2	22815-22820	users	_	
132-3	22821-22824	had	_	
132-4	22825-22838	significantly	_	
132-5	22839-22845	higher	_	
132-6	22846-22857	discounting	_	
132-7	22858-22863	rates	_	
132-8	22864-22866	on	_	
132-9	22867-22870	the	_	
132-10	22871-22874	MCQ	_	
132-11	22875-22876	(	_	
132-12	22876-22881	Table	_	
132-13	22882-22883	1	_	
132-14	22883-22884	)	_	
132-15	22884-22885	.	_	

#Text=The groups performed similarly on the BART and IGT.
133-1	22886-22889	The	_	
133-2	22890-22896	groups	_	
133-3	22897-22906	performed	_	
133-4	22907-22916	similarly	_	
133-5	22917-22919	on	_	
133-6	22920-22923	the	_	
133-7	22924-22928	BART	_	
133-8	22929-22932	and	_	
133-9	22933-22936	IGT	_	
133-10	22936-22937	.	_	

#Text=Group comparisons of between-network rsFC
#Text=ANCOVAs were used to compare between-network connectivity across cocaine users and controls.
134-1	22938-22943	Group	_	
134-2	22944-22955	comparisons	_	
134-3	22956-22958	of	_	
134-4	22959-22974	between-network	_	
134-5	22975-22979	rsFC	_	
134-6	22980-22987	ANCOVAs	_	
134-7	22988-22992	were	_	
134-8	22993-22997	used	_	
134-9	22998-23000	to	_	
134-10	23001-23008	compare	_	
134-11	23009-23024	between-network	_	
134-12	23025-23037	connectivity	_	
134-13	23038-23044	across	_	
134-14	23045-23052	cocaine	_	
134-15	23053-23058	users	_	
134-16	23059-23062	and	_	
134-17	23063-23071	controls	_	
134-18	23071-23072	.	_	

#Text=There were no significant group differences in between-network connectivity.
135-1	23073-23078	There	_	
135-2	23079-23083	were	_	
135-3	23084-23086	no	_	
135-4	23087-23098	significant	_	
135-5	23099-23104	group	_	
135-6	23105-23116	differences	_	
135-7	23117-23119	in	_	
135-8	23120-23135	between-network	_	
135-9	23136-23148	connectivity	_	
135-10	23148-23149	.	_	

#Text=Average between-network rsFC values are displayed by group in Table 2.
136-1	23150-23157	Average	_	
136-2	23158-23173	between-network	_	
136-3	23174-23178	rsFC	_	
136-4	23179-23185	values	_	
136-5	23186-23189	are	_	
136-6	23190-23199	displayed	_	
136-7	23200-23202	by	_	
136-8	23203-23208	group	_	
136-9	23209-23211	in	_	
136-10	23212-23217	Table	_	
136-11	23218-23219	2	_	
136-12	23219-23220	.	_	

#Text=Moderation analyses
#Text=Linear regression analyses examined cocaine use as a moderator between network rsFC and impulsivity on the decision-making tasks.
137-1	23221-23231	Moderation	_	
137-2	23232-23240	analyses	_	
137-3	23241-23247	Linear	_	
137-4	23248-23258	regression	_	
137-5	23259-23267	analyses	_	
137-6	23268-23276	examined	_	
137-7	23277-23284	cocaine	_	
137-8	23285-23288	use	_	
137-9	23289-23291	as	_	
137-10	23292-23293	a	_	
137-11	23294-23303	moderator	_	
137-12	23304-23311	between	_	
137-13	23312-23319	network	_	
137-14	23320-23324	rsFC	_	
137-15	23325-23328	and	_	
137-16	23329-23340	impulsivity	_	
137-17	23341-23343	on	_	
137-18	23344-23347	the	_	
137-19	23348-23363	decision-making	_	
137-20	23364-23369	tasks	_	
137-21	23369-23370	.	_	

#Text=Stronger inverse coupling between the extended reward network and the left cognitive control network was associated with higher risk-taking propensity on the BART for cocaine users but not for control participants.
138-1	23371-23379	Stronger	_	
138-2	23380-23387	inverse	_	
138-3	23388-23396	coupling	_	
138-4	23397-23404	between	_	
138-5	23405-23408	the	_	
138-6	23409-23417	extended	_	
138-7	23418-23424	reward	_	
138-8	23425-23432	network	_	
138-9	23433-23436	and	_	
138-10	23437-23440	the	_	
138-11	23441-23445	left	_	
138-12	23446-23455	cognitive	_	
138-13	23456-23463	control	_	
138-14	23464-23471	network	_	
138-15	23472-23475	was	_	
138-16	23476-23486	associated	_	
138-17	23487-23491	with	_	
138-18	23492-23498	higher	_	
138-19	23499-23510	risk-taking	_	
138-20	23511-23521	propensity	_	
138-21	23522-23524	on	_	
138-22	23525-23528	the	_	
138-23	23529-23533	BART	_	
138-24	23534-23537	for	_	
138-25	23538-23545	cocaine	_	
138-26	23546-23551	users	_	
138-27	23552-23555	but	_	
138-28	23556-23559	not	_	
138-29	23560-23563	for	_	
138-30	23564-23571	control	_	
138-31	23572-23584	participants	_	
138-32	23584-23585	.	_	

#Text=Coupling between the core reward and attentional salience networks was unrelated to impulsivity on the MCQ for cocaine users, but negatively associated with impulsivity for control participants (Table 3, Figure 2).
139-1	23586-23594	Coupling	_	
139-2	23595-23602	between	_	
139-3	23603-23606	the	_	
139-4	23607-23611	core	_	
139-5	23612-23618	reward	_	
139-6	23619-23622	and	_	
139-7	23623-23634	attentional	_	
139-8	23635-23643	salience	_	
139-9	23644-23652	networks	_	
139-10	23653-23656	was	_	
139-11	23657-23666	unrelated	_	
139-12	23667-23669	to	_	
139-13	23670-23681	impulsivity	_	
139-14	23682-23684	on	_	
139-15	23685-23688	the	_	
139-16	23689-23692	MCQ	_	
139-17	23693-23696	for	_	
139-18	23697-23704	cocaine	_	
139-19	23705-23710	users	_	
139-20	23710-23711	,	_	
139-21	23712-23715	but	_	
139-22	23716-23726	negatively	_	
139-23	23727-23737	associated	_	
139-24	23738-23742	with	_	
139-25	23743-23754	impulsivity	_	
139-26	23755-23758	for	_	
139-27	23759-23766	control	_	
139-28	23767-23779	participants	_	
139-29	23780-23781	(	_	
139-30	23781-23786	Table	_	
139-31	23787-23788	3	_	
139-32	23788-23789	,	_	
139-33	23790-23796	Figure	_	
139-34	23797-23798	2	_	
139-35	23798-23799	)	_	
139-36	23799-23800	.	_	

#Text=No other group by between-network rsFC interactions were significant.
140-1	23801-23803	No	_	
140-2	23804-23809	other	_	
140-3	23810-23815	group	_	
140-4	23816-23818	by	_	
140-5	23819-23834	between-network	_	
140-6	23835-23839	rsFC	_	
140-7	23840-23852	interactions	_	
140-8	23853-23857	were	_	
140-9	23858-23869	significant	_	
140-10	23869-23870	.	_	

#Text=Discussion
#Text=The current study used a large-scale, functional network approach to examine cocaine-related differences in the association between network rsFC and impulsivity on reward-based decision-making tasks.
141-1	23871-23881	Discussion	_	
141-2	23882-23885	The	_	
141-3	23886-23893	current	_	
141-4	23894-23899	study	_	
141-5	23900-23904	used	_	
141-6	23905-23906	a	_	
141-7	23907-23918	large-scale	_	
141-8	23918-23919	,	_	
141-9	23920-23930	functional	_	
141-10	23931-23938	network	_	
141-11	23939-23947	approach	_	
141-12	23948-23950	to	_	
141-13	23951-23958	examine	_	
141-14	23959-23974	cocaine-related	_	
141-15	23975-23986	differences	_	
141-16	23987-23989	in	_	
141-17	23990-23993	the	_	
141-18	23994-24005	association	_	
141-19	24006-24013	between	_	
141-20	24014-24021	network	_	
141-21	24022-24026	rsFC	_	
141-22	24027-24030	and	_	
141-23	24031-24042	impulsivity	_	
141-24	24043-24045	on	_	
141-25	24046-24058	reward-based	_	
141-26	24059-24074	decision-making	_	
141-27	24075-24080	tasks	_	
141-28	24080-24081	.	_	

#Text=We examined rsFC between two networks involved in reward processing and expectancies and two cortical executive control networks involved in cognitive control and attentional salience.
142-1	24082-24084	We	_	
142-2	24085-24093	examined	_	
142-3	24094-24098	rsFC	_	
142-4	24099-24106	between	_	
142-5	24107-24110	two	_	
142-6	24111-24119	networks	_	
142-7	24120-24128	involved	_	
142-8	24129-24131	in	_	
142-9	24132-24138	reward	_	
142-10	24139-24149	processing	_	
142-11	24150-24153	and	_	
142-12	24154-24166	expectancies	_	
142-13	24167-24170	and	_	
142-14	24171-24174	two	_	
142-15	24175-24183	cortical	_	
142-16	24184-24193	executive	_	
142-17	24194-24201	control	_	
142-18	24202-24210	networks	_	
142-19	24211-24219	involved	_	
142-20	24220-24222	in	_	
142-21	24223-24232	cognitive	_	
142-22	24233-24240	control	_	
142-23	24241-24244	and	_	
142-24	24245-24256	attentional	_	
142-25	24257-24265	salience	_	
142-26	24265-24266	.	_	

#Text=We found that cocaine users had aberrant associations between network connectivity and impulsivity compared to controls.
143-1	24267-24269	We	_	
143-2	24270-24275	found	_	
143-3	24276-24280	that	_	
143-4	24281-24288	cocaine	_	
143-5	24289-24294	users	_	
143-6	24295-24298	had	_	
143-7	24299-24307	aberrant	_	
143-8	24308-24320	associations	_	
143-9	24321-24328	between	_	
143-10	24329-24336	network	_	
143-11	24337-24349	connectivity	_	
143-12	24350-24353	and	_	
143-13	24354-24365	impulsivity	_	
143-14	24366-24374	compared	_	
143-15	24375-24377	to	_	
143-16	24378-24386	controls	_	
143-17	24386-24387	.	_	

#Text=For cocaine users in the current study, stronger inverse coupling between the extended reward network and the left cognitive control network was associated with more risk-taking propensity on the BART task compared to controls.
144-1	24388-24391	For	_	
144-2	24392-24399	cocaine	_	
144-3	24400-24405	users	_	
144-4	24406-24408	in	_	
144-5	24409-24412	the	_	
144-6	24413-24420	current	_	
144-7	24421-24426	study	_	
144-8	24426-24427	,	_	
144-9	24428-24436	stronger	_	
144-10	24437-24444	inverse	_	
144-11	24445-24453	coupling	_	
144-12	24454-24461	between	_	
144-13	24462-24465	the	_	
144-14	24466-24474	extended	_	
144-15	24475-24481	reward	_	
144-16	24482-24489	network	_	
144-17	24490-24493	and	_	
144-18	24494-24497	the	_	
144-19	24498-24502	left	_	
144-20	24503-24512	cognitive	_	
144-21	24513-24520	control	_	
144-22	24521-24528	network	_	
144-23	24529-24532	was	_	
144-24	24533-24543	associated	_	
144-25	24544-24548	with	_	
144-26	24549-24553	more	_	
144-27	24554-24565	risk-taking	_	
144-28	24566-24576	propensity	_	
144-29	24577-24579	on	_	
144-30	24580-24583	the	_	
144-31	24584-24588	BART	_	
144-32	24589-24593	task	_	
144-33	24594-24602	compared	_	
144-34	24603-24605	to	_	
144-35	24606-24614	controls	_	
144-36	24614-24615	.	_	

#Text=This finding supported our hypothesis that stronger reward and cognitive control connectivity would be associated with more balloon pumps (i.e., risk) on the task for cocaine users.
145-1	24616-24620	This	_	
145-2	24621-24628	finding	_	
145-3	24629-24638	supported	_	
145-4	24639-24642	our	_	
145-5	24643-24653	hypothesis	_	
145-6	24654-24658	that	_	
145-7	24659-24667	stronger	_	
145-8	24668-24674	reward	_	
145-9	24675-24678	and	_	
145-10	24679-24688	cognitive	_	
145-11	24689-24696	control	_	
145-12	24697-24709	connectivity	_	
145-13	24710-24715	would	_	
145-14	24716-24718	be	_	
145-15	24719-24729	associated	_	
145-16	24730-24734	with	_	
145-17	24735-24739	more	_	
145-18	24740-24747	balloon	_	
145-19	24748-24753	pumps	_	
145-20	24754-24755	(	_	
145-21	24755-24758	i.e	_	
145-22	24758-24759	.	_	
145-23	24759-24760	,	_	
145-24	24761-24765	risk	_	
145-25	24765-24766	)	_	
145-26	24767-24769	on	_	
145-27	24770-24773	the	_	
145-28	24774-24778	task	_	
145-29	24779-24782	for	_	
145-30	24783-24790	cocaine	_	
145-31	24791-24796	users	_	
145-32	24796-24797	.	_	

#Text=This finding is consistent with prior research and models that conceptualize impulsive decision making among drug users as over-active reward function that diminishes or redirects executive control functions toward compulsive behavior.
146-1	24798-24802	This	_	
146-2	24803-24810	finding	_	
146-3	24811-24813	is	_	
146-4	24814-24824	consistent	_	
146-5	24825-24829	with	_	
146-6	24830-24835	prior	_	
146-7	24836-24844	research	_	
146-8	24845-24848	and	_	
146-9	24849-24855	models	_	
146-10	24856-24860	that	_	
146-11	24861-24874	conceptualize	_	
146-12	24875-24884	impulsive	_	
146-13	24885-24893	decision	_	
146-14	24894-24900	making	_	
146-15	24901-24906	among	_	
146-16	24907-24911	drug	_	
146-17	24912-24917	users	_	
146-18	24918-24920	as	_	
146-19	24921-24932	over-active	_	
146-20	24933-24939	reward	_	
146-21	24940-24948	function	_	
146-22	24949-24953	that	_	
146-23	24954-24964	diminishes	_	
146-24	24965-24967	or	_	
146-25	24968-24977	redirects	_	
146-26	24978-24987	executive	_	
146-27	24988-24995	control	_	
146-28	24996-25005	functions	_	
146-29	25006-25012	toward	_	
146-30	25013-25023	compulsive	_	
146-31	25024-25032	behavior	_	
146-32	25032-25033	.	_	

#Text=Our findings suggest that this imbalance in reward and executive control functions may be measurable using rsFC, not just during task engagement.
147-1	25034-25037	Our	_	
147-2	25038-25046	findings	_	
147-3	25047-25054	suggest	_	
147-4	25055-25059	that	_	
147-5	25060-25064	this	_	
147-6	25065-25074	imbalance	_	
147-7	25075-25077	in	_	
147-8	25078-25084	reward	_	
147-9	25085-25088	and	_	
147-10	25089-25098	executive	_	
147-11	25099-25106	control	_	
147-12	25107-25116	functions	_	
147-13	25117-25120	may	_	
147-14	25121-25123	be	_	
147-15	25124-25134	measurable	_	
147-16	25135-25140	using	_	
147-17	25141-25145	rsFC	_	
147-18	25145-25146	,	_	
147-19	25147-25150	not	_	
147-20	25151-25155	just	_	
147-21	25156-25162	during	_	
147-22	25163-25167	task	_	
147-23	25168-25178	engagement	_	
147-24	25178-25179	.	_	

#Text=Risky behavior on the BART has been linked to inverse functional activation of the extended reward and cognitive control networks and negative connectivity between these networks at rest may predispose cocaine users to make impulsive choices when presented with a risky decision.
148-1	25180-25185	Risky	_	
148-2	25186-25194	behavior	_	
148-3	25195-25197	on	_	
148-4	25198-25201	the	_	
148-5	25202-25206	BART	_	
148-6	25207-25210	has	_	
148-7	25211-25215	been	_	
148-8	25216-25222	linked	_	
148-9	25223-25225	to	_	
148-10	25226-25233	inverse	_	
148-11	25234-25244	functional	_	
148-12	25245-25255	activation	_	
148-13	25256-25258	of	_	
148-14	25259-25262	the	_	
148-15	25263-25271	extended	_	
148-16	25272-25278	reward	_	
148-17	25279-25282	and	_	
148-18	25283-25292	cognitive	_	
148-19	25293-25300	control	_	
148-20	25301-25309	networks	_	
148-21	25310-25313	and	_	
148-22	25314-25322	negative	_	
148-23	25323-25335	connectivity	_	
148-24	25336-25343	between	_	
148-25	25344-25349	these	_	
148-26	25350-25358	networks	_	
148-27	25359-25361	at	_	
148-28	25362-25366	rest	_	
148-29	25367-25370	may	_	
148-30	25371-25381	predispose	_	
148-31	25382-25389	cocaine	_	
148-32	25390-25395	users	_	
148-33	25396-25398	to	_	
148-34	25399-25403	make	_	
148-35	25404-25413	impulsive	_	
148-36	25414-25421	choices	_	
148-37	25422-25426	when	_	
148-38	25427-25436	presented	_	
148-39	25437-25441	with	_	
148-40	25442-25443	a	_	
148-41	25444-25449	risky	_	
148-42	25450-25458	decision	_	
148-43	25458-25459	.	_	

#Text=This finding was not consistent with our second hypothesis or with prior seed-based connectivity studies that found worse decision making and learning performance with increased positive rsFC between core reward and cognitive control brain regions.
149-1	25460-25464	This	_	
149-2	25465-25472	finding	_	
149-3	25473-25476	was	_	
149-4	25477-25480	not	_	
149-5	25481-25491	consistent	_	
149-6	25492-25496	with	_	
149-7	25497-25500	our	_	
149-8	25501-25507	second	_	
149-9	25508-25518	hypothesis	_	
149-10	25519-25521	or	_	
149-11	25522-25526	with	_	
149-12	25527-25532	prior	_	
149-13	25533-25543	seed-based	_	
149-14	25544-25556	connectivity	_	
149-15	25557-25564	studies	_	
149-16	25565-25569	that	_	
149-17	25570-25575	found	_	
149-18	25576-25581	worse	_	
149-19	25582-25590	decision	_	
149-20	25591-25597	making	_	
149-21	25598-25601	and	_	
149-22	25602-25610	learning	_	
149-23	25611-25622	performance	_	
149-24	25623-25627	with	_	
149-25	25628-25637	increased	_	
149-26	25638-25646	positive	_	
149-27	25647-25651	rsFC	_	
149-28	25652-25659	between	_	
149-29	25660-25664	core	_	
149-30	25665-25671	reward	_	
149-31	25672-25675	and	_	
149-32	25676-25685	cognitive	_	
149-33	25686-25693	control	_	
149-34	25694-25699	brain	_	
149-35	25700-25707	regions	_	
149-36	25707-25708	.	_	

#Text=Prior fMRI research has found that cashing out (i.e., safe choices), but not pumps (i.e., risky choices), on the BART are linked with activation of the caudate nucleus and hippocampus of the core reward network.
150-1	25709-25714	Prior	_	
150-2	25715-25719	fMRI	_	
150-3	25720-25728	research	_	
150-4	25729-25732	has	_	
150-5	25733-25738	found	_	
150-6	25739-25743	that	_	
150-7	25744-25745		_	
150-8	25745-25752	cashing	_	
150-9	25753-25756	out	_	
150-10	25756-25757		_	
150-11	25758-25759	(	_	
150-12	25759-25762	i.e	_	
150-13	25762-25763	.	_	
150-14	25763-25764	,	_	
150-15	25765-25769	safe	_	
150-16	25770-25777	choices	_	
150-17	25777-25778	)	_	
150-18	25778-25779	,	_	
150-19	25780-25783	but	_	
150-20	25784-25787	not	_	
150-21	25788-25793	pumps	_	
150-22	25794-25795	(	_	
150-23	25795-25798	i.e	_	
150-24	25798-25799	.	_	
150-25	25799-25800	,	_	
150-26	25801-25806	risky	_	
150-27	25807-25814	choices	_	
150-28	25814-25815	)	_	
150-29	25815-25816	,	_	
150-30	25817-25819	on	_	
150-31	25820-25823	the	_	
150-32	25824-25828	BART	_	
150-33	25829-25832	are	_	
150-34	25833-25839	linked	_	
150-35	25840-25844	with	_	
150-36	25845-25855	activation	_	
150-37	25856-25858	of	_	
150-38	25859-25862	the	_	
150-39	25863-25870	caudate	_	
150-40	25871-25878	nucleus	_	
150-41	25879-25882	and	_	
150-42	25883-25894	hippocampus	_	
150-43	25895-25897	of	_	
150-44	25898-25901	the	_	
150-45	25902-25906	core	_	
150-46	25907-25913	reward	_	
150-47	25914-25921	network	_	
150-48	25921-25922	.	_	

#Text=The core reward network is more closely linked with reward processing and learning after receipt of the reward, and may be less involved in the pre-decision reward anticipation on tasks like the BART as the extended reward and cognitive control networks.
151-1	25923-25926	The	_	
151-2	25927-25931	core	_	
151-3	25932-25938	reward	_	
151-4	25939-25946	network	_	
151-5	25947-25949	is	_	
151-6	25950-25954	more	_	
151-7	25955-25962	closely	_	
151-8	25963-25969	linked	_	
151-9	25970-25974	with	_	
151-10	25975-25981	reward	_	
151-11	25982-25992	processing	_	
151-12	25993-25996	and	_	
151-13	25997-26005	learning	_	
151-14	26006-26011	after	_	
151-15	26012-26019	receipt	_	
151-16	26020-26022	of	_	
151-17	26023-26026	the	_	
151-18	26027-26033	reward	_	
151-19	26033-26034	,	_	
151-20	26035-26038	and	_	
151-21	26039-26042	may	_	
151-22	26043-26045	be	_	
151-23	26046-26050	less	_	
151-24	26051-26059	involved	_	
151-25	26060-26062	in	_	
151-26	26063-26066	the	_	
151-27	26067-26079	pre-decision	_	
151-28	26080-26086	reward	_	
151-29	26087-26099	anticipation	_	
151-30	26100-26102	on	_	
151-31	26103-26108	tasks	_	
151-32	26109-26113	like	_	
151-33	26114-26117	the	_	
151-34	26118-26122	BART	_	
151-35	26123-26125	as	_	
151-36	26126-26129	the	_	
151-37	26130-26138	extended	_	
151-38	26139-26145	reward	_	
151-39	26146-26149	and	_	
151-40	26150-26159	cognitive	_	
151-41	26160-26167	control	_	
151-42	26168-26176	networks	_	
151-43	26176-26177	.	_	

#Text=Our divergent results may also be due to our use of data-driven intrinsic networks, rather than a priori seeds; this allowed us to examine the interactions among brain regions within separate functional networks.
152-1	26178-26181	Our	_	
152-2	26182-26191	divergent	_	
152-3	26192-26199	results	_	
152-4	26200-26203	may	_	
152-5	26204-26208	also	_	
152-6	26209-26211	be	_	
152-7	26212-26215	due	_	
152-8	26216-26218	to	_	
152-9	26219-26222	our	_	
152-10	26223-26226	use	_	
152-11	26227-26229	of	_	
152-12	26230-26241	data-driven	_	
152-13	26242-26251	intrinsic	_	
152-14	26252-26260	networks	_	
152-15	26260-26261	,	_	
152-16	26262-26268	rather	_	
152-17	26269-26273	than	_	
152-18	26274-26275	a	_	
152-19	26276-26282	priori	_	
152-20	26283-26288	seeds	_	
152-21	26288-26289	;	_	
152-22	26290-26294	this	_	
152-23	26295-26302	allowed	_	
152-24	26303-26305	us	_	
152-25	26306-26308	to	_	
152-26	26309-26316	examine	_	
152-27	26317-26320	the	_	
152-28	26321-26333	interactions	_	
152-29	26334-26339	among	_	
152-30	26340-26345	brain	_	
152-31	26346-26353	regions	_	
152-32	26354-26360	within	_	
152-33	26361-26369	separate	_	
152-34	26370-26380	functional	_	
152-35	26381-26389	networks	_	
152-36	26389-26390	.	_	

#Text=One of the strengths of ICA is the ability to identify connectivity strength within overlapping networks and to detect and remove signal noise that confounds seed-based connectivity analyses.
153-1	26391-26394	One	_	
153-2	26395-26397	of	_	
153-3	26398-26401	the	_	
153-4	26402-26411	strengths	_	
153-5	26412-26414	of	_	
153-6	26415-26418	ICA	_	
153-7	26419-26421	is	_	
153-8	26422-26425	the	_	
153-9	26426-26433	ability	_	
153-10	26434-26436	to	_	
153-11	26437-26445	identify	_	
153-12	26446-26458	connectivity	_	
153-13	26459-26467	strength	_	
153-14	26468-26474	within	_	
153-15	26475-26486	overlapping	_	
153-16	26487-26495	networks	_	
153-17	26496-26499	and	_	
153-18	26500-26502	to	_	
153-19	26503-26509	detect	_	
153-20	26510-26513	and	_	
153-21	26514-26520	remove	_	
153-22	26521-26527	signal	_	
153-23	26528-26533	noise	_	
153-24	26534-26538	that	_	
153-25	26539-26548	confounds	_	
153-26	26549-26559	seed-based	_	
153-27	26560-26572	connectivity	_	
153-28	26573-26581	analyses	_	
153-29	26581-26582	.	_	

#Text=For these reasons, connectivity within large-scale functional networks may be more predictive of behavior than seed-regions or even task-related activity in affected brain regions.
154-1	26583-26586	For	_	
154-2	26587-26592	these	_	
154-3	26593-26600	reasons	_	
154-4	26600-26601	,	_	
154-5	26602-26614	connectivity	_	
154-6	26615-26621	within	_	
154-7	26622-26633	large-scale	_	
154-8	26634-26644	functional	_	
154-9	26645-26653	networks	_	
154-10	26654-26657	may	_	
154-11	26658-26660	be	_	
154-12	26661-26665	more	_	
154-13	26666-26676	predictive	_	
154-14	26677-26679	of	_	
154-15	26680-26688	behavior	_	
154-16	26689-26693	than	_	
154-17	26694-26706	seed-regions	_	
154-18	26707-26709	or	_	
154-19	26710-26714	even	_	
154-20	26715-26727	task-related	_	
154-21	26728-26736	activity	_	
154-22	26737-26739	in	_	
154-23	26740-26748	affected	_	
154-24	26749-26754	brain	_	
154-25	26755-26762	regions	_	
154-26	26762-26763	.	_	

#Text=Our results did not support our hypothesis that inverse connectivity between the extended reward and cognitive control network would be linked with worse learning on the IGT.
155-1	26764-26767	Our	_	
155-2	26768-26775	results	_	
155-3	26776-26779	did	_	
155-4	26780-26783	not	_	
155-5	26784-26791	support	_	
155-6	26792-26795	our	_	
155-7	26796-26806	hypothesis	_	
155-8	26807-26811	that	_	
155-9	26812-26819	inverse	_	
155-10	26820-26832	connectivity	_	
155-11	26833-26840	between	_	
155-12	26841-26844	the	_	
155-13	26845-26853	extended	_	
155-14	26854-26860	reward	_	
155-15	26861-26864	and	_	
155-16	26865-26874	cognitive	_	
155-17	26875-26882	control	_	
155-18	26883-26890	network	_	
155-19	26891-26896	would	_	
155-20	26897-26899	be	_	
155-21	26900-26906	linked	_	
155-22	26907-26911	with	_	
155-23	26912-26917	worse	_	
155-24	26918-26926	learning	_	
155-25	26927-26929	on	_	
155-26	26930-26933	the	_	
155-27	26934-26937	IGT	_	
155-28	26937-26938	.	_	

#Text=This was surprising, considering that extended reward and cognitive control inverse connectivity was associated with BART performance for cocaine users in the study.
156-1	26939-26943	This	_	
156-2	26944-26947	was	_	
156-3	26948-26958	surprising	_	
156-4	26958-26959	,	_	
156-5	26960-26971	considering	_	
156-6	26972-26976	that	_	
156-7	26977-26985	extended	_	
156-8	26986-26992	reward	_	
156-9	26993-26996	and	_	
156-10	26997-27006	cognitive	_	
156-11	27007-27014	control	_	
156-12	27015-27022	inverse	_	
156-13	27023-27035	connectivity	_	
156-14	27036-27039	was	_	
156-15	27040-27050	associated	_	
156-16	27051-27055	with	_	
156-17	27056-27060	BART	_	
156-18	27061-27072	performance	_	
156-19	27073-27076	for	_	
156-20	27077-27084	cocaine	_	
156-21	27085-27090	users	_	
156-22	27091-27093	in	_	
156-23	27094-27097	the	_	
156-24	27098-27103	study	_	
156-25	27103-27104	.	_	

#Text=While we did not specify right or left cognitive control networks in our hypotheses since both are linked with decision-making and inhibitory control, prior fMRI and PET research on IGT and BART performance with stimulant users has implicated right-sided cognitive control network activity involved in reasoning, inhibition, and memory.
157-1	27105-27110	While	_	
157-2	27111-27113	we	_	
157-3	27114-27117	did	_	
157-4	27118-27121	not	_	
157-5	27122-27129	specify	_	
157-6	27130-27135	right	_	
157-7	27136-27138	or	_	
157-8	27139-27143	left	_	
157-9	27144-27153	cognitive	_	
157-10	27154-27161	control	_	
157-11	27162-27170	networks	_	
157-12	27171-27173	in	_	
157-13	27174-27177	our	_	
157-14	27178-27188	hypotheses	_	
157-15	27189-27194	since	_	
157-16	27195-27199	both	_	
157-17	27200-27203	are	_	
157-18	27204-27210	linked	_	
157-19	27211-27215	with	_	
157-20	27216-27231	decision-making	_	
157-21	27232-27235	and	_	
157-22	27236-27246	inhibitory	_	
157-23	27247-27254	control	_	
157-24	27254-27255	,	_	
157-25	27256-27261	prior	_	
157-26	27262-27266	fMRI	_	
157-27	27267-27270	and	_	
157-28	27271-27274	PET	_	
157-29	27275-27283	research	_	
157-30	27284-27286	on	_	
157-31	27287-27290	IGT	_	
157-32	27291-27294	and	_	
157-33	27295-27299	BART	_	
157-34	27300-27311	performance	_	
157-35	27312-27316	with	_	
157-36	27317-27326	stimulant	_	
157-37	27327-27332	users	_	
157-38	27333-27336	has	_	
157-39	27337-27347	implicated	_	
157-40	27348-27359	right-sided	_	
157-41	27360-27369	cognitive	_	
157-42	27370-27377	control	_	
157-43	27378-27385	network	_	
157-44	27386-27394	activity	_	
157-45	27395-27403	involved	_	
157-46	27404-27406	in	_	
157-47	27407-27416	reasoning	_	
157-48	27416-27417	,	_	
157-49	27418-27428	inhibition	_	
157-50	27428-27429	,	_	
157-51	27430-27433	and	_	
157-52	27434-27440	memory	_	
157-53	27440-27441	.	_	

#Text=Alternatively, we found BART performance to be associated with extended reward and left-sided cognitive control network connectivity, primarily involved in language processing and recall of associative cues.
158-1	27442-27455	Alternatively	_	
158-2	27455-27456	,	_	
158-3	27457-27459	we	_	
158-4	27460-27465	found	_	
158-5	27466-27470	BART	_	
158-6	27471-27482	performance	_	
158-7	27483-27485	to	_	
158-8	27486-27488	be	_	
158-9	27489-27499	associated	_	
158-10	27500-27504	with	_	
158-11	27505-27513	extended	_	
158-12	27514-27520	reward	_	
158-13	27521-27524	and	_	
158-14	27525-27535	left-sided	_	
158-15	27536-27545	cognitive	_	
158-16	27546-27553	control	_	
158-17	27554-27561	network	_	
158-18	27562-27574	connectivity	_	
158-19	27574-27575	,	_	
158-20	27576-27585	primarily	_	
158-21	27586-27594	involved	_	
158-22	27595-27597	in	_	
158-23	27598-27606	language	_	
158-24	27607-27617	processing	_	
158-25	27618-27621	and	_	
158-26	27622-27628	recall	_	
158-27	27629-27631	of	_	
158-28	27632-27643	associative	_	
158-29	27644-27648	cues	_	
158-30	27648-27649	.	_	

#Text=Compulsive behavior in addiction is, in part, facilitated by associative learning between drug cues and reward expectancies and chronic cocaine users show reduced interhemispheric connectivity of the cognitive control networks.
159-1	27650-27660	Compulsive	_	
159-2	27661-27669	behavior	_	
159-3	27670-27672	in	_	
159-4	27673-27682	addiction	_	
159-5	27683-27685	is	_	
159-6	27685-27686	,	_	
159-7	27687-27689	in	_	
159-8	27690-27694	part	_	
159-9	27694-27695	,	_	
159-10	27696-27707	facilitated	_	
159-11	27708-27710	by	_	
159-12	27711-27722	associative	_	
159-13	27723-27731	learning	_	
159-14	27732-27739	between	_	
159-15	27740-27744	drug	_	
159-16	27745-27749	cues	_	
159-17	27750-27753	and	_	
159-18	27754-27760	reward	_	
159-19	27761-27773	expectancies	_	
159-20	27774-27777	and	_	
159-21	27778-27785	chronic	_	
159-22	27786-27793	cocaine	_	
159-23	27794-27799	users	_	
159-24	27800-27804	show	_	
159-25	27805-27812	reduced	_	
159-26	27813-27829	interhemispheric	_	
159-27	27830-27842	connectivity	_	
159-28	27843-27845	of	_	
159-29	27846-27849	the	_	
159-30	27850-27859	cognitive	_	
159-31	27860-27867	control	_	
159-32	27868-27876	networks	_	
159-33	27876-27877	.	_	

#Text=Our findings may point to an increasing role of associative recall facilitated by the left cognitive control network during decision making for cocaine users.
160-1	27878-27881	Our	_	
160-2	27882-27890	findings	_	
160-3	27891-27894	may	_	
160-4	27895-27900	point	_	
160-5	27901-27903	to	_	
160-6	27904-27906	an	_	
160-7	27907-27917	increasing	_	
160-8	27918-27922	role	_	
160-9	27923-27925	of	_	
160-10	27926-27937	associative	_	
160-11	27938-27944	recall	_	
160-12	27945-27956	facilitated	_	
160-13	27957-27959	by	_	
160-14	27960-27963	the	_	
160-15	27964-27968	left	_	
160-16	27969-27978	cognitive	_	
160-17	27979-27986	control	_	
160-18	27987-27994	network	_	
160-19	27995-28001	during	_	
160-20	28002-28010	decision	_	
160-21	28011-28017	making	_	
160-22	28018-28021	for	_	
160-23	28022-28029	cocaine	_	
160-24	28030-28035	users	_	
160-25	28035-28036	.	_	

#Text=This is supported by prior research showing cocaine-related increases in left cognitive control network rsFC.
161-1	28037-28041	This	_	
161-2	28042-28044	is	_	
161-3	28045-28054	supported	_	
161-4	28055-28057	by	_	
161-5	28058-28063	prior	_	
161-6	28064-28072	research	_	
161-7	28073-28080	showing	_	
161-8	28081-28096	cocaine-related	_	
161-9	28097-28106	increases	_	
161-10	28107-28109	in	_	
161-11	28110-28114	left	_	
161-12	28115-28124	cognitive	_	
161-13	28125-28132	control	_	
161-14	28133-28140	network	_	
161-15	28141-28145	rsFC	_	
161-16	28145-28146	.	_	

#Text=Future research using rsFC and task-based activity may be able to parse out the distinct roles of each hemisphere in impulsivity and addictive behavior.
162-1	28147-28153	Future	_	
162-2	28154-28162	research	_	
162-3	28163-28168	using	_	
162-4	28169-28173	rsFC	_	
162-5	28174-28177	and	_	
162-6	28178-28188	task-based	_	
162-7	28189-28197	activity	_	
162-8	28198-28201	may	_	
162-9	28202-28204	be	_	
162-10	28205-28209	able	_	
162-11	28210-28212	to	_	
162-12	28213-28218	parse	_	
162-13	28219-28222	out	_	
162-14	28223-28226	the	_	
162-15	28227-28235	distinct	_	
162-16	28236-28241	roles	_	
162-17	28242-28244	of	_	
162-18	28245-28249	each	_	
162-19	28250-28260	hemisphere	_	
162-20	28261-28263	in	_	
162-21	28264-28275	impulsivity	_	
162-22	28276-28279	and	_	
162-23	28280-28289	addictive	_	
162-24	28290-28298	behavior	_	
162-25	28298-28299	.	_	

#Text=Although cocaine users demonstrated strong links between rsFC and BART performance, they had an insignificant association between rsFC and intertemporal discounting on the MCT.
163-1	28300-28308	Although	_	
163-2	28309-28316	cocaine	_	
163-3	28317-28322	users	_	
163-4	28323-28335	demonstrated	_	
163-5	28336-28342	strong	_	
163-6	28343-28348	links	_	
163-7	28349-28356	between	_	
163-8	28357-28361	rsFC	_	
163-9	28362-28365	and	_	
163-10	28366-28370	BART	_	
163-11	28371-28382	performance	_	
163-12	28382-28383	,	_	
163-13	28384-28388	they	_	
163-14	28389-28392	had	_	
163-15	28393-28395	an	_	
163-16	28396-28409	insignificant	_	
163-17	28410-28421	association	_	
163-18	28422-28429	between	_	
163-19	28430-28434	rsFC	_	
163-20	28435-28438	and	_	
163-21	28439-28452	intertemporal	_	
163-22	28453-28464	discounting	_	
163-23	28465-28467	on	_	
163-24	28468-28471	the	_	
163-25	28472-28475	MCT	_	
163-26	28475-28476	.	_	

#Text=We hypothesized that inverse connectivity of reward and attentional salience networks would be indicative of network imbalance and related to higher discount rates for cocaine users.
164-1	28477-28479	We	_	
164-2	28480-28492	hypothesized	_	
164-3	28493-28497	that	_	
164-4	28498-28505	inverse	_	
164-5	28506-28518	connectivity	_	
164-6	28519-28521	of	_	
164-7	28522-28528	reward	_	
164-8	28529-28532	and	_	
164-9	28533-28544	attentional	_	
164-10	28545-28553	salience	_	
164-11	28554-28562	networks	_	
164-12	28563-28568	would	_	
164-13	28569-28571	be	_	
164-14	28572-28582	indicative	_	
164-15	28583-28585	of	_	
164-16	28586-28593	network	_	
164-17	28594-28603	imbalance	_	
164-18	28604-28607	and	_	
164-19	28608-28615	related	_	
164-20	28616-28618	to	_	
164-21	28619-28625	higher	_	
164-22	28626-28634	discount	_	
164-23	28635-28640	rates	_	
164-24	28641-28644	for	_	
164-25	28645-28652	cocaine	_	
164-26	28653-28658	users	_	
164-27	28658-28659	.	_	

#Text=Instead, this was true for the control participants.
165-1	28660-28667	Instead	_	
165-2	28667-28668	,	_	
165-3	28669-28673	this	_	
165-4	28674-28677	was	_	
165-5	28678-28682	true	_	
165-6	28683-28686	for	_	
165-7	28687-28690	the	_	
165-8	28691-28698	control	_	
165-9	28699-28711	participants	_	
165-10	28711-28712	.	_	

#Text=The core reward network is linked with immediate reward valuation while the attentional salience network is linked with delayed reward valuation.
166-1	28713-28716	The	_	
166-2	28717-28721	core	_	
166-3	28722-28728	reward	_	
166-4	28729-28736	network	_	
166-5	28737-28739	is	_	
166-6	28740-28746	linked	_	
166-7	28747-28751	with	_	
166-8	28752-28761	immediate	_	
166-9	28762-28768	reward	_	
166-10	28769-28778	valuation	_	
166-11	28779-28784	while	_	
166-12	28785-28788	the	_	
166-13	28789-28800	attentional	_	
166-14	28801-28809	salience	_	
166-15	28810-28817	network	_	
166-16	28818-28820	is	_	
166-17	28821-28827	linked	_	
166-18	28828-28832	with	_	
166-19	28833-28840	delayed	_	
166-20	28841-28847	reward	_	
166-21	28848-28857	valuation	_	
166-22	28857-28858	.	_	

#Text=The significant association between resting-state connectivity and intertemporal discounting may be predictive of healthy and expected functional network control over the valuation of delayed over immediate rewards for our control participants who had a wide range of discounting rates.
167-1	28859-28862	The	_	
167-2	28863-28874	significant	_	
167-3	28875-28886	association	_	
167-4	28887-28894	between	_	
167-5	28895-28908	resting-state	_	
167-6	28909-28921	connectivity	_	
167-7	28922-28925	and	_	
167-8	28926-28939	intertemporal	_	
167-9	28940-28951	discounting	_	
167-10	28952-28955	may	_	
167-11	28956-28958	be	_	
167-12	28959-28969	predictive	_	
167-13	28970-28972	of	_	
167-14	28973-28980	healthy	_	
167-15	28981-28984	and	_	
167-16	28985-28993	expected	_	
167-17	28994-29004	functional	_	
167-18	29005-29012	network	_	
167-19	29013-29020	control	_	
167-20	29021-29025	over	_	
167-21	29026-29029	the	_	
167-22	29030-29039	valuation	_	
167-23	29040-29042	of	_	
167-24	29043-29050	delayed	_	
167-25	29051-29055	over	_	
167-26	29056-29065	immediate	_	
167-27	29066-29073	rewards	_	
167-28	29074-29077	for	_	
167-29	29078-29081	our	_	
167-30	29082-29089	control	_	
167-31	29090-29102	participants	_	
167-32	29103-29106	who	_	
167-33	29107-29110	had	_	
167-34	29111-29112	a	_	
167-35	29113-29117	wide	_	
167-36	29118-29123	range	_	
167-37	29124-29126	of	_	
167-38	29127-29138	discounting	_	
167-39	29139-29144	rates	_	
167-40	29144-29145	.	_	

#Text=While prior research found that an uncoupling of salience and reward networks was related to higher impulsivity for cocaine users, our results suggest that imbalance may instead be observed as a dissociation between rsFC and impulsive behavior.
168-1	29146-29151	While	_	
168-2	29152-29157	prior	_	
168-3	29158-29166	research	_	
168-4	29167-29172	found	_	
168-5	29173-29177	that	_	
168-6	29178-29180	an	_	
168-7	29181-29191	uncoupling	_	
168-8	29192-29194	of	_	
168-9	29195-29203	salience	_	
168-10	29204-29207	and	_	
168-11	29208-29214	reward	_	
168-12	29215-29223	networks	_	
168-13	29224-29227	was	_	
168-14	29228-29235	related	_	
168-15	29236-29238	to	_	
168-16	29239-29245	higher	_	
168-17	29246-29257	impulsivity	_	
168-18	29258-29261	for	_	
168-19	29262-29269	cocaine	_	
168-20	29270-29275	users	_	
168-21	29275-29276	,	_	
168-22	29277-29280	our	_	
168-23	29281-29288	results	_	
168-24	29289-29296	suggest	_	
168-25	29297-29301	that	_	
168-26	29302-29311	imbalance	_	
168-27	29312-29315	may	_	
168-28	29316-29323	instead	_	
168-29	29324-29326	be	_	
168-30	29327-29335	observed	_	
168-31	29336-29338	as	_	
168-32	29339-29340	a	_	
168-33	29341-29353	dissociation	_	
168-34	29354-29361	between	_	
168-35	29362-29366	rsFC	_	
168-36	29367-29370	and	_	
168-37	29371-29380	impulsive	_	
168-38	29381-29389	behavior	_	
168-39	29389-29390	.	_	

#Text=Prior studies have found a disconnection between cocaine users self-perception and actual task performance, which could be described as neural-behavioral dissociation.
169-1	29391-29396	Prior	_	
169-2	29397-29404	studies	_	
169-3	29405-29409	have	_	
169-4	29410-29415	found	_	
169-5	29416-29417	a	_	
169-6	29418-29431	disconnection	_	
169-7	29432-29439	between	_	
169-8	29440-29447	cocaine	_	
169-9	29448-29453	users	_	
169-10	29453-29454		_	
169-11	29455-29470	self-perception	_	
169-12	29471-29474	and	_	
169-13	29475-29481	actual	_	
169-14	29482-29486	task	_	
169-15	29487-29498	performance	_	
169-16	29498-29499	,	_	
169-17	29500-29505	which	_	
169-18	29506-29511	could	_	
169-19	29512-29514	be	_	
169-20	29515-29524	described	_	
169-21	29525-29527	as	_	
169-22	29528-29545	neural-behavioral	_	
169-23	29546-29558	dissociation	_	
169-24	29558-29559	.	_	

#Text=Neural-behavioral dissociation occurs when autonomic responses fail to predict behavioral outcomes, which is believed to be caused by reduced input from cortical executive control over subcortical regions involved in emotion and conditioned responding.
170-1	29560-29577	Neural-behavioral	_	
170-2	29578-29590	dissociation	_	
170-3	29591-29597	occurs	_	
170-4	29598-29602	when	_	
170-5	29603-29612	autonomic	_	
170-6	29613-29622	responses	_	
170-7	29623-29627	fail	_	
170-8	29628-29630	to	_	
170-9	29631-29638	predict	_	
170-10	29639-29649	behavioral	_	
170-11	29650-29658	outcomes	_	
170-12	29658-29659	,	_	
170-13	29660-29665	which	_	
170-14	29666-29668	is	_	
170-15	29669-29677	believed	_	
170-16	29678-29680	to	_	
170-17	29681-29683	be	_	
170-18	29684-29690	caused	_	
170-19	29691-29693	by	_	
170-20	29694-29701	reduced	_	
170-21	29702-29707	input	_	
170-22	29708-29712	from	_	
170-23	29713-29721	cortical	_	
170-24	29722-29731	executive	_	
170-25	29732-29739	control	_	
170-26	29740-29744	over	_	
170-27	29745-29756	subcortical	_	
170-28	29757-29764	regions	_	
170-29	29765-29773	involved	_	
170-30	29774-29776	in	_	
170-31	29777-29784	emotion	_	
170-32	29785-29788	and	_	
170-33	29789-29800	conditioned	_	
170-34	29801-29811	responding	_	
170-35	29811-29812	.	_	

#Text=Our results suggest a dissociation between the behavioral responses driven by the core reward network involved in autonomic responses to drug rewards, and the attentional salience network involved in informing behavioral decision making.
171-1	29813-29816	Our	_	
171-2	29817-29824	results	_	
171-3	29825-29832	suggest	_	
171-4	29833-29834	a	_	
171-5	29835-29847	dissociation	_	
171-6	29848-29855	between	_	
171-7	29856-29859	the	_	
171-8	29860-29870	behavioral	_	
171-9	29871-29880	responses	_	
171-10	29881-29887	driven	_	
171-11	29888-29890	by	_	
171-12	29891-29894	the	_	
171-13	29895-29899	core	_	
171-14	29900-29906	reward	_	
171-15	29907-29914	network	_	
171-16	29915-29923	involved	_	
171-17	29924-29926	in	_	
171-18	29927-29936	autonomic	_	
171-19	29937-29946	responses	_	
171-20	29947-29949	to	_	
171-21	29950-29954	drug	_	
171-22	29955-29962	rewards	_	
171-23	29962-29963	,	_	
171-24	29964-29967	and	_	
171-25	29968-29971	the	_	
171-26	29972-29983	attentional	_	
171-27	29984-29992	salience	_	
171-28	29993-30000	network	_	
171-29	30001-30009	involved	_	
171-30	30010-30012	in	_	
171-31	30013-30022	informing	_	
171-32	30023-30033	behavioral	_	
171-33	30034-30042	decision	_	
171-34	30043-30049	making	_	
171-35	30049-30050	.	_	

#Text=The current study adds to the literature by demonstrating how functional connectivity between large-scale networks is associated with impulsive decision making for cocaine users.
172-1	30051-30054	The	_	
172-2	30055-30062	current	_	
172-3	30063-30068	study	_	
172-4	30069-30073	adds	_	
172-5	30074-30076	to	_	
172-6	30077-30080	the	_	
172-7	30081-30091	literature	_	
172-8	30092-30094	by	_	
172-9	30095-30108	demonstrating	_	
172-10	30109-30112	how	_	
172-11	30113-30123	functional	_	
172-12	30124-30136	connectivity	_	
172-13	30137-30144	between	_	
172-14	30145-30156	large-scale	_	
172-15	30157-30165	networks	_	
172-16	30166-30168	is	_	
172-17	30169-30179	associated	_	
172-18	30180-30184	with	_	
172-19	30185-30194	impulsive	_	
172-20	30195-30203	decision	_	
172-21	30204-30210	making	_	
172-22	30211-30214	for	_	
172-23	30215-30222	cocaine	_	
172-24	30223-30228	users	_	
172-25	30228-30229	.	_	

#Text=The strengths of the study include its use of data-driven networks, a relatively large sample size compared to prior research in this area, generalizability to real-world cocaine users, and a focus on reward and executive control networks implicated in impulsive decision making in the context of addiction.
173-1	30230-30233	The	_	
173-2	30234-30243	strengths	_	
173-3	30244-30246	of	_	
173-4	30247-30250	the	_	
173-5	30251-30256	study	_	
173-6	30257-30264	include	_	
173-7	30265-30268	its	_	
173-8	30269-30272	use	_	
173-9	30273-30275	of	_	
173-10	30276-30287	data-driven	_	
173-11	30288-30296	networks	_	
173-12	30296-30297	,	_	
173-13	30298-30299	a	_	
173-14	30300-30310	relatively	_	
173-15	30311-30316	large	_	
173-16	30317-30323	sample	_	
173-17	30324-30328	size	_	
173-18	30329-30337	compared	_	
173-19	30338-30340	to	_	
173-20	30341-30346	prior	_	
173-21	30347-30355	research	_	
173-22	30356-30358	in	_	
173-23	30359-30363	this	_	
173-24	30364-30368	area	_	
173-25	30368-30369	,	_	
173-26	30370-30386	generalizability	_	
173-27	30387-30389	to	_	
173-28	30390-30400	real-world	_	
173-29	30401-30408	cocaine	_	
173-30	30409-30414	users	_	
173-31	30414-30415	,	_	
173-32	30416-30419	and	_	
173-33	30420-30421	a	_	
173-34	30422-30427	focus	_	
173-35	30428-30430	on	_	
173-36	30431-30437	reward	_	
173-37	30438-30441	and	_	
173-38	30442-30451	executive	_	
173-39	30452-30459	control	_	
173-40	30460-30468	networks	_	
173-41	30469-30479	implicated	_	
173-42	30480-30482	in	_	
173-43	30483-30492	impulsive	_	
173-44	30493-30501	decision	_	
173-45	30502-30508	making	_	
173-46	30509-30511	in	_	
173-47	30512-30515	the	_	
173-48	30516-30523	context	_	
173-49	30524-30526	of	_	
173-50	30527-30536	addiction	_	
173-51	30536-30537	.	_	

#Text=The effects of cocaine use in these results are more accurately described as the effects of a cocaine use disorder, in which cocaine use is the primary drug of choice and co-occurs with polysubstance use (i.e., smoking, alcohol, and marijuana).
174-1	30538-30541	The	_	
174-2	30542-30549	effects	_	
174-3	30550-30552	of	_	
174-4	30553-30560	cocaine	_	
174-5	30561-30564	use	_	
174-6	30565-30567	in	_	
174-7	30568-30573	these	_	
174-8	30574-30581	results	_	
174-9	30582-30585	are	_	
174-10	30586-30590	more	_	
174-11	30591-30601	accurately	_	
174-12	30602-30611	described	_	
174-13	30612-30614	as	_	
174-14	30615-30618	the	_	
174-15	30619-30626	effects	_	
174-16	30627-30629	of	_	
174-17	30630-30631	a	_	
174-18	30632-30639	cocaine	_	
174-19	30640-30643	use	_	
174-20	30644-30652	disorder	_	
174-21	30652-30653	,	_	
174-22	30654-30656	in	_	
174-23	30657-30662	which	_	
174-24	30663-30670	cocaine	_	
174-25	30671-30674	use	_	
174-26	30675-30677	is	_	
174-27	30678-30681	the	_	
174-28	30682-30689	primary	_	
174-29	30690-30694	drug	_	
174-30	30695-30697	of	_	
174-31	30698-30704	choice	_	
174-32	30705-30708	and	_	
174-33	30709-30718	co-occurs	_	
174-34	30719-30723	with	_	
174-35	30724-30737	polysubstance	_	
174-36	30738-30741	use	_	
174-37	30742-30743	(	_	
174-38	30743-30746	i.e	_	
174-39	30746-30747	.	_	
174-40	30747-30748	,	_	
174-41	30749-30756	smoking	_	
174-42	30756-30757	,	_	
174-43	30758-30765	alcohol	_	
174-44	30765-30766	,	_	
174-45	30767-30770	and	_	
174-46	30771-30780	marijuana	_	
174-47	30780-30781	)	_	
174-48	30781-30782	.	_	

#Text=While this may introduce confounding effects from multiple substances, recruiting participants who only use cocaine would have limited our generalizability to the poly-substance cocaine users typically seen in the United States.
175-1	30783-30788	While	_	
175-2	30789-30793	this	_	
175-3	30794-30797	may	_	
175-4	30798-30807	introduce	_	
175-5	30808-30819	confounding	_	
175-6	30820-30827	effects	_	
175-7	30828-30832	from	_	
175-8	30833-30841	multiple	_	
175-9	30842-30852	substances	_	
175-10	30852-30853	,	_	
175-11	30854-30864	recruiting	_	
175-12	30865-30877	participants	_	
175-13	30878-30881	who	_	
175-14	30882-30886	only	_	
175-15	30887-30890	use	_	
175-16	30891-30898	cocaine	_	
175-17	30899-30904	would	_	
175-18	30905-30909	have	_	
175-19	30910-30917	limited	_	
175-20	30918-30921	our	_	
175-21	30922-30938	generalizability	_	
175-22	30939-30941	to	_	
175-23	30942-30945	the	_	
175-24	30946-30960	poly-substance	_	
175-25	30961-30968	cocaine	_	
175-26	30969-30974	users	_	
175-27	30975-30984	typically	_	
175-28	30985-30989	seen	_	
175-29	30990-30992	in	_	
175-30	30993-30996	the	_	
175-31	30997-31003	United	_	
175-32	31004-31010	States	_	
175-33	31010-31011	.	_	

#Text=The study also had several limitations.
176-1	31012-31015	The	_	
176-2	31016-31021	study	_	
176-3	31022-31026	also	_	
176-4	31027-31030	had	_	
176-5	31031-31038	several	_	
176-6	31039-31050	limitations	_	
176-7	31050-31051	.	_	

#Text=Age, education, and motion differed across groups and were controlled for in the group analyses.
177-1	31052-31055	Age	_	
177-2	31055-31056	,	_	
177-3	31057-31066	education	_	
177-4	31066-31067	,	_	
177-5	31068-31071	and	_	
177-6	31072-31078	motion	_	
177-7	31079-31087	differed	_	
177-8	31088-31094	across	_	
177-9	31095-31101	groups	_	
177-10	31102-31105	and	_	
177-11	31106-31110	were	_	
177-12	31111-31121	controlled	_	
177-13	31122-31125	for	_	
177-14	31126-31128	in	_	
177-15	31129-31132	the	_	
177-16	31133-31138	group	_	
177-17	31139-31147	analyses	_	
177-18	31147-31148	.	_	

#Text=Although results were unchanged with these variables removed from the analysis, differences in demographic characteristics could have contributed to the group effects detected considering their known influence on rsFC.
178-1	31149-31157	Although	_	
178-2	31158-31165	results	_	
178-3	31166-31170	were	_	
178-4	31171-31180	unchanged	_	
178-5	31181-31185	with	_	
178-6	31186-31191	these	_	
178-7	31192-31201	variables	_	
178-8	31202-31209	removed	_	
178-9	31210-31214	from	_	
178-10	31215-31218	the	_	
178-11	31219-31227	analysis	_	
178-12	31227-31228	,	_	
178-13	31229-31240	differences	_	
178-14	31241-31243	in	_	
178-15	31244-31255	demographic	_	
178-16	31256-31271	characteristics	_	
178-17	31272-31277	could	_	
178-18	31278-31282	have	_	
178-19	31283-31294	contributed	_	
178-20	31295-31297	to	_	
178-21	31298-31301	the	_	
178-22	31302-31307	group	_	
178-23	31308-31315	effects	_	
178-24	31316-31324	detected	_	
178-25	31325-31336	considering	_	
178-26	31337-31342	their	_	
178-27	31343-31348	known	_	
178-28	31349-31358	influence	_	
178-29	31359-31361	on	_	
178-30	31362-31366	rsFC	_	
178-31	31366-31367	.	_	

#Text=Future research with samples that include more variability on these factors would provide an opportunity to examine their influence on functional connectivity and cognitive outcomes.
179-1	31368-31374	Future	_	
179-2	31375-31383	research	_	
179-3	31384-31388	with	_	
179-4	31389-31396	samples	_	
179-5	31397-31401	that	_	
179-6	31402-31409	include	_	
179-7	31410-31414	more	_	
179-8	31415-31426	variability	_	
179-9	31427-31429	on	_	
179-10	31430-31435	these	_	
179-11	31436-31443	factors	_	
179-12	31444-31449	would	_	
179-13	31450-31457	provide	_	
179-14	31458-31460	an	_	
179-15	31461-31472	opportunity	_	
179-16	31473-31475	to	_	
179-17	31476-31483	examine	_	
179-18	31484-31489	their	_	
179-19	31490-31499	influence	_	
179-20	31500-31502	on	_	
179-21	31503-31513	functional	_	
179-22	31514-31526	connectivity	_	
179-23	31527-31530	and	_	
179-24	31531-31540	cognitive	_	
179-25	31541-31549	outcomes	_	
179-26	31549-31550	.	_	

#Text=Given the cross-sectional nature of the current research in this area, it is unclear if changes in rsFC and impulsivity are due to chronic substance use, or predisposing genetic, individual, or environmental factors.
180-1	31551-31556	Given	_	
180-2	31557-31560	the	_	
180-3	31561-31576	cross-sectional	_	
180-4	31577-31583	nature	_	
180-5	31584-31586	of	_	
180-6	31587-31590	the	_	
180-7	31591-31598	current	_	
180-8	31599-31607	research	_	
180-9	31608-31610	in	_	
180-10	31611-31615	this	_	
180-11	31616-31620	area	_	
180-12	31620-31621	,	_	
180-13	31622-31624	it	_	
180-14	31625-31627	is	_	
180-15	31628-31635	unclear	_	
180-16	31636-31638	if	_	
180-17	31639-31646	changes	_	
180-18	31647-31649	in	_	
180-19	31650-31654	rsFC	_	
180-20	31655-31658	and	_	
180-21	31659-31670	impulsivity	_	
180-22	31671-31674	are	_	
180-23	31675-31678	due	_	
180-24	31679-31681	to	_	
180-25	31682-31689	chronic	_	
180-26	31690-31699	substance	_	
180-27	31700-31703	use	_	
180-28	31703-31704	,	_	
180-29	31705-31707	or	_	
180-30	31708-31720	predisposing	_	
180-31	31721-31728	genetic	_	
180-32	31728-31729	,	_	
180-33	31730-31740	individual	_	
180-34	31740-31741	,	_	
180-35	31742-31744	or	_	
180-36	31745-31758	environmental	_	
180-37	31759-31766	factors	_	
180-38	31766-31767	.	_	

#Text=In addition, the moderation analyses may have been underpowered to detect small interaction effects and we did not correct for multiple comparisons, given that the hypotheses were derived independently and a priori.
181-1	31768-31770	In	_	
181-2	31771-31779	addition	_	
181-3	31779-31780	,	_	
181-4	31781-31784	the	_	
181-5	31785-31795	moderation	_	
181-6	31796-31804	analyses	_	
181-7	31805-31808	may	_	
181-8	31809-31813	have	_	
181-9	31814-31818	been	_	
181-10	31819-31831	underpowered	_	
181-11	31832-31834	to	_	
181-12	31835-31841	detect	_	
181-13	31842-31847	small	_	
181-14	31848-31859	interaction	_	
181-15	31860-31867	effects	_	
181-16	31868-31871	and	_	
181-17	31872-31874	we	_	
181-18	31875-31878	did	_	
181-19	31879-31882	not	_	
181-20	31883-31890	correct	_	
181-21	31891-31894	for	_	
181-22	31895-31903	multiple	_	
181-23	31904-31915	comparisons	_	
181-24	31915-31916	,	_	
181-25	31917-31922	given	_	
181-26	31923-31927	that	_	
181-27	31928-31931	the	_	
181-28	31932-31942	hypotheses	_	
181-29	31943-31947	were	_	
181-30	31948-31955	derived	_	
181-31	31956-31969	independently	_	
181-32	31970-31973	and	_	
181-33	31974-31975	a	_	
181-34	31976-31982	priori	_	
181-35	31982-31983	.	_	

#Text=Finally, the findings should be interpreted with caution in light of recent research showing that the traditional five-minute resting-state fMRI scan may not be as reliable as longer scans.
182-1	31984-31991	Finally	_	
182-2	31991-31992	,	_	
182-3	31993-31996	the	_	
182-4	31997-32005	findings	_	
182-5	32006-32012	should	_	
182-6	32013-32015	be	_	
182-7	32016-32027	interpreted	_	
182-8	32028-32032	with	_	
182-9	32033-32040	caution	_	
182-10	32041-32043	in	_	
182-11	32044-32049	light	_	
182-12	32050-32052	of	_	
182-13	32053-32059	recent	_	
182-14	32060-32068	research	_	
182-15	32069-32076	showing	_	
182-16	32077-32081	that	_	
182-17	32082-32085	the	_	
182-18	32086-32097	traditional	_	
182-19	32098-32109	five-minute	_	
182-20	32110-32123	resting-state	_	
182-21	32124-32128	fMRI	_	
182-22	32129-32133	scan	_	
182-23	32134-32137	may	_	
182-24	32138-32141	not	_	
182-25	32142-32144	be	_	
182-26	32145-32147	as	_	
182-27	32148-32156	reliable	_	
182-28	32157-32159	as	_	
182-29	32160-32166	longer	_	
182-30	32167-32172	scans	_	
182-31	32172-32173	.	_	

#Text=A priori defined networks, such as the fronto-parietal network, tend to be the most reliable, but test-retest reliability is diminished in subcortical networks due to smaller anatomical regions and potentially unique activity patterns.
183-1	32174-32175	A	_	
183-2	32176-32182	priori	_	
183-3	32183-32190	defined	_	
183-4	32191-32199	networks	_	
183-5	32199-32200	,	_	
183-6	32201-32205	such	_	
183-7	32206-32208	as	_	
183-8	32209-32212	the	_	
183-9	32213-32228	fronto-parietal	_	
183-10	32229-32236	network	_	
183-11	32236-32237	,	_	
183-12	32238-32242	tend	_	
183-13	32243-32245	to	_	
183-14	32246-32248	be	_	
183-15	32249-32252	the	_	
183-16	32253-32257	most	_	
183-17	32258-32266	reliable	_	
183-18	32266-32267	,	_	
183-19	32268-32271	but	_	
183-20	32272-32283	test-retest	_	
183-21	32284-32295	reliability	_	
183-22	32296-32298	is	_	
183-23	32299-32309	diminished	_	
183-24	32310-32312	in	_	
183-25	32313-32324	subcortical	_	
183-26	32325-32333	networks	_	
183-27	32334-32337	due	_	
183-28	32338-32340	to	_	
183-29	32341-32348	smaller	_	
183-30	32349-32359	anatomical	_	
183-31	32360-32367	regions	_	
183-32	32368-32371	and	_	
183-33	32372-32383	potentially	_	
183-34	32384-32390	unique	_	
183-35	32391-32399	activity	_	
183-36	32400-32408	patterns	_	
183-37	32408-32409	.	_	

#Text=In conclusion, the results of the current study suggest cocaine use disorder is related to altered associations between impulsivity and reward and executive control network rsFC coupling.
184-1	32410-32412	In	_	
184-2	32413-32423	conclusion	_	
184-3	32423-32424	,	_	
184-4	32425-32428	the	_	
184-5	32429-32436	results	_	
184-6	32437-32439	of	_	
184-7	32440-32443	the	_	
184-8	32444-32451	current	_	
184-9	32452-32457	study	_	
184-10	32458-32465	suggest	_	
184-11	32466-32473	cocaine	_	
184-12	32474-32477	use	_	
184-13	32478-32486	disorder	_	
184-14	32487-32489	is	_	
184-15	32490-32497	related	_	
184-16	32498-32500	to	_	
184-17	32501-32508	altered	_	
184-18	32509-32521	associations	_	
184-19	32522-32529	between	_	
184-20	32530-32541	impulsivity	_	
184-21	32542-32545	and	_	
184-22	32546-32552	reward	_	
184-23	32553-32556	and	_	
184-24	32557-32566	executive	_	
184-25	32567-32574	control	_	
184-26	32575-32582	network	_	
184-27	32583-32587	rsFC	_	
184-28	32588-32596	coupling	_	
184-29	32596-32597	.	_	

#Text=Given prior links between functional connectivity with drug treatment outcomes and the known plasticity of these connections, developing interventions to manipulate connectivity could potentially improve clinical and behavioral outcomes for cocaine users.
185-1	32598-32603	Given	_	
185-2	32604-32609	prior	_	
185-3	32610-32615	links	_	
185-4	32616-32623	between	_	
185-5	32624-32634	functional	_	
185-6	32635-32647	connectivity	_	
185-7	32648-32652	with	_	
185-8	32653-32657	drug	_	
185-9	32658-32667	treatment	_	
185-10	32668-32676	outcomes	_	
185-11	32677-32680	and	_	
185-12	32681-32684	the	_	
185-13	32685-32690	known	_	
185-14	32691-32701	plasticity	_	
185-15	32702-32704	of	_	
185-16	32705-32710	these	_	
185-17	32711-32722	connections	_	
185-18	32722-32723	,	_	
185-19	32724-32734	developing	_	
185-20	32735-32748	interventions	_	
185-21	32749-32751	to	_	
185-22	32752-32762	manipulate	_	
185-23	32763-32775	connectivity	_	
185-24	32776-32781	could	_	
185-25	32782-32793	potentially	_	
185-26	32794-32801	improve	_	
185-27	32802-32810	clinical	_	
185-28	32811-32814	and	_	
185-29	32815-32825	behavioral	_	
185-30	32826-32834	outcomes	_	
185-31	32835-32838	for	_	
185-32	32839-32846	cocaine	_	
185-33	32847-32852	users	_	
185-34	32852-32853	.	_	

#Text=Future research using longitudinal designs and multimodal imaging that incorporates structural and task-based functional data may add to our understanding of the temporal course, directionality, and specificity of these associations to identify intervention targets.
186-1	32854-32860	Future	_	
186-2	32861-32869	research	_	
186-3	32870-32875	using	_	
186-4	32876-32888	longitudinal	_	
186-5	32889-32896	designs	_	
186-6	32897-32900	and	_	
186-7	32901-32911	multimodal	_	
186-8	32912-32919	imaging	_	
186-9	32920-32924	that	_	
186-10	32925-32937	incorporates	_	
186-11	32938-32948	structural	_	
186-12	32949-32952	and	_	
186-13	32953-32963	task-based	_	
186-14	32964-32974	functional	_	
186-15	32975-32979	data	_	
186-16	32980-32983	may	_	
186-17	32984-32987	add	_	
186-18	32988-32990	to	_	
186-19	32991-32994	our	_	
186-20	32995-33008	understanding	_	
186-21	33009-33011	of	_	
186-22	33012-33015	the	_	
186-23	33016-33024	temporal	_	
186-24	33025-33031	course	_	
186-25	33031-33032	,	_	
186-26	33033-33047	directionality	_	
186-27	33047-33048	,	_	
186-28	33049-33052	and	_	
186-29	33053-33064	specificity	_	
186-30	33065-33067	of	_	
186-31	33068-33073	these	_	
186-32	33074-33086	associations	_	
186-33	33087-33089	to	_	
186-34	33090-33098	identify	_	
186-35	33099-33111	intervention	_	
186-36	33112-33119	targets	_	
186-37	33119-33120	.	_	

#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
187-1	33121-33125	This	_	
187-2	33126-33128	is	_	
187-3	33129-33130	a	_	
187-4	33131-33134	PDF	_	
187-5	33135-33139	file	_	
187-6	33140-33142	of	_	
187-7	33143-33145	an	_	
187-8	33146-33154	unedited	_	
187-9	33155-33165	manuscript	_	
187-10	33166-33170	that	_	
187-11	33171-33174	has	_	
187-12	33175-33179	been	_	
187-13	33180-33188	accepted	_	
187-14	33189-33192	for	_	
187-15	33193-33204	publication	_	
187-16	33204-33205	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
188-1	33206-33208	As	_	
188-2	33209-33210	a	_	
188-3	33211-33218	service	_	
188-4	33219-33221	to	_	
188-5	33222-33225	our	_	
188-6	33226-33235	customers	_	
188-7	33236-33238	we	_	
188-8	33239-33242	are	_	
188-9	33243-33252	providing	_	
188-10	33253-33257	this	_	
188-11	33258-33263	early	_	
188-12	33264-33271	version	_	
188-13	33272-33274	of	_	
188-14	33275-33278	the	_	
188-15	33279-33289	manuscript	_	
188-16	33289-33290	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
189-1	33291-33294	The	_	
189-2	33295-33305	manuscript	_	
189-3	33306-33310	will	_	
189-4	33311-33318	undergo	_	
189-5	33319-33330	copyediting	_	
189-6	33330-33331	,	_	
189-7	33332-33343	typesetting	_	
189-8	33343-33344	,	_	
189-9	33345-33348	and	_	
189-10	33349-33355	review	_	
189-11	33356-33358	of	_	
189-12	33359-33362	the	_	
189-13	33363-33372	resulting	_	
189-14	33373-33378	proof	_	
189-15	33379-33385	before	_	
189-16	33386-33388	it	_	
189-17	33389-33391	is	_	
189-18	33392-33401	published	_	
189-19	33402-33404	in	_	
189-20	33405-33408	its	_	
189-21	33409-33414	final	_	
189-22	33415-33422	citable	_	
189-23	33423-33427	form	_	
189-24	33427-33428	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
190-1	33429-33435	Please	_	
190-2	33436-33440	note	_	
190-3	33441-33445	that	_	
190-4	33446-33452	during	_	
190-5	33453-33456	the	_	
190-6	33457-33467	production	_	
190-7	33468-33475	process	_	
190-8	33476-33482	errors	_	
190-9	33483-33486	may	_	
190-10	33487-33489	be	_	
190-11	33490-33500	discovered	_	
190-12	33501-33506	which	_	
190-13	33507-33512	could	_	
190-14	33513-33519	affect	_	
190-15	33520-33523	the	_	
190-16	33524-33531	content	_	
190-17	33531-33532	,	_	
190-18	33533-33536	and	_	
190-19	33537-33540	all	_	
190-20	33541-33546	legal	_	
190-21	33547-33558	disclaimers	_	
190-22	33559-33563	that	_	
190-23	33564-33569	apply	_	
190-24	33570-33572	to	_	
190-25	33573-33576	the	_	
190-26	33577-33584	journal	_	
190-27	33585-33592	pertain	_	
190-28	33592-33593	.	_	

#Text=Conflict of interest
#Text=The authors declare that they have no conflict of interest.
191-1	33594-33602	Conflict	_	
191-2	33603-33605	of	_	
191-3	33606-33614	interest	_	
191-4	33615-33618	The	_	
191-5	33619-33626	authors	_	
191-6	33627-33634	declare	_	
191-7	33635-33639	that	_	
191-8	33640-33644	they	_	
191-9	33645-33649	have	_	
191-10	33650-33652	no	_	
191-11	33653-33661	conflict	_	
191-12	33662-33664	of	_	
191-13	33665-33673	interest	_	
191-14	33673-33674	.	_	

#Text=References
#Text=Insensitivity to future consequences following damage to human prefrontal cortex
#Text=Investigations into resting-state connectivity using independent component analysis
#Text=Group comparison of resting-state fMRI data using multi-subject ICA and dual regression
#Text=Probabilistic independent component analysis for functional magnetic resonance imaging
#Text=Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence
#Text=Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task
#Text=Frontal hyperconnectivity related to discounting and reversal learning in cocaine subjects
#Text=Altered functional connectivity of the insular cortex across prefrontal networks in cocaine addiction
#Text=Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals
#Text=Reduced resting-state brain activity in the default network in normal aging
#Text=Drug addiction as dopamine-dependent associative learning disorder
#Text=Reward system and addiction: What dopamine does and doesnt do
#Text=Decision-making in a risk-taking task: A PET study
#Text=Review: Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction
#Text=Measuring and manipulating brain connectivity with resting state functional connectivity magnetic resonance imaging (fcMRI) and transcranial magnetic stimulation (TMS)
#Text=Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging
#Text=Decision making in the Balloon Analogue Risk Task (BART): Anterior cingulate cortex signals loss aversion but not the infrequency of risky choices
#Text=Greater risk sensitivity of dorsolateral prefrontal cortex in young smokers than in nonsmokers
#Text=Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction?
192-1	33675-33685	References	_	
192-2	33686-33699	Insensitivity	_	
192-3	33700-33702	to	_	
192-4	33703-33709	future	_	
192-5	33710-33722	consequences	_	
192-6	33723-33732	following	_	
192-7	33733-33739	damage	_	
192-8	33740-33742	to	_	
192-9	33743-33748	human	_	
192-10	33749-33759	prefrontal	_	
192-11	33760-33766	cortex	_	
192-12	33767-33781	Investigations	_	
192-13	33782-33786	into	_	
192-14	33787-33800	resting-state	_	
192-15	33801-33813	connectivity	_	
192-16	33814-33819	using	_	
192-17	33820-33831	independent	_	
192-18	33832-33841	component	_	
192-19	33842-33850	analysis	_	
192-20	33851-33856	Group	_	
192-21	33857-33867	comparison	_	
192-22	33868-33870	of	_	
192-23	33871-33884	resting-state	_	
192-24	33885-33889	fMRI	_	
192-25	33890-33894	data	_	
192-26	33895-33900	using	_	
192-27	33901-33914	multi-subject	_	
192-28	33915-33918	ICA	_	
192-29	33919-33922	and	_	
192-30	33923-33927	dual	_	
192-31	33928-33938	regression	_	
192-32	33939-33952	Probabilistic	_	
192-33	33953-33964	independent	_	
192-34	33965-33974	component	_	
192-35	33975-33983	analysis	_	
192-36	33984-33987	for	_	
192-37	33988-33998	functional	_	
192-38	33999-34007	magnetic	_	
192-39	34008-34017	resonance	_	
192-40	34018-34025	imaging	_	
192-41	34026-34035	Excessive	_	
192-42	34036-34047	discounting	_	
192-43	34048-34050	of	_	
192-44	34051-34058	delayed	_	
192-45	34059-34070	reinforcers	_	
192-46	34071-34073	as	_	
192-47	34074-34075	a	_	
192-48	34076-34089	trans-disease	_	
192-49	34090-34097	process	_	
192-50	34098-34110	contributing	_	
192-51	34111-34113	to	_	
192-52	34114-34123	addiction	_	
192-53	34124-34127	and	_	
192-54	34128-34133	other	_	
192-55	34134-34149	disease-related	_	
192-56	34150-34165	vulnerabilities	_	
192-57	34165-34166	:	_	
192-58	34167-34175	emerging	_	
192-59	34176-34184	evidence	_	
192-60	34185-34198	Orbitofrontal	_	
192-61	34199-34205	cortex	_	
192-62	34206-34217	dysfunction	_	
192-63	34218-34220	in	_	
192-64	34221-34230	abstinent	_	
192-65	34231-34238	cocaine	_	
192-66	34239-34246	abusers	_	
192-67	34247-34257	performing	_	
192-68	34258-34259	a	_	
192-69	34260-34275	decision-making	_	
192-70	34276-34280	task	_	
192-71	34281-34288	Frontal	_	
192-72	34289-34306	hyperconnectivity	_	
192-73	34307-34314	related	_	
192-74	34315-34317	to	_	
192-75	34318-34329	discounting	_	
192-76	34330-34333	and	_	
192-77	34334-34342	reversal	_	
192-78	34343-34351	learning	_	
192-79	34352-34354	in	_	
192-80	34355-34362	cocaine	_	
192-81	34363-34371	subjects	_	
192-82	34372-34379	Altered	_	
192-83	34380-34390	functional	_	
192-84	34391-34403	connectivity	_	
192-85	34404-34406	of	_	
192-86	34407-34410	the	_	
192-87	34411-34418	insular	_	
192-88	34419-34425	cortex	_	
192-89	34426-34432	across	_	
192-90	34433-34443	prefrontal	_	
192-91	34444-34452	networks	_	
192-92	34453-34455	in	_	
192-93	34456-34463	cocaine	_	
192-94	34464-34473	addiction	_	
192-95	34474-34485	Impulsivity	_	
192-96	34486-34489	and	_	
192-97	34490-34495	rapid	_	
192-98	34496-34507	discounting	_	
192-99	34508-34510	of	_	
192-100	34511-34518	delayed	_	
192-101	34519-34531	hypothetical	_	
192-102	34532-34539	rewards	_	
192-103	34540-34542	in	_	
192-104	34543-34560	cocaine-dependent	_	
192-105	34561-34572	individuals	_	
192-106	34573-34580	Reduced	_	
192-107	34581-34594	resting-state	_	
192-108	34595-34600	brain	_	
192-109	34601-34609	activity	_	
192-110	34610-34612	in	_	
192-111	34613-34616	the	_	
192-112	34617-34618		_	
192-113	34618-34625	default	_	
192-114	34626-34633	network	_	
192-115	34633-34634		_	
192-116	34635-34637	in	_	
192-117	34638-34644	normal	_	
192-118	34645-34650	aging	_	
192-119	34651-34655	Drug	_	
192-120	34656-34665	addiction	_	
192-121	34666-34668	as	_	
192-122	34669-34687	dopamine-dependent	_	
192-123	34688-34699	associative	_	
192-124	34700-34708	learning	_	
192-125	34709-34717	disorder	_	
192-126	34718-34724	Reward	_	
192-127	34725-34731	system	_	
192-128	34732-34735	and	_	
192-129	34736-34745	addiction	_	
192-130	34745-34746	:	_	
192-131	34747-34751	What	_	
192-132	34752-34760	dopamine	_	
192-133	34761-34765	does	_	
192-134	34766-34769	and	_	
192-135	34770-34775	doesn	_	
192-136	34775-34776		_	
192-137	34776-34777	t	_	
192-138	34778-34780	do	_	
192-139	34781-34796	Decision-making	_	
192-140	34797-34799	in	_	
192-141	34800-34801	a	_	
192-142	34802-34813	risk-taking	_	
192-143	34814-34818	task	_	
192-144	34818-34819	:	_	
192-145	34820-34821	A	_	
192-146	34822-34825	PET	_	
192-147	34826-34831	study	_	
192-148	34832-34838	Review	_	
192-149	34838-34839	:	_	
192-150	34840-34846	Neural	_	
192-151	34847-34857	mechanisms	_	
192-152	34858-34868	underlying	_	
192-153	34869-34872	the	_	
192-154	34873-34886	vulnerability	_	
192-155	34887-34889	to	_	
192-156	34890-34897	develop	_	
192-157	34898-34908	compulsive	_	
192-158	34909-34921	drug-seeking	_	
192-159	34922-34928	habits	_	
192-160	34929-34932	and	_	
192-161	34933-34942	addiction	_	
192-162	34943-34952	Measuring	_	
192-163	34953-34956	and	_	
192-164	34957-34969	manipulating	_	
192-165	34970-34975	brain	_	
192-166	34976-34988	connectivity	_	
192-167	34989-34993	with	_	
192-168	34994-35001	resting	_	
192-169	35002-35007	state	_	
192-170	35008-35018	functional	_	
192-171	35019-35031	connectivity	_	
192-172	35032-35040	magnetic	_	
192-173	35041-35050	resonance	_	
192-174	35051-35058	imaging	_	
192-175	35059-35060	(	_	
192-176	35060-35065	fcMRI	_	
192-177	35065-35066	)	_	
192-178	35067-35070	and	_	
192-179	35071-35083	transcranial	_	
192-180	35084-35092	magnetic	_	
192-181	35093-35104	stimulation	_	
192-182	35105-35106	(	_	
192-183	35106-35109	TMS	_	
192-184	35109-35110	)	_	
192-185	35111-35122	Spontaneous	_	
192-186	35123-35135	fluctuations	_	
192-187	35136-35138	in	_	
192-188	35139-35144	brain	_	
192-189	35145-35153	activity	_	
192-190	35154-35162	observed	_	
192-191	35163-35167	with	_	
192-192	35168-35178	functional	_	
192-193	35179-35187	magnetic	_	
192-194	35188-35197	resonance	_	
192-195	35198-35205	imaging	_	
192-196	35206-35214	Decision	_	
192-197	35215-35221	making	_	
192-198	35222-35224	in	_	
192-199	35225-35228	the	_	
192-200	35229-35236	Balloon	_	
192-201	35237-35245	Analogue	_	
192-202	35246-35250	Risk	_	
192-203	35251-35255	Task	_	
192-204	35256-35257	(	_	
192-205	35257-35261	BART	_	
192-206	35261-35262	)	_	
192-207	35262-35263	:	_	
192-208	35264-35272	Anterior	_	
192-209	35273-35282	cingulate	_	
192-210	35283-35289	cortex	_	
192-211	35290-35297	signals	_	
192-212	35298-35302	loss	_	
192-213	35303-35311	aversion	_	
192-214	35312-35315	but	_	
192-215	35316-35319	not	_	
192-216	35320-35323	the	_	
192-217	35324-35335	infrequency	_	
192-218	35336-35338	of	_	
192-219	35339-35344	risky	_	
192-220	35345-35352	choices	_	
192-221	35353-35360	Greater	_	
192-222	35361-35365	risk	_	
192-223	35366-35377	sensitivity	_	
192-224	35378-35380	of	_	
192-225	35381-35393	dorsolateral	_	
192-226	35394-35404	prefrontal	_	
192-227	35405-35411	cortex	_	
192-228	35412-35414	in	_	
192-229	35415-35420	young	_	
192-230	35421-35428	smokers	_	
192-231	35429-35433	than	_	
192-232	35434-35436	in	_	
192-233	35437-35447	nonsmokers	_	
192-234	35448-35450	Is	_	
192-235	35451-35460	decreased	_	
192-236	35461-35471	prefrontal	_	
192-237	35472-35480	cortical	_	
192-238	35481-35492	sensitivity	_	
192-239	35493-35495	to	_	
192-240	35496-35504	monetary	_	
192-241	35505-35511	reward	_	
192-242	35512-35522	associated	_	
192-243	35523-35527	with	_	
192-244	35528-35536	impaired	_	
192-245	35537-35547	motivation	_	
192-246	35548-35551	and	_	
192-247	35552-35564	self-control	_	
192-248	35565-35567	in	_	
192-249	35568-35575	cocaine	_	
192-250	35576-35585	addiction	_	
192-251	35585-35586	?	_	

#Text=Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications
#Text=Drug abusers show impaired performance in a laboratory test of decision making
#Text=Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity
#Text=
#Text=Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls
#Text=Executive dysfunction in cocaine addiction: Evidence for discordant frontal, cingulate, and cerebellar activity
#Text=Impaired functional connectivity within and between frontostriatal circuits and its association with compulsive drug use and trait impulsivity in cocaine addiction
#Text=
#Text=Improved optimization for the robust and accurate linear registration and motion correction of brain images
#Text=FSL
#Text=Reduced interhemispheric resting state functional connectivity in cocaine addiction
#Text=Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls
#Text=Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls
#Text=Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence
#Text=Neurobiology of addiction: a neurocircuitry analysis
#Text=Common biology of craving across legal and illegal drugs - A quantitative meta-analysis of cue-reactivity brain response
#Text=Behavioral interpretations of intrinsic connectivity networks
#Text=Evaluation of a behavioral measure of risk taking: The Balloon Analogue Risk Task (BART)
#Text=The Iowa Gambling Task in fMRI images
#Text=Effect of cocaine dependence on brain connections: clinical implications
#Text=Amphetamine-induced dopamine release: Markedly blunded in cocaine dependence and predictive of choice to self-administer cocaine
#Text=Statistical difficulties of detecting interactions and moderator effects
#Text=Separate neural systems value immediate and delayed monetary rewards
#Text=Striatal-insula circuits in cocaine addiction: Implications for impulsivity and relapse risk
#Text=Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States
#Text=Large-scale brain networks and psychopathology: A unifying triple network model
#Text=Impaired insight in cocaine addiction: laboratory evidence and effects on cocaine-seeking behaviour
#Text=Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task
#Text=Influences on the test-retest reliability of functional connectivity MRI and its relationship with behavioral utility
#Text=Deep brain stimulation for the treatment of addiction: Basic and clinical studies and potential mechanisms of action
#Text=Methods to detect, characterize, and remove motion artifact in resting state fMRI
#Text=ICA-AROMA: A robust ICA-based strategy for removing motion artifacts from fMRI data
#Text=Neural correlates of voluntary and involuntary risk taking in the human brain: An fMRI Study of the Balloon Analog Risk Task (BART)
#Text=Altered functional connectivity strength in abstinent chronic cocaine smokers compared to healthy controls
#Text=Connectivity analysis is essential to understand neurological disorders
#Text=Decreasing ventromedial prefrontal cortex activity during sequential risk-taking: An FMRI investigation of the balloon analog risk task
#Text=Dissociable intrinsic connectivity networks for salience processing and executive control
#Text=Advances in functional and structural MR image analysis and implementation as FSL
#Text=Resting state functional connectivity in addiction: Lessons learned and a road ahead
#Text=Hemisphere- and gender-related differences in small-world brain networks: a resting-state functional MRI study
#Text=Adaptation of the Monetary Choice Questionnaire to accommodate extreme monetary discounting in cocaine users
#Text=Perfusion abnormalities and decision making in cocaine dependence
#Text=Precuneus is a functional core of the default-mode network
#Text=The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task
#Text=Stages of dysfunctional decision-making in addiction
#Text=Cognitive impulsivity in cocaine and heroin polysubstance abusers
#Text=Evidence for a frontoparietal control system revealed by intrinsic functional connectivity
#Text=Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brains control circuit
#Text=Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine
#Text=Prefrontal transcranial direct current stimulation alters activation and connectivity in cortical and subcortical reward systems: A tDCS-fMRI study
#Text=Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders
#Text=An intrinsic connectivity network approach to insula-derived dysfunctions among cocaine users
#Text=Time and decision making: Differential contribution of the posterior insular cortex and the striatum during a delay discounting task
#Text=Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome
#Text=Mean spatial maps derived from independent component analysis (ICA).
193-1	35587-35598	Dysfunction	_	
193-2	35599-35601	of	_	
193-3	35602-35605	the	_	
193-4	35606-35616	prefrontal	_	
193-5	35617-35623	cortex	_	
193-6	35624-35626	in	_	
193-7	35627-35636	addiction	_	
193-8	35636-35637	:	_	
193-9	35638-35650	Neuroimaging	_	
193-10	35651-35659	findings	_	
193-11	35660-35663	and	_	
193-12	35664-35672	clinical	_	
193-13	35673-35685	implications	_	
193-14	35686-35690	Drug	_	
193-15	35691-35698	abusers	_	
193-16	35699-35703	show	_	
193-17	35704-35712	impaired	_	
193-18	35713-35724	performance	_	
193-19	35725-35727	in	_	
193-20	35728-35729	a	_	
193-21	35730-35740	laboratory	_	
193-22	35741-35745	test	_	
193-23	35746-35748	of	_	
193-24	35749-35757	decision	_	
193-25	35758-35764	making	_	
193-26	35765-35782	Mesocorticolimbic	_	
193-27	35783-35791	circuits	_	
193-28	35792-35795	are	_	
193-29	35796-35804	impaired	_	
193-30	35805-35807	in	_	
193-31	35808-35815	chronic	_	
193-32	35816-35823	cocaine	_	
193-33	35824-35829	users	_	
193-34	35830-35832	as	_	
193-35	35833-35845	demonstrated	_	
193-36	35846-35848	by	_	
193-37	35849-35862	resting-state	_	
193-38	35863-35873	functional	_	
193-39	35874-35886	connectivity	_	
193-40	35888-35893	Delay	_	
193-41	35894-35905	discounting	_	
193-42	35906-35908	in	_	
193-43	35909-35918	currently	_	
193-44	35919-35924	using	_	
193-45	35925-35928	and	_	
193-46	35929-35938	currently	_	
193-47	35939-35948	abstinent	_	
193-48	35949-35966	cocaine-dependent	_	
193-49	35967-35978	outpatients	_	
193-50	35979-35982	and	_	
193-51	35983-35997	non-drug-using	_	
193-52	35998-36005	matched	_	
193-53	36006-36014	controls	_	
193-54	36015-36024	Executive	_	
193-55	36025-36036	dysfunction	_	
193-56	36037-36039	in	_	
193-57	36040-36047	cocaine	_	
193-58	36048-36057	addiction	_	
193-59	36057-36058	:	_	
193-60	36059-36067	Evidence	_	
193-61	36068-36071	for	_	
193-62	36072-36082	discordant	_	
193-63	36083-36090	frontal	_	
193-64	36090-36091	,	_	
193-65	36092-36101	cingulate	_	
193-66	36101-36102	,	_	
193-67	36103-36106	and	_	
193-68	36107-36117	cerebellar	_	
193-69	36118-36126	activity	_	
193-70	36127-36135	Impaired	_	
193-71	36136-36146	functional	_	
193-72	36147-36159	connectivity	_	
193-73	36160-36166	within	_	
193-74	36167-36170	and	_	
193-75	36171-36178	between	_	
193-76	36179-36193	frontostriatal	_	
193-77	36194-36202	circuits	_	
193-78	36203-36206	and	_	
193-79	36207-36210	its	_	
193-80	36211-36222	association	_	
193-81	36223-36227	with	_	
193-82	36228-36238	compulsive	_	
193-83	36239-36243	drug	_	
193-84	36244-36247	use	_	
193-85	36248-36251	and	_	
193-86	36252-36257	trait	_	
193-87	36258-36269	impulsivity	_	
193-88	36270-36272	in	_	
193-89	36273-36280	cocaine	_	
193-90	36281-36290	addiction	_	
193-91	36292-36300	Improved	_	
193-92	36301-36313	optimization	_	
193-93	36314-36317	for	_	
193-94	36318-36321	the	_	
193-95	36322-36328	robust	_	
193-96	36329-36332	and	_	
193-97	36333-36341	accurate	_	
193-98	36342-36348	linear	_	
193-99	36349-36361	registration	_	
193-100	36362-36365	and	_	
193-101	36366-36372	motion	_	
193-102	36373-36383	correction	_	
193-103	36384-36386	of	_	
193-104	36387-36392	brain	_	
193-105	36393-36399	images	_	
193-106	36400-36403	FSL	_	
193-107	36404-36411	Reduced	_	
193-108	36412-36428	interhemispheric	_	
193-109	36429-36436	resting	_	
193-110	36437-36442	state	_	
193-111	36443-36453	functional	_	
193-112	36454-36466	connectivity	_	
193-113	36467-36469	in	_	
193-114	36470-36477	cocaine	_	
193-115	36478-36487	addiction	_	
193-116	36488-36494	Heroin	_	
193-117	36495-36498	and	_	
193-118	36499-36506	cocaine	_	
193-119	36507-36514	abusers	_	
193-120	36515-36519	have	_	
193-121	36520-36526	higher	_	
193-122	36527-36535	discount	_	
193-123	36536-36541	rates	_	
193-124	36542-36545	for	_	
193-125	36546-36553	delayed	_	
193-126	36554-36561	rewards	_	
193-127	36562-36566	than	_	
193-128	36567-36577	alcoholics	_	
193-129	36578-36580	or	_	
193-130	36581-36595	non-drug-using	_	
193-131	36596-36604	controls	_	
193-132	36605-36611	Heroin	_	
193-133	36612-36619	addicts	_	
193-134	36620-36624	have	_	
193-135	36625-36631	higher	_	
193-136	36632-36640	discount	_	
193-137	36641-36646	rates	_	
193-138	36647-36650	for	_	
193-139	36651-36658	delayed	_	
193-140	36659-36666	rewards	_	
193-141	36667-36671	than	_	
193-142	36672-36686	non-drug-using	_	
193-143	36687-36695	controls	_	
193-144	36696-36701	Risky	_	
193-145	36702-36710	decision	_	
193-146	36711-36717	making	_	
193-147	36717-36718	,	_	
193-148	36719-36729	prefrontal	_	
193-149	36730-36736	cortex	_	
193-150	36736-36737	,	_	
193-151	36738-36741	and	_	
193-152	36742-36759	mesocorticolimbic	_	
193-153	36760-36770	functional	_	
193-154	36771-36783	connectivity	_	
193-155	36784-36786	in	_	
193-156	36787-36802	methamphetamine	_	
193-157	36803-36813	dependence	_	
193-158	36814-36826	Neurobiology	_	
193-159	36827-36829	of	_	
193-160	36830-36839	addiction	_	
193-161	36839-36840	:	_	
193-162	36841-36842	a	_	
193-163	36843-36857	neurocircuitry	_	
193-164	36858-36866	analysis	_	
193-165	36867-36873	Common	_	
193-166	36874-36881	biology	_	
193-167	36882-36884	of	_	
193-168	36885-36892	craving	_	
193-169	36893-36899	across	_	
193-170	36900-36905	legal	_	
193-171	36906-36909	and	_	
193-172	36910-36917	illegal	_	
193-173	36918-36923	drugs	_	
193-174	36924-36925	-	_	
193-175	36926-36927	A	_	
193-176	36928-36940	quantitative	_	
193-177	36941-36954	meta-analysis	_	
193-178	36955-36957	of	_	
193-179	36958-36972	cue-reactivity	_	
193-180	36973-36978	brain	_	
193-181	36979-36987	response	_	
193-182	36988-36998	Behavioral	_	
193-183	36999-37014	interpretations	_	
193-184	37015-37017	of	_	
193-185	37018-37027	intrinsic	_	
193-186	37028-37040	connectivity	_	
193-187	37041-37049	networks	_	
193-188	37050-37060	Evaluation	_	
193-189	37061-37063	of	_	
193-190	37064-37065	a	_	
193-191	37066-37076	behavioral	_	
193-192	37077-37084	measure	_	
193-193	37085-37087	of	_	
193-194	37088-37092	risk	_	
193-195	37093-37099	taking	_	
193-196	37099-37100	:	_	
193-197	37101-37104	The	_	
193-198	37105-37112	Balloon	_	
193-199	37113-37121	Analogue	_	
193-200	37122-37126	Risk	_	
193-201	37127-37131	Task	_	
193-202	37132-37133	(	_	
193-203	37133-37137	BART	_	
193-204	37137-37138	)	_	
193-205	37139-37142	The	_	
193-206	37143-37147	Iowa	_	
193-207	37148-37156	Gambling	_	
193-208	37157-37161	Task	_	
193-209	37162-37164	in	_	
193-210	37165-37169	fMRI	_	
193-211	37170-37176	images	_	
193-212	37177-37183	Effect	_	
193-213	37184-37186	of	_	
193-214	37187-37194	cocaine	_	
193-215	37195-37205	dependence	_	
193-216	37206-37208	on	_	
193-217	37209-37214	brain	_	
193-218	37215-37226	connections	_	
193-219	37226-37227	:	_	
193-220	37228-37236	clinical	_	
193-221	37237-37249	implications	_	
193-222	37250-37269	Amphetamine-induced	_	
193-223	37270-37278	dopamine	_	
193-224	37279-37286	release	_	
193-225	37286-37287	:	_	
193-226	37288-37296	Markedly	_	
193-227	37297-37304	blunded	_	
193-228	37305-37307	in	_	
193-229	37308-37315	cocaine	_	
193-230	37316-37326	dependence	_	
193-231	37327-37330	and	_	
193-232	37331-37341	predictive	_	
193-233	37342-37344	of	_	
193-234	37345-37351	choice	_	
193-235	37352-37354	to	_	
193-236	37355-37370	self-administer	_	
193-237	37371-37378	cocaine	_	
193-238	37379-37390	Statistical	_	
193-239	37391-37403	difficulties	_	
193-240	37404-37406	of	_	
193-241	37407-37416	detecting	_	
193-242	37417-37429	interactions	_	
193-243	37430-37433	and	_	
193-244	37434-37443	moderator	_	
193-245	37444-37451	effects	_	
193-246	37452-37460	Separate	_	
193-247	37461-37467	neural	_	
193-248	37468-37475	systems	_	
193-249	37476-37481	value	_	
193-250	37482-37491	immediate	_	
193-251	37492-37495	and	_	
193-252	37496-37503	delayed	_	
193-253	37504-37512	monetary	_	
193-254	37513-37520	rewards	_	
193-255	37521-37536	Striatal-insula	_	
193-256	37537-37545	circuits	_	
193-257	37546-37548	in	_	
193-258	37549-37556	cocaine	_	
193-259	37557-37566	addiction	_	
193-260	37566-37567	:	_	
193-261	37568-37580	Implications	_	
193-262	37581-37584	for	_	
193-263	37585-37596	impulsivity	_	
193-264	37597-37600	and	_	
193-265	37601-37608	relapse	_	
193-266	37609-37613	risk	_	
193-267	37614-37625	Independent	_	
193-268	37626-37633	effects	_	
193-269	37634-37636	of	_	
193-270	37637-37640	HIV	_	
193-271	37641-37650	infection	_	
193-272	37651-37654	and	_	
193-273	37655-37662	cocaine	_	
193-274	37663-37673	dependence	_	
193-275	37674-37676	on	_	
193-276	37677-37691	neurocognitive	_	
193-277	37692-37702	impairment	_	
193-278	37703-37705	in	_	
193-279	37706-37707	a	_	
193-280	37708-37717	community	_	
193-281	37718-37724	sample	_	
193-282	37725-37731	living	_	
193-283	37732-37734	in	_	
193-284	37735-37738	the	_	
193-285	37739-37747	southern	_	
193-286	37748-37754	United	_	
193-287	37755-37761	States	_	
193-288	37762-37773	Large-scale	_	
193-289	37774-37779	brain	_	
193-290	37780-37788	networks	_	
193-291	37789-37792	and	_	
193-292	37793-37808	psychopathology	_	
193-293	37808-37809	:	_	
193-294	37810-37811	A	_	
193-295	37812-37820	unifying	_	
193-296	37821-37827	triple	_	
193-297	37828-37835	network	_	
193-298	37836-37841	model	_	
193-299	37842-37850	Impaired	_	
193-300	37851-37858	insight	_	
193-301	37859-37861	in	_	
193-302	37862-37869	cocaine	_	
193-303	37870-37879	addiction	_	
193-304	37879-37880	:	_	
193-305	37881-37891	laboratory	_	
193-306	37892-37900	evidence	_	
193-307	37901-37904	and	_	
193-308	37905-37912	effects	_	
193-309	37913-37915	on	_	
193-310	37916-37931	cocaine-seeking	_	
193-311	37932-37941	behaviour	_	
193-312	37942-37956	Frontoparietal	_	
193-313	37957-37965	cortical	_	
193-314	37966-37974	activity	_	
193-315	37975-37977	of	_	
193-316	37978-38003	methamphetamine-dependent	_	
193-317	38004-38007	and	_	
193-318	38008-38018	comparison	_	
193-319	38019-38027	subjects	_	
193-320	38028-38038	performing	_	
193-321	38039-38040	a	_	
193-322	38041-38046	delay	_	
193-323	38047-38058	discounting	_	
193-324	38059-38063	task	_	
193-325	38064-38074	Influences	_	
193-326	38075-38077	on	_	
193-327	38078-38081	the	_	
193-328	38082-38093	test-retest	_	
193-329	38094-38105	reliability	_	
193-330	38106-38108	of	_	
193-331	38109-38119	functional	_	
193-332	38120-38132	connectivity	_	
193-333	38133-38136	MRI	_	
193-334	38137-38140	and	_	
193-335	38141-38144	its	_	
193-336	38145-38157	relationship	_	
193-337	38158-38162	with	_	
193-338	38163-38173	behavioral	_	
193-339	38174-38181	utility	_	
193-340	38182-38186	Deep	_	
193-341	38187-38192	brain	_	
193-342	38193-38204	stimulation	_	
193-343	38205-38208	for	_	
193-344	38209-38212	the	_	
193-345	38213-38222	treatment	_	
193-346	38223-38225	of	_	
193-347	38226-38235	addiction	_	
193-348	38235-38236	:	_	
193-349	38237-38242	Basic	_	
193-350	38243-38246	and	_	
193-351	38247-38255	clinical	_	
193-352	38256-38263	studies	_	
193-353	38264-38267	and	_	
193-354	38268-38277	potential	_	
193-355	38278-38288	mechanisms	_	
193-356	38289-38291	of	_	
193-357	38292-38298	action	_	
193-358	38299-38306	Methods	_	
193-359	38307-38309	to	_	
193-360	38310-38316	detect	_	
193-361	38316-38317	,	_	
193-362	38318-38330	characterize	_	
193-363	38330-38331	,	_	
193-364	38332-38335	and	_	
193-365	38336-38342	remove	_	
193-366	38343-38349	motion	_	
193-367	38350-38358	artifact	_	
193-368	38359-38361	in	_	
193-369	38362-38369	resting	_	
193-370	38370-38375	state	_	
193-371	38376-38380	fMRI	_	
193-372	38381-38390	ICA-AROMA	_	
193-373	38390-38391	:	_	
193-374	38392-38393	A	_	
193-375	38394-38400	robust	_	
193-376	38401-38410	ICA-based	_	
193-377	38411-38419	strategy	_	
193-378	38420-38423	for	_	
193-379	38424-38432	removing	_	
193-380	38433-38439	motion	_	
193-381	38440-38449	artifacts	_	
193-382	38450-38454	from	_	
193-383	38455-38459	fMRI	_	
193-384	38460-38464	data	_	
193-385	38465-38471	Neural	_	
193-386	38472-38482	correlates	_	
193-387	38483-38485	of	_	
193-388	38486-38495	voluntary	_	
193-389	38496-38499	and	_	
193-390	38500-38511	involuntary	_	
193-391	38512-38516	risk	_	
193-392	38517-38523	taking	_	
193-393	38524-38526	in	_	
193-394	38527-38530	the	_	
193-395	38531-38536	human	_	
193-396	38537-38542	brain	_	
193-397	38542-38543	:	_	
193-398	38544-38546	An	_	
193-399	38547-38551	fMRI	_	
193-400	38552-38557	Study	_	
193-401	38558-38560	of	_	
193-402	38561-38564	the	_	
193-403	38565-38572	Balloon	_	
193-404	38573-38579	Analog	_	
193-405	38580-38584	Risk	_	
193-406	38585-38589	Task	_	
193-407	38590-38591	(	_	
193-408	38591-38595	BART	_	
193-409	38595-38596	)	_	
193-410	38597-38604	Altered	_	
193-411	38605-38615	functional	_	
193-412	38616-38628	connectivity	_	
193-413	38629-38637	strength	_	
193-414	38638-38640	in	_	
193-415	38641-38650	abstinent	_	
193-416	38651-38658	chronic	_	
193-417	38659-38666	cocaine	_	
193-418	38667-38674	smokers	_	
193-419	38675-38683	compared	_	
193-420	38684-38686	to	_	
193-421	38687-38694	healthy	_	
193-422	38695-38703	controls	_	
193-423	38704-38716	Connectivity	_	
193-424	38717-38725	analysis	_	
193-425	38726-38728	is	_	
193-426	38729-38738	essential	_	
193-427	38739-38741	to	_	
193-428	38742-38752	understand	_	
193-429	38753-38765	neurological	_	
193-430	38766-38775	disorders	_	
193-431	38776-38786	Decreasing	_	
193-432	38787-38799	ventromedial	_	
193-433	38800-38810	prefrontal	_	
193-434	38811-38817	cortex	_	
193-435	38818-38826	activity	_	
193-436	38827-38833	during	_	
193-437	38834-38844	sequential	_	
193-438	38845-38856	risk-taking	_	
193-439	38856-38857	:	_	
193-440	38858-38860	An	_	
193-441	38861-38865	FMRI	_	
193-442	38866-38879	investigation	_	
193-443	38880-38882	of	_	
193-444	38883-38886	the	_	
193-445	38887-38894	balloon	_	
193-446	38895-38901	analog	_	
193-447	38902-38906	risk	_	
193-448	38907-38911	task	_	
193-449	38912-38923	Dissociable	_	
193-450	38924-38933	intrinsic	_	
193-451	38934-38946	connectivity	_	
193-452	38947-38955	networks	_	
193-453	38956-38959	for	_	
193-454	38960-38968	salience	_	
193-455	38969-38979	processing	_	
193-456	38980-38983	and	_	
193-457	38984-38993	executive	_	
193-458	38994-39001	control	_	
193-459	39002-39010	Advances	_	
193-460	39011-39013	in	_	
193-461	39014-39024	functional	_	
193-462	39025-39028	and	_	
193-463	39029-39039	structural	_	
193-464	39040-39042	MR	_	
193-465	39043-39048	image	_	
193-466	39049-39057	analysis	_	
193-467	39058-39061	and	_	
193-468	39062-39076	implementation	_	
193-469	39077-39079	as	_	
193-470	39080-39083	FSL	_	
193-471	39084-39091	Resting	_	
193-472	39092-39097	state	_	
193-473	39098-39108	functional	_	
193-474	39109-39121	connectivity	_	
193-475	39122-39124	in	_	
193-476	39125-39134	addiction	_	
193-477	39134-39135	:	_	
193-478	39136-39143	Lessons	_	
193-479	39144-39151	learned	_	
193-480	39152-39155	and	_	
193-481	39156-39157	a	_	
193-482	39158-39162	road	_	
193-483	39163-39168	ahead	_	
193-484	39169-39179	Hemisphere	_	
193-485	39179-39180	-	_	
193-486	39181-39184	and	_	
193-487	39185-39199	gender-related	_	
193-488	39200-39211	differences	_	
193-489	39212-39214	in	_	
193-490	39215-39226	small-world	_	
193-491	39227-39232	brain	_	
193-492	39233-39241	networks	_	
193-493	39241-39242	:	_	
193-494	39243-39244	a	_	
193-495	39245-39258	resting-state	_	
193-496	39259-39269	functional	_	
193-497	39270-39273	MRI	_	
193-498	39274-39279	study	_	
193-499	39280-39290	Adaptation	_	
193-500	39291-39293	of	_	
193-501	39294-39297	the	_	
193-502	39298-39306	Monetary	_	
193-503	39307-39313	Choice	_	
193-504	39314-39327	Questionnaire	_	
193-505	39328-39330	to	_	
193-506	39331-39342	accommodate	_	
193-507	39343-39350	extreme	_	
193-508	39351-39359	monetary	_	
193-509	39360-39371	discounting	_	
193-510	39372-39374	in	_	
193-511	39375-39382	cocaine	_	
193-512	39383-39388	users	_	
193-513	39389-39398	Perfusion	_	
193-514	39399-39412	abnormalities	_	
193-515	39413-39416	and	_	
193-516	39417-39425	decision	_	
193-517	39426-39432	making	_	
193-518	39433-39435	in	_	
193-519	39436-39443	cocaine	_	
193-520	39444-39454	dependence	_	
193-521	39455-39464	Precuneus	_	
193-522	39465-39467	is	_	
193-523	39468-39469	a	_	
193-524	39470-39480	functional	_	
193-525	39481-39485	core	_	
193-526	39486-39488	of	_	
193-527	39489-39492	the	_	
193-528	39493-39505	default-mode	_	
193-529	39506-39513	network	_	
193-530	39514-39517	The	_	
193-531	39518-39530	differential	_	
193-532	39531-39543	relationship	_	
193-533	39544-39551	between	_	
193-534	39552-39559	cocaine	_	
193-535	39560-39563	use	_	
193-536	39564-39567	and	_	
193-537	39568-39577	marijuana	_	
193-538	39578-39581	use	_	
193-539	39582-39584	on	_	
193-540	39585-39600	decision-making	_	
193-541	39601-39612	performance	_	
193-542	39613-39617	over	_	
193-543	39618-39624	repeat	_	
193-544	39625-39632	testing	_	
193-545	39633-39637	with	_	
193-546	39638-39641	the	_	
193-547	39642-39646	Iowa	_	
193-548	39647-39655	Gambling	_	
193-549	39656-39660	Task	_	
193-550	39661-39667	Stages	_	
193-551	39668-39670	of	_	
193-552	39671-39684	dysfunctional	_	
193-553	39685-39700	decision-making	_	
193-554	39701-39703	in	_	
193-555	39704-39713	addiction	_	
193-556	39714-39723	Cognitive	_	
193-557	39724-39735	impulsivity	_	
193-558	39736-39738	in	_	
193-559	39739-39746	cocaine	_	
193-560	39747-39750	and	_	
193-561	39751-39757	heroin	_	
193-562	39758-39771	polysubstance	_	
193-563	39772-39779	abusers	_	
193-564	39780-39788	Evidence	_	
193-565	39789-39792	for	_	
193-566	39793-39794	a	_	
193-567	39795-39809	frontoparietal	_	
193-568	39810-39817	control	_	
193-569	39818-39824	system	_	
193-570	39825-39833	revealed	_	
193-571	39834-39836	by	_	
193-572	39837-39846	intrinsic	_	
193-573	39847-39857	functional	_	
193-574	39858-39870	connectivity	_	
193-575	39871-39880	Addiction	_	
193-576	39880-39881	:	_	
193-577	39882-39891	Decreased	_	
193-578	39892-39898	reward	_	
193-579	39899-39910	sensitivity	_	
193-580	39911-39914	and	_	
193-581	39915-39924	increased	_	
193-582	39925-39936	expectation	_	
193-583	39937-39948	sensitivity	_	
193-584	39949-39957	conspire	_	
193-585	39958-39960	to	_	
193-586	39961-39970	overwhelm	_	
193-587	39971-39974	the	_	
193-588	39975-39980	brain	_	
193-589	39980-39981		_	
193-590	39981-39982	s	_	
193-591	39983-39990	control	_	
193-592	39991-39998	circuit	_	
193-593	39999-40003	Into	_	
193-594	40004-40007	the	_	
193-595	40008-40013	world	_	
193-596	40014-40016	of	_	
193-597	40017-40024	illegal	_	
193-598	40025-40029	drug	_	
193-599	40030-40033	use	_	
193-600	40033-40034	:	_	
193-601	40035-40043	Exposure	_	
193-602	40044-40055	opportunity	_	
193-603	40056-40059	and	_	
193-604	40060-40065	other	_	
193-605	40066-40076	mechanisms	_	
193-606	40077-40084	linking	_	
193-607	40085-40088	the	_	
193-608	40089-40092	use	_	
193-609	40093-40095	of	_	
193-610	40096-40103	alcohol	_	
193-611	40103-40104	,	_	
193-612	40105-40112	tobacco	_	
193-613	40112-40113	,	_	
193-614	40114-40123	marijuana	_	
193-615	40123-40124	,	_	
193-616	40125-40128	and	_	
193-617	40129-40136	cocaine	_	
193-618	40137-40147	Prefrontal	_	
193-619	40148-40160	transcranial	_	
193-620	40161-40167	direct	_	
193-621	40168-40175	current	_	
193-622	40176-40187	stimulation	_	
193-623	40188-40194	alters	_	
193-624	40195-40205	activation	_	
193-625	40206-40209	and	_	
193-626	40210-40222	connectivity	_	
193-627	40223-40225	in	_	
193-628	40226-40234	cortical	_	
193-629	40235-40238	and	_	
193-630	40239-40250	subcortical	_	
193-631	40251-40257	reward	_	
193-632	40258-40265	systems	_	
193-633	40265-40266	:	_	
193-634	40267-40268	A	_	
193-635	40269-40278	tDCS-fMRI	_	
193-636	40279-40284	study	_	
193-637	40285-40293	Enhanced	_	
193-638	40294-40297	cue	_	
193-639	40298-40308	reactivity	_	
193-640	40309-40312	and	_	
193-641	40313-40328	fronto-striatal	_	
193-642	40329-40339	functional	_	
193-643	40340-40352	connectivity	_	
193-644	40353-40355	in	_	
193-645	40356-40363	cocaine	_	
193-646	40364-40367	use	_	
193-647	40368-40377	disorders	_	
193-648	40378-40380	An	_	
193-649	40381-40390	intrinsic	_	
193-650	40391-40403	connectivity	_	
193-651	40404-40411	network	_	
193-652	40412-40420	approach	_	
193-653	40421-40423	to	_	
193-654	40424-40438	insula-derived	_	
193-655	40439-40451	dysfunctions	_	
193-656	40452-40457	among	_	
193-657	40458-40465	cocaine	_	
193-658	40466-40471	users	_	
193-659	40472-40476	Time	_	
193-660	40477-40480	and	_	
193-661	40481-40489	decision	_	
193-662	40490-40496	making	_	
193-663	40496-40497	:	_	
193-664	40498-40510	Differential	_	
193-665	40511-40523	contribution	_	
193-666	40524-40526	of	_	
193-667	40527-40530	the	_	
193-668	40531-40540	posterior	_	
193-669	40541-40548	insular	_	
193-670	40549-40555	cortex	_	
193-671	40556-40559	and	_	
193-672	40560-40563	the	_	
193-673	40564-40572	striatum	_	
193-674	40573-40579	during	_	
193-675	40580-40581	a	_	
193-676	40582-40587	delay	_	
193-677	40588-40599	discounting	_	
193-678	40600-40604	task	_	
193-679	40605-40615	Functional	_	
193-680	40616-40621	brain	_	
193-681	40622-40630	networks	_	
193-682	40631-40641	associated	_	
193-683	40642-40646	with	_	
193-684	40647-40656	cognitive	_	
193-685	40657-40664	control	_	
193-686	40664-40665	,	_	
193-687	40666-40673	cocaine	_	
193-688	40674-40684	dependence	_	
193-689	40684-40685	,	_	
193-690	40686-40689	and	_	
193-691	40690-40699	treatment	_	
193-692	40700-40707	outcome	_	
193-693	40708-40712	Mean	_	
193-694	40713-40720	spatial	_	
193-695	40721-40725	maps	_	
193-696	40726-40733	derived	_	
193-697	40734-40738	from	_	
193-698	40739-40750	independent	_	
193-699	40751-40760	component	_	
193-700	40761-40769	analysis	_	
193-701	40770-40771	(	_	
193-702	40771-40774	ICA	_	
193-703	40774-40775	)	_	
193-704	40775-40776	.	_	

#Text=Components were chosen based on correlations with intrinsic connectivity network templates provided by.
194-1	40777-40787	Components	_	
194-2	40788-40792	were	_	
194-3	40793-40799	chosen	_	
194-4	40800-40805	based	_	
194-5	40806-40808	on	_	
194-6	40809-40821	correlations	_	
194-7	40822-40826	with	_	
194-8	40827-40836	intrinsic	_	
194-9	40837-40849	connectivity	_	
194-10	40850-40857	network	_	
194-11	40858-40867	templates	_	
194-12	40868-40876	provided	_	
194-13	40877-40879	by	_	
194-14	40879-40880	.	_	

#Text=All images scaled from z=2.3 through 5.
195-1	40881-40884	All	_	
195-2	40885-40891	images	_	
195-3	40892-40898	scaled	_	
195-4	40899-40903	from	_	
195-5	40904-40905	z	_	
195-6	40905-40906	=	_	
195-7	40906-40909	2.3	_	
195-8	40910-40917	through	_	
195-9	40918-40919	5	_	
195-10	40919-40920	.	_	

#Text=Significant group by between-network connectivity interaction effects on task impulsivity measures.
196-1	40921-40932	Significant	_	
196-2	40933-40938	group	_	
196-3	40939-40941	by	_	
196-4	40942-40957	between-network	_	
196-5	40958-40970	connectivity	_	
196-6	40971-40982	interaction	_	
196-7	40983-40990	effects	_	
196-8	40991-40993	on	_	
196-9	40994-40998	task	_	
196-10	40999-41010	impulsivity	_	
196-11	41011-41019	measures	_	
196-12	41019-41020	.	_	

#Text=Black circles represent data points from cocaine users (COC+) and gray triangles represent data points from controls (COC).
197-1	41021-41026	Black	_	
197-2	41027-41034	circles	_	
197-3	41035-41044	represent	_	
197-4	41045-41049	data	_	
197-5	41050-41056	points	_	
197-6	41057-41061	from	_	
197-7	41062-41069	cocaine	_	
197-8	41070-41075	users	_	
197-9	41076-41077	(	_	
197-10	41077-41080	COC	_	
197-11	41080-41081	+	_	
197-12	41081-41082	)	_	
197-13	41083-41086	and	_	
197-14	41087-41091	gray	_	
197-15	41092-41101	triangles	_	
197-16	41102-41111	represent	_	
197-17	41112-41116	data	_	
197-18	41117-41123	points	_	
197-19	41124-41128	from	_	
197-20	41129-41137	controls	_	
197-21	41138-41139	(	_	
197-22	41139-41142	COC	_	
197-23	41142-41143		_	
197-24	41143-41144	)	_	
197-25	41144-41145	.	_	

#Text=Lines represent the conditional effects of between-network resting-state connectivity on task impulsivity for cocaine users (black solid line) and controls (gray-dashed line).
198-1	41146-41151	Lines	_	
198-2	41152-41161	represent	_	
198-3	41162-41165	the	_	
198-4	41166-41177	conditional	_	
198-5	41178-41185	effects	_	
198-6	41186-41188	of	_	
198-7	41189-41204	between-network	_	
198-8	41205-41218	resting-state	_	
198-9	41219-41231	connectivity	_	
198-10	41232-41234	on	_	
198-11	41235-41239	task	_	
198-12	41240-41251	impulsivity	_	
198-13	41252-41255	for	_	
198-14	41256-41263	cocaine	_	
198-15	41264-41269	users	_	
198-16	41270-41271	(	_	
198-17	41271-41276	black	_	
198-18	41277-41282	solid	_	
198-19	41283-41287	line	_	
198-20	41287-41288	)	_	
198-21	41289-41292	and	_	
198-22	41293-41301	controls	_	
198-23	41302-41303	(	_	
198-24	41303-41314	gray-dashed	_	
198-25	41315-41319	line	_	
198-26	41319-41320	)	_	
198-27	41320-41321	.	_	

#Text=Error bars display the standard error of the conditional effects.
199-1	41322-41327	Error	_	
199-2	41328-41332	bars	_	
199-3	41333-41340	display	_	
199-4	41341-41344	the	_	
199-5	41345-41353	standard	_	
199-6	41354-41359	error	_	
199-7	41360-41362	of	_	
199-8	41363-41366	the	_	
199-9	41367-41378	conditional	_	
199-10	41379-41386	effects	_	
199-11	41386-41387	.	_	

#Text=A.
200-1	41388-41389	A	_	
200-2	41389-41390	.	_	

#Text=Higher average balloon pumps on the Balloon Analogue Risk Task (BART) indicates higher impulsivity.
201-1	41391-41397	Higher	_	
201-2	41398-41405	average	_	
201-3	41406-41413	balloon	_	
201-4	41414-41419	pumps	_	
201-5	41420-41422	on	_	
201-6	41423-41426	the	_	
201-7	41427-41434	Balloon	_	
201-8	41435-41443	Analogue	_	
201-9	41444-41448	Risk	_	
201-10	41449-41453	Task	_	
201-11	41454-41455	(	_	
201-12	41455-41459	BART	_	
201-13	41459-41460	)	_	
201-14	41461-41470	indicates	_	
201-15	41471-41477	higher	_	
201-16	41478-41489	impulsivity	_	
201-17	41489-41490	.	_	

#Text=B.
202-1	41491-41492	B	_	
202-2	41492-41493	.	_	

#Text=Larger, positive natural log (ln) K values on the Monetary Choice Questionnaire (MCQ) indicate higher discounting rates (i.e., impulsivity).
203-1	41494-41500	Larger	_	
203-2	41500-41501	,	_	
203-3	41502-41510	positive	_	
203-4	41511-41518	natural	_	
203-5	41519-41522	log	_	
203-6	41523-41524	(	_	
203-7	41524-41526	ln	_	
203-8	41526-41527	)	_	
203-9	41528-41529	K	_	
203-10	41530-41536	values	_	
203-11	41537-41539	on	_	
203-12	41540-41543	the	_	
203-13	41544-41552	Monetary	_	
203-14	41553-41559	Choice	_	
203-15	41560-41573	Questionnaire	_	
203-16	41574-41575	(	_	
203-17	41575-41578	MCQ	_	
203-18	41578-41579	)	_	
203-19	41580-41588	indicate	_	
203-20	41589-41595	higher	_	
203-21	41596-41607	discounting	_	
203-22	41608-41613	rates	_	
203-23	41614-41615	(	_	
203-24	41615-41618	i.e	_	
203-25	41618-41619	.	_	
203-26	41619-41620	,	_	
203-27	41621-41632	impulsivity	_	
203-28	41632-41633	)	_	
203-29	41633-41634	.	_	

#Text=Participant characteristics by group
#Text=\tCocaine Users (N= 37)\tControls (N=35)\tTotal (N=72)\tTest Statistic\t \tDemographics\t\t\t\t\t \tFemale Gender, n (%)\t12 (32%)\t13 (37%)\t25 (35%)\t2(1,72)=0.18\t \tAge, M (SD)\t45.30 (6.23)\t41.29 (9.43)\t43.35 (8.14)\tt(70)=2.14*\t \tAfrican American, n (%)\t33 (89%)\t28 (80%)\t61 (85%)\t2(l,72)=1.17\t \tYears of Education, M (SD)\t12.65 (2.51)\t13.97 (2.42)\t13.29 (2.54)\tt(70)=2.28*\t \tOther substance use\t\t\t\t\t \tCurrent Smokers, n (%)\t25 (68%)\t8 (23%)\t33 (46%)\t2(1,72)=14.48***\t \tDays of alcohol intoxication in past 30, M (SD)\t9.73 (10.37)\t1.51 (2.96)\t5.74 (8.71)\tt(70)=4.52***\t \tDays of marijuana use in past 30, M (SD)\t4.95 (8.98)\t0.31 (1.35)\t2.69 (6.87)\tt(70)=3.02**\t \tBehavioral task performance\t\t\t\t\t \tBART, M (SD)\t37.94 (14.70)\t37.47 (15.89)\t37.71 (15.18)\tt(70)=0.13\t \tIGT, M (SD)\t2.54 (25.37)\t10.57 (38.54)\t3.83 (32.88)\tt(70)=1.71\t \tMCQ, M (SD)\t2.64 (1.16)\t3.56 (1.90)\t3.09 (1.62)\tt(68)=2.45*\t \t
#Text=Note: Balloon Analogue Risk Task (BART), Iowa Gambling Task (IGT), Monetary Choice Questionnaire (MCQ)
#Text=p<.05,
#Text=p<.01,
#Text=p<.001
#Text=One participant included as African American identified as mixed race.
204-1	41635-41646	Participant	_	
204-2	41647-41662	characteristics	_	
204-3	41663-41665	by	_	
204-4	41666-41671	group	_	
204-5	41673-41680	Cocaine	_	
204-6	41681-41686	Users	_	
204-7	41687-41688	(	_	
204-8	41688-41689	N	_	
204-9	41689-41690	=	_	
204-10	41691-41693	37	_	
204-11	41693-41694	)	_	
204-12	41695-41703	Controls	_	
204-13	41704-41705	(	_	
204-14	41705-41706	N	_	
204-15	41706-41707	=	_	
204-16	41707-41709	35	_	
204-17	41709-41710	)	_	
204-18	41711-41716	Total	_	
204-19	41717-41718	(	_	
204-20	41718-41719	N	_	
204-21	41719-41720	=	_	
204-22	41720-41722	72	_	
204-23	41722-41723	)	_	
204-24	41724-41728	Test	_	
204-25	41729-41738	Statistic	_	
204-26	41741-41753	Demographics	_	
204-27	41761-41767	Female	_	
204-28	41768-41774	Gender	_	
204-29	41774-41775	,	_	
204-30	41776-41777	n	_	
204-31	41778-41779	(	_	
204-32	41779-41780	%	_	
204-33	41780-41781	)	_	
204-34	41782-41784	12	_	
204-35	41785-41786	(	_	
204-36	41786-41789	32%	_	
204-37	41789-41790	)	_	
204-38	41791-41793	13	_	
204-39	41794-41795	(	_	
204-40	41795-41798	37%	_	
204-41	41798-41799	)	_	
204-42	41800-41802	25	_	
204-43	41803-41804	(	_	
204-44	41804-41807	35%	_	
204-45	41807-41808	)	_	
204-46	41809-41811	2	_	
204-47	41811-41812	(	_	
204-48	41812-41816	1,72	_	
204-49	41816-41817	)	_	
204-50	41817-41818	=	_	
204-51	41818-41822	0.18	_	
204-52	41826-41829	Age	_	
204-53	41829-41830	,	_	
204-54	41831-41832	M	_	
204-55	41833-41834	(	_	
204-56	41834-41836	SD	_	
204-57	41836-41837	)	_	
204-58	41838-41843	45.30	_	
204-59	41844-41845	(	_	
204-60	41845-41849	6.23	_	
204-61	41849-41850	)	_	
204-62	41851-41856	41.29	_	
204-63	41857-41858	(	_	
204-64	41858-41862	9.43	_	
204-65	41862-41863	)	_	
204-66	41864-41869	43.35	_	
204-67	41870-41871	(	_	
204-68	41871-41875	8.14	_	
204-69	41875-41876	)	_	
204-70	41877-41878	t	_	
204-71	41878-41879	(	_	
204-72	41879-41881	70	_	
204-73	41881-41882	)	_	
204-74	41882-41883	=	_	
204-75	41883-41887	2.14	_	
204-76	41887-41888	*	_	
204-77	41892-41899	African	_	
204-78	41900-41909	American	_	
204-79	41909-41910	,	_	
204-80	41911-41912	n	_	
204-81	41913-41914	(	_	
204-82	41914-41915	%	_	
204-83	41915-41916	)	_	
204-84	41917-41919	33	_	
204-85	41920-41921	(	_	
204-86	41921-41924	89%	_	
204-87	41924-41925	)	_	
204-88	41926-41928	28	_	
204-89	41929-41930	(	_	
204-90	41930-41933	80%	_	
204-91	41933-41934	)	_	
204-92	41935-41937	61	_	
204-93	41938-41939	(	_	
204-94	41939-41942	85%	_	
204-95	41942-41943	)	_	
204-96	41944-41946	2	_	
204-97	41946-41947	(	_	
204-98	41947-41948	l	_	
204-99	41948-41949	,	_	
204-100	41949-41951	72	_	
204-101	41951-41952	)	_	
204-102	41952-41953	=	_	
204-103	41953-41957	1.17	_	
204-104	41961-41966	Years	_	
204-105	41967-41969	of	_	
204-106	41970-41979	Education	_	
204-107	41979-41980	,	_	
204-108	41981-41982	M	_	
204-109	41983-41984	(	_	
204-110	41984-41986	SD	_	
204-111	41986-41987	)	_	
204-112	41988-41993	12.65	_	
204-113	41994-41995	(	_	
204-114	41995-41999	2.51	_	
204-115	41999-42000	)	_	
204-116	42001-42006	13.97	_	
204-117	42007-42008	(	_	
204-118	42008-42012	2.42	_	
204-119	42012-42013	)	_	
204-120	42014-42019	13.29	_	
204-121	42020-42021	(	_	
204-122	42021-42025	2.54	_	
204-123	42025-42026	)	_	
204-124	42027-42028	t	_	
204-125	42028-42029	(	_	
204-126	42029-42031	70	_	
204-127	42031-42032	)	_	
204-128	42032-42033	=	_	
204-129	42033-42037	2.28	_	
204-130	42037-42038	*	_	
204-131	42041-42046	Other	_	
204-132	42047-42056	substance	_	
204-133	42057-42060	use	_	
204-134	42068-42075	Current	_	
204-135	42076-42083	Smokers	_	
204-136	42083-42084	,	_	
204-137	42085-42086	n	_	
204-138	42087-42088	(	_	
204-139	42088-42089	%	_	
204-140	42089-42090	)	_	
204-141	42091-42093	25	_	
204-142	42094-42095	(	_	
204-143	42095-42098	68%	_	
204-144	42098-42099	)	_	
204-145	42100-42101	8	_	
204-146	42102-42103	(	_	
204-147	42103-42106	23%	_	
204-148	42106-42107	)	_	
204-149	42108-42110	33	_	
204-150	42111-42112	(	_	
204-151	42112-42115	46%	_	
204-152	42115-42116	)	_	
204-153	42117-42119	2	_	
204-154	42119-42120	(	_	
204-155	42120-42124	1,72	_	
204-156	42124-42125	)	_	
204-157	42125-42126	=	_	
204-158	42126-42131	14.48	_	
204-159	42131-42132	*	_	
204-160	42132-42133	*	_	
204-161	42133-42134	*	_	
204-162	42138-42142	Days	_	
204-163	42143-42145	of	_	
204-164	42146-42153	alcohol	_	
204-165	42154-42166	intoxication	_	
204-166	42167-42169	in	_	
204-167	42170-42174	past	_	
204-168	42175-42177	30	_	
204-169	42177-42178	,	_	
204-170	42179-42180	M	_	
204-171	42181-42182	(	_	
204-172	42182-42184	SD	_	
204-173	42184-42185	)	_	
204-174	42186-42190	9.73	_	
204-175	42191-42192	(	_	
204-176	42192-42197	10.37	_	
204-177	42197-42198	)	_	
204-178	42199-42203	1.51	_	
204-179	42204-42205	(	_	
204-180	42205-42209	2.96	_	
204-181	42209-42210	)	_	
204-182	42211-42215	5.74	_	
204-183	42216-42217	(	_	
204-184	42217-42221	8.71	_	
204-185	42221-42222	)	_	
204-186	42223-42224	t	_	
204-187	42224-42225	(	_	
204-188	42225-42227	70	_	
204-189	42227-42228	)	_	
204-190	42228-42229	=	_	
204-191	42229-42233	4.52	_	
204-192	42233-42234	*	_	
204-193	42234-42235	*	_	
204-194	42235-42236	*	_	
204-195	42240-42244	Days	_	
204-196	42245-42247	of	_	
204-197	42248-42257	marijuana	_	
204-198	42258-42261	use	_	
204-199	42262-42264	in	_	
204-200	42265-42269	past	_	
204-201	42270-42272	30	_	
204-202	42272-42273	,	_	
204-203	42274-42275	M	_	
204-204	42276-42277	(	_	
204-205	42277-42279	SD	_	
204-206	42279-42280	)	_	
204-207	42281-42285	4.95	_	
204-208	42286-42287	(	_	
204-209	42287-42291	8.98	_	
204-210	42291-42292	)	_	
204-211	42293-42297	0.31	_	
204-212	42298-42299	(	_	
204-213	42299-42303	1.35	_	
204-214	42303-42304	)	_	
204-215	42305-42309	2.69	_	
204-216	42310-42311	(	_	
204-217	42311-42315	6.87	_	
204-218	42315-42316	)	_	
204-219	42317-42318	t	_	
204-220	42318-42319	(	_	
204-221	42319-42321	70	_	
204-222	42321-42322	)	_	
204-223	42322-42323	=	_	
204-224	42323-42327	3.02	_	
204-225	42327-42328	*	_	
204-226	42328-42329	*	_	
204-227	42332-42342	Behavioral	_	
204-228	42343-42347	task	_	
204-229	42348-42359	performance	_	
204-230	42367-42371	BART	_	
204-231	42371-42372	,	_	
204-232	42373-42374	M	_	
204-233	42375-42376	(	_	
204-234	42376-42378	SD	_	
204-235	42378-42379	)	_	
204-236	42380-42385	37.94	_	
204-237	42386-42387	(	_	
204-238	42387-42392	14.70	_	
204-239	42392-42393	)	_	
204-240	42394-42399	37.47	_	
204-241	42400-42401	(	_	
204-242	42401-42406	15.89	_	
204-243	42406-42407	)	_	
204-244	42408-42413	37.71	_	
204-245	42414-42415	(	_	
204-246	42415-42420	15.18	_	
204-247	42420-42421	)	_	
204-248	42422-42423	t	_	
204-249	42423-42424	(	_	
204-250	42424-42426	70	_	
204-251	42426-42427	)	_	
204-252	42427-42428	=	_	
204-253	42428-42432	0.13	_	
204-254	42436-42439	IGT	_	
204-255	42439-42440	,	_	
204-256	42441-42442	M	_	
204-257	42443-42444	(	_	
204-258	42444-42446	SD	_	
204-259	42446-42447	)	_	
204-260	42448-42449		_	
204-261	42449-42453	2.54	_	
204-262	42454-42455	(	_	
204-263	42455-42460	25.37	_	
204-264	42460-42461	)	_	
204-265	42462-42467	10.57	_	
204-266	42468-42469	(	_	
204-267	42469-42474	38.54	_	
204-268	42474-42475	)	_	
204-269	42476-42480	3.83	_	
204-270	42481-42482	(	_	
204-271	42482-42487	32.88	_	
204-272	42487-42488	)	_	
204-273	42489-42490	t	_	
204-274	42490-42491	(	_	
204-275	42491-42493	70	_	
204-276	42493-42494	)	_	
204-277	42494-42495	=	_	
204-278	42495-42496		_	
204-279	42496-42500	1.71	_	
204-280	42504-42508	MCQ	_	
204-281	42508-42509	,	_	
204-282	42510-42511	M	_	
204-283	42512-42513	(	_	
204-284	42513-42515	SD	_	
204-285	42515-42516	)	_	
204-286	42517-42518		_	
204-287	42518-42522	2.64	_	
204-288	42523-42524	(	_	
204-289	42524-42528	1.16	_	
204-290	42528-42529	)	_	
204-291	42530-42531		_	
204-292	42531-42535	3.56	_	
204-293	42536-42537	(	_	
204-294	42537-42541	1.90	_	
204-295	42541-42542	)	_	
204-296	42543-42544		_	
204-297	42544-42548	3.09	_	
204-298	42549-42550	(	_	
204-299	42550-42554	1.62	_	
204-300	42554-42555	)	_	
204-301	42556-42557	t	_	
204-302	42557-42558	(	_	
204-303	42558-42560	68	_	
204-304	42560-42561	)	_	
204-305	42561-42562	=	_	
204-306	42562-42566	2.45	_	
204-307	42566-42567	*	_	
204-308	42571-42575	Note	_	
204-309	42575-42576	:	_	
204-310	42577-42584	Balloon	_	
204-311	42585-42593	Analogue	_	
204-312	42594-42598	Risk	_	
204-313	42599-42603	Task	_	
204-314	42604-42605	(	_	
204-315	42605-42609	BART	_	
204-316	42609-42610	)	_	
204-317	42610-42611	,	_	
204-318	42612-42616	Iowa	_	
204-319	42617-42625	Gambling	_	
204-320	42626-42630	Task	_	
204-321	42631-42632	(	_	
204-322	42632-42635	IGT	_	
204-323	42635-42636	)	_	
204-324	42636-42637	,	_	
204-325	42638-42646	Monetary	_	
204-326	42647-42653	Choice	_	
204-327	42654-42667	Questionnaire	_	
204-328	42668-42669	(	_	
204-329	42669-42672	MCQ	_	
204-330	42672-42673	)	_	
204-331	42674-42675	p	_	
204-332	42675-42676	<	_	
204-333	42676-42679	.05	_	
204-334	42679-42680	,	_	
204-335	42681-42682	p	_	
204-336	42682-42683	<	_	
204-337	42683-42686	.01	_	
204-338	42686-42687	,	_	
204-339	42688-42689	p	_	
204-340	42689-42690	<	_	
204-341	42690-42694	.001	_	
204-342	42695-42698	One	_	
204-343	42699-42710	participant	_	
204-344	42711-42719	included	_	
204-345	42720-42722	as	_	
204-346	42723-42730	African	_	
204-347	42731-42739	American	_	
204-348	42740-42750	identified	_	
204-349	42751-42753	as	_	
204-350	42754-42759	mixed	_	
204-351	42760-42764	race	_	
204-352	42764-42765	.	_	

#Text=In k value; Cocaine use group n = 36, Non-drug use group n=34.
205-1	42766-42768	In	_	
205-2	42769-42770	k	_	
205-3	42771-42776	value	_	
205-4	42776-42777	;	_	
205-5	42778-42785	Cocaine	_	
205-6	42786-42789	use	_	
205-7	42790-42795	group	_	
205-8	42796-42797	n	_	
205-9	42798-42799	=	_	
205-10	42800-42802	36	_	
205-11	42802-42803	,	_	
205-12	42804-42812	Non-drug	_	
205-13	42813-42816	use	_	
205-14	42817-42822	group	_	
205-15	42823-42824	n	_	
205-16	42824-42825	=	_	
205-17	42825-42827	34	_	
205-18	42827-42828	.	_	

#Text=Group comparisons of between-network rsFC
#Text=\tCocaine Users, M (SD)\tControls, M (SD)\tF-value\t \tExtended reward network with:\t \tAttentional salience\t0.11 (0.22)\t0.05 (0.18)\tF(1,66)= 3.37\t \tRight cognitive control\t0.01 (0.23)\t0.01 (0.15)\tF(1,66)= 0.09\t \tLeft cognitive control\t0.09 (0.24)\t0.11 (0.18)\tF(1,66)= 0.34\t \tCore reward\t0.06 (0.21)\t0.01 (0.30)\tF(1,66)= 1.17\t \tCore reward network with:\t \tAttentional salience\t0.06 (0.23)\t0.04 (0.26)\tF(1,66)= 0.02\t \tRight cognitive control\t0.11 (0.24)\t0.04 (0.19)\tF(1,66)= 2.29\t \tLeft cognitive control\t0.02 (0.19)\t0.06 (0.21)\tF(1,66)= 2.76\t \t
#Text=Note: rsFC= resting state functional connectivity; between-nework rsFC listed as pearson partial correlation coefficient (r) and analyses of variance (ANOVA) conducted on Fischer z transformations with age, gender, years of education, and motion included as covariates
#Text=Significant group by rsFC interaction effects on behavioral task performance
#Text=\tCocaine Users\tControls\t\t\t \t\tr\tr\tt\tB (95% CI)\t \tBART  Extended reward and L Cognitive control\t0.51**\t0.14\t2.68**\t20.44 (5.20: 35.69)\t \tMCT  Core reward and Attentional salience\t0.07\t0.37*\t2.30*\t1.45 (3.00: 0.21)\t \t
#Text=Note:
#Text=p<.05,
#Text=p<.01,
#Text=p<.001;
#Text=rsFC=resting state functional connectivity
#Text=Highlights
#Text=Functional changes in reward and executive brain circuitry occur in addiction
#Text=Resting-state connectivity was related to risk-taking propensity for cocaine users
#Text=Resting-state connectivity was related to delay discounting for controls
206-1	42829-42834	Group	_	
206-2	42835-42846	comparisons	_	
206-3	42847-42849	of	_	
206-4	42850-42865	between-network	_	
206-5	42866-42870	rsFC	_	
206-6	42872-42879	Cocaine	_	
206-7	42880-42885	Users	_	
206-8	42885-42886	,	_	
206-9	42887-42888	M	_	
206-10	42889-42890	(	_	
206-11	42890-42892	SD	_	
206-12	42892-42893	)	_	
206-13	42894-42902	Controls	_	
206-14	42902-42903	,	_	
206-15	42904-42905	M	_	
206-16	42906-42907	(	_	
206-17	42907-42909	SD	_	
206-18	42909-42910	)	_	
206-19	42911-42918	F-value	_	
206-20	42921-42929	Extended	_	
206-21	42930-42936	reward	_	
206-22	42937-42944	network	_	
206-23	42945-42949	with	_	
206-24	42949-42950	:	_	
206-25	42954-42965	Attentional	_	
206-26	42966-42974	salience	_	
206-27	42975-42976		_	
206-28	42976-42980	0.11	_	
206-29	42981-42982	(	_	
206-30	42982-42986	0.22	_	
206-31	42986-42987	)	_	
206-32	42988-42989		_	
206-33	42989-42993	0.05	_	
206-34	42994-42995	(	_	
206-35	42995-42999	0.18	_	
206-36	42999-43000	)	_	
206-37	43001-43002	F	_	
206-38	43002-43003	(	_	
206-39	43003-43007	1,66	_	
206-40	43007-43008	)	_	
206-41	43008-43009	=	_	
206-42	43010-43014	3.37	_	
206-43	43018-43023	Right	_	
206-44	43024-43033	cognitive	_	
206-45	43034-43041	control	_	
206-46	43042-43046	0.01	_	
206-47	43047-43048	(	_	
206-48	43048-43052	0.23	_	
206-49	43052-43053	)	_	
206-50	43054-43055		_	
206-51	43055-43059	0.01	_	
206-52	43060-43061	(	_	
206-53	43061-43065	0.15	_	
206-54	43065-43066	)	_	
206-55	43067-43068	F	_	
206-56	43068-43069	(	_	
206-57	43069-43073	1,66	_	
206-58	43073-43074	)	_	
206-59	43074-43075	=	_	
206-60	43076-43080	0.09	_	
206-61	43084-43088	Left	_	
206-62	43089-43098	cognitive	_	
206-63	43099-43106	control	_	
206-64	43107-43108		_	
206-65	43108-43112	0.09	_	
206-66	43113-43114	(	_	
206-67	43114-43118	0.24	_	
206-68	43118-43119	)	_	
206-69	43120-43121		_	
206-70	43121-43125	0.11	_	
206-71	43126-43127	(	_	
206-72	43127-43131	0.18	_	
206-73	43131-43132	)	_	
206-74	43133-43134	F	_	
206-75	43134-43135	(	_	
206-76	43135-43139	1,66	_	
206-77	43139-43140	)	_	
206-78	43140-43141	=	_	
206-79	43142-43146	0.34	_	
206-80	43150-43154	Core	_	
206-81	43155-43161	reward	_	
206-82	43162-43166	0.06	_	
206-83	43167-43168	(	_	
206-84	43168-43172	0.21	_	
206-85	43172-43173	)	_	
206-86	43174-43178	0.01	_	
206-87	43179-43180	(	_	
206-88	43180-43184	0.30	_	
206-89	43184-43185	)	_	
206-90	43186-43187	F	_	
206-91	43187-43188	(	_	
206-92	43188-43192	1,66	_	
206-93	43192-43193	)	_	
206-94	43193-43194	=	_	
206-95	43195-43199	1.17	_	
206-96	43202-43206	Core	_	
206-97	43207-43213	reward	_	
206-98	43214-43221	network	_	
206-99	43222-43226	with	_	
206-100	43226-43227	:	_	
206-101	43231-43242	Attentional	_	
206-102	43243-43251	salience	_	
206-103	43252-43256	0.06	_	
206-104	43257-43258	(	_	
206-105	43258-43262	0.23	_	
206-106	43262-43263	)	_	
206-107	43264-43268	0.04	_	
206-108	43269-43270	(	_	
206-109	43270-43274	0.26	_	
206-110	43274-43275	)	_	
206-111	43276-43277	F	_	
206-112	43277-43278	(	_	
206-113	43278-43282	1,66	_	
206-114	43282-43283	)	_	
206-115	43283-43284	=	_	
206-116	43285-43289	0.02	_	
206-117	43293-43298	Right	_	
206-118	43299-43308	cognitive	_	
206-119	43309-43316	control	_	
206-120	43317-43321	0.11	_	
206-121	43322-43323	(	_	
206-122	43323-43327	0.24	_	
206-123	43327-43328	)	_	
206-124	43329-43333	0.04	_	
206-125	43334-43335	(	_	
206-126	43335-43339	0.19	_	
206-127	43339-43340	)	_	
206-128	43341-43342	F	_	
206-129	43342-43343	(	_	
206-130	43343-43347	1,66	_	
206-131	43347-43348	)	_	
206-132	43348-43349	=	_	
206-133	43350-43354	2.29	_	
206-134	43358-43362	Left	_	
206-135	43363-43372	cognitive	_	
206-136	43373-43380	control	_	
206-137	43381-43382		_	
206-138	43382-43386	0.02	_	
206-139	43387-43388	(	_	
206-140	43388-43392	0.19	_	
206-141	43392-43393	)	_	
206-142	43394-43398	0.06	_	
206-143	43399-43400	(	_	
206-144	43400-43404	0.21	_	
206-145	43404-43405	)	_	
206-146	43406-43407	F	_	
206-147	43407-43408	(	_	
206-148	43408-43412	1,66	_	
206-149	43412-43413	)	_	
206-150	43413-43414	=	_	
206-151	43415-43419	2.76	_	
206-152	43423-43427	Note	_	
206-153	43427-43428	:	_	
206-154	43429-43433	rsFC	_	
206-155	43433-43434	=	_	
206-156	43435-43442	resting	_	
206-157	43443-43448	state	_	
206-158	43449-43459	functional	_	
206-159	43460-43472	connectivity	_	
206-160	43472-43473	;	_	
206-161	43474-43488	between-nework	_	
206-162	43489-43493	rsFC	_	
206-163	43494-43500	listed	_	
206-164	43501-43503	as	_	
206-165	43504-43511	pearson	_	
206-166	43512-43519	partial	_	
206-167	43520-43531	correlation	_	
206-168	43532-43543	coefficient	_	
206-169	43544-43545	(	_	
206-170	43545-43546	r	_	
206-171	43546-43547	)	_	
206-172	43548-43551	and	_	
206-173	43552-43560	analyses	_	
206-174	43561-43563	of	_	
206-175	43564-43572	variance	_	
206-176	43573-43574	(	_	
206-177	43574-43579	ANOVA	_	
206-178	43579-43580	)	_	
206-179	43581-43590	conducted	_	
206-180	43591-43593	on	_	
206-181	43594-43601	Fischer	_	
206-182	43602-43603	z	_	
206-183	43604-43619	transformations	_	
206-184	43620-43624	with	_	
206-185	43625-43628	age	_	
206-186	43628-43629	,	_	
206-187	43630-43636	gender	_	
206-188	43636-43637	,	_	
206-189	43638-43643	years	_	
206-190	43644-43646	of	_	
206-191	43647-43656	education	_	
206-192	43656-43657	,	_	
206-193	43658-43661	and	_	
206-194	43662-43668	motion	_	
206-195	43669-43677	included	_	
206-196	43678-43680	as	_	
206-197	43681-43691	covariates	_	
206-198	43692-43703	Significant	_	
206-199	43704-43709	group	_	
206-200	43710-43712	by	_	
206-201	43713-43717	rsFC	_	
206-202	43718-43729	interaction	_	
206-203	43730-43737	effects	_	
206-204	43738-43740	on	_	
206-205	43741-43751	behavioral	_	
206-206	43752-43756	task	_	
206-207	43757-43768	performance	_	
206-208	43770-43777	Cocaine	_	
206-209	43778-43783	Users	_	
206-210	43784-43792	Controls	_	
206-211	43798-43799	r	_	
206-212	43800-43801	r	_	
206-213	43802-43803	t	_	
206-214	43804-43805	B	_	
206-215	43806-43807	(	_	
206-216	43807-43810	95%	_	
206-217	43811-43813	CI	_	
206-218	43813-43814	)	_	
206-219	43817-43821	BART	_	
206-220	43822-43823		_	
206-221	43824-43832	Extended	_	
206-222	43833-43839	reward	_	
206-223	43840-43843	and	_	
206-224	43844-43845	L	_	
206-225	43846-43855	Cognitive	_	
206-226	43856-43863	control	_	
206-227	43864-43865		_	
206-228	43865-43869	0.51	_	
206-229	43869-43870	*	_	
206-230	43870-43871	*	_	
206-231	43872-43876	0.14	_	
206-232	43877-43881	2.68	_	
206-233	43881-43882	*	_	
206-234	43882-43883	*	_	
206-235	43884-43889	20.44	_	
206-236	43890-43891	(	_	
206-237	43891-43895	5.20	_	
206-238	43895-43896	:	_	
206-239	43897-43902	35.69	_	
206-240	43902-43903	)	_	
206-241	43906-43909	MCT	_	
206-242	43910-43911		_	
206-243	43912-43916	Core	_	
206-244	43917-43923	reward	_	
206-245	43924-43927	and	_	
206-246	43928-43939	Attentional	_	
206-247	43940-43948	salience	_	
206-248	43949-43953	0.07	_	
206-249	43954-43955		_	
206-250	43955-43959	0.37	_	
206-251	43959-43960	*	_	
206-252	43961-43962		_	
206-253	43962-43966	2.30	_	
206-254	43966-43967	*	_	
206-255	43968-43969		_	
206-256	43969-43973	1.45	_	
206-257	43974-43975	(	_	
206-258	43975-43976		_	
206-259	43976-43980	3.00	_	
206-260	43980-43981	:	_	
206-261	43982-43983		_	
206-262	43983-43987	0.21	_	
206-263	43987-43988	)	_	
206-264	43992-43996	Note	_	
206-265	43996-43997	:	_	
206-266	43998-43999	p	_	
206-267	43999-44000	<	_	
206-268	44000-44003	.05	_	
206-269	44003-44004	,	_	
206-270	44005-44006	p	_	
206-271	44006-44007	<	_	
206-272	44007-44010	.01	_	
206-273	44010-44011	,	_	
206-274	44012-44013	p	_	
206-275	44013-44014	<	_	
206-276	44014-44018	.001	_	
206-277	44018-44019	;	_	
206-278	44020-44024	rsFC	_	
206-279	44024-44025	=	_	
206-280	44025-44032	resting	_	
206-281	44033-44038	state	_	
206-282	44039-44049	functional	_	
206-283	44050-44062	connectivity	_	
206-284	44063-44073	Highlights	_	
206-285	44074-44084	Functional	_	
206-286	44085-44092	changes	_	
206-287	44093-44095	in	_	
206-288	44096-44102	reward	_	
206-289	44103-44106	and	_	
206-290	44107-44116	executive	_	
206-291	44117-44122	brain	_	
206-292	44123-44132	circuitry	_	
206-293	44133-44138	occur	_	
206-294	44139-44141	in	_	
206-295	44142-44151	addiction	_	
206-296	44152-44165	Resting-state	_	
206-297	44166-44178	connectivity	_	
206-298	44179-44182	was	_	
206-299	44183-44190	related	_	
206-300	44191-44193	to	_	
206-301	44194-44205	risk-taking	_	
206-302	44206-44216	propensity	_	
206-303	44217-44220	for	_	
206-304	44221-44228	cocaine	_	
206-305	44229-44234	users	_	
206-306	44235-44248	Resting-state	_	
206-307	44249-44261	connectivity	_	
206-308	44262-44265	was	_	
206-309	44266-44273	related	_	
206-310	44274-44276	to	_	
206-311	44277-44282	delay	_	
206-312	44283-44294	discounting	_	
206-313	44295-44298	for	_	
206-314	44299-44307	controls	_	
